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Abstract
The versatile Escherichia coli facilitates protein expression with relative simplicity, high cell 
density on inexpensive substrates, well known genetics, variety of expression vectors, mutant 
strains, co-overexpression technology, extracytoplasmic secretion systems, and recombinant 
protein fusion partners. Although, the protocol is rather simple for soluble proteins, 
heterologous protein expression is frequently encountered by major technical limitations 
including inefficient translation, formation of insoluble inclusion bodies, lack of
posttranslational modification mechanisms, degradation by host proteases, and impaired cell 
physiology due to host/protein toxicity, in achieving functional expression of stable, soluble,
and bioactive protein.. In this thesis, model protein expression systems are used to address 
the technical issues for enhancing recombinant protein expression in E. coli.
When yellow fluorescence protein (YFP) was displayed on E. coli cell surface, the 
integrity of the cell envelope was compromised and cell physiology was severely impaired, 
resulting in poor display performance, which was restored by the coexpression of Skp, a 
periplasmic chaperone. On the basis of monitoring the promoter activities of degP, rpoH, and 
cpxP under various culture conditions, it was demonstrated that the cell-surface display 
induced the σE extracytoplasmic stress response, and PdegP::lacZ was proposed to be a 
suitable “sensor” for monitoring extracytoplasmic stress.
Intracellular proteolysis has been recognized as one of the key factors limiting 
recombinant protein production, particularly for eukaryotic proteins heterologously 
expressed in the prokaryotic expression systems of E. coli. Two amino acids, Leu149 and 
Val223, were identified as proteolytically sensitive when Pseudozyma antarctica lipase 
(PalB) was heterologously expressed in Escherichia coli. The functional expression was 
enhanced using the double mutant for cultivation. However, the recombinant protein 
production was still limited by PalB misfolding, which was resolved by DsbA coexpression.
The study offers an alternative genetic strategy in molecular manipulation to enhance 
recombinant protein production in E. coli.
To overcome the technical limitations of protein misfolding, ineffective disulfide 
bond formation, and protein instability associated with intracellular proteolysis in the 
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functional expression of recombinant Pseudozyma antarctica lipase B (PalB) in Escherichia 
coli, an alternative approach was explored by extracellular secretion of PalB via two Sec-
independent secretion systems, i.e. the α-hemolysin (Type I) and the modified flagellar (Type 
III) secretion systems, which can export proteins of interest from the cytoplasm directly to 
the exterior of the cell. Bioactive PalB was expressed and secreted extracellularly either as 
HlyA fusion (i.e. PalB-HlyA via Type I system) or an intact protein (via Type III system)
with minimum impact on cell physiology. However, the secretion intermediates in the 
intracellular fraction of culture samples were non-bioactive even though they were soluble, 
suggesting that the extracellular secretion did mediate the development of PalB activity. PalB 
secretion via Type I system was fast with higher specific PalB activities but poor cell growth. 
On the other hand, the secretion via Type III system was slow with lower specific PalB 
activities but effective cell growth. 
Functional expression of lipase from Burkholderia sp. C20 (Lip) in various cellular 
compartments of Escherichia coli was explored. The poor expression in the cytoplasm was 
improved by several strategies, including coexpression of the cytoplasmic chaperone 
GroEL/ES, using a mutant E. coli host strain with an oxidative cytoplasm, and protein fusion 
technology. Fusing Lip with the N-terminal peptide tags of T7PK, DsbA, and DsbC was 
effective in boosting the solubility and biological activity. Non-fused Lip or Lip fusions 
heterologously expressed in the periplasm formed insoluble aggregates with a minimum 
activity. Biologically active and intact Lip was obtained upon the secretion into the 
extracellular medium using the native signal peptide and the expression performance was 
further improved by coexpression of the periplasmic chaperon Skp. The extracellular 
expression was even more effective when Lip was secreted as a Lip-HlyA fusion via the α-
hemolysin transporter. Finally, Lip could be functionally displayed on the E. coli cell surface 
when fused with the carrier EstA.
Keywords: Escherichia coli, recombinant protein expression, YFP, lipase, cell-surface 
display, protein secretion, inclusion bodies, proteolysis, mutagenesis, chaperone, fusion tags, 
cell physiology, stress pathways.
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Figure 2.1 Schematic presentation of the salient features and sequence elements of a 
prokaryotic expression vector. Shown as an example, is the hybrid tac promoter 
(P) consisting of the 235 and 210 sequences, which are separated by a 17-base 
spacer. The arrow indicates the direction of transcription. The RBS consists of the 
SD sequence followed by an A1T-rich translational spacer that has an optimal 
length of approximately 8 bases. The SD sequence interacts with the 39 end of the 
16S rRNA during translational initiation, as shown. The three start codons are 
shown, along with the frequency of their usage in E. coli. Among the three stop 
codons, UAA followed by U is the most efficient translational termination 
sequence in E. coli. The repressor is encoded by a regulatory gene (R), which may 
be present on the vector itself or may be integrated in the host chromosome, and it 
modulates the activity of the promoter. The transcription terminator (TT) serves to 
stabilize the mRNA and the vector, as explained in the text. In addition, an 
antibiotic resistance gene, e.g., for tetracycline, facilitates phenotypic selection of 
the vector, and the origin of replication (Ori) determines the vector copy number 
(171). ........................................................................................................................ 9
Figure 2.2 Cell surface display systems in gram negative bacteria (a) surface display systems 
(b) cell surface display using ice nucleation protein (INP) (c) surface display using 
E. coli OmpC (159). ............................................................................................... 15
Figure 2.3 Chaperone assisted protein folding in the cytoplasm of E. coli Trigger factor (TF) 
and DnaK/J engage solvent exposed hydrophobic amino acids of nascent 
polypeptides to shield them from both solvent and each other. The polypeptides 
released from TF or GrpE mediated DnaK/J release, either they attain a native 
conformation, recycles to DnaK/J, or transfers to the GroEL/ES chamber for 
folding at infinite dilution. In times of stress (red arrows), thermolabile proteins 
unfold and aggregate. IbpB binds partially folded proteins on its surface to serve as 
a reservoir of unfolded intermediates until folding chaperones become available 
and intercalates within large aggregates. The holding chaperones Hsp33 and Hsp31 
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become important under oxidative and severe thermal stress, respectively. ClpB 
promotes the shearing and disaggregation of thermally unfolded host proteins and 
cooperates with DnaK-DnaJ-GrpE to reactivate them once stress has abated. 
Recombinant proteins that miss an early interaction with TF or DnaK/DnaJ, that 
undergo multiple cycles of abortive interactions with folding chaperones or titrate 
them out, accumulate in inclusion bodies (green arrows) (15). ............................. 18
Figure 2.4 Export and periplasmic folding pathways. Proteins destined for export can be 
translocated across the inner membrane in three different fashions. (A) Preproteins 
with highly nonpolar signal sequences (green) or transmembrane segments of inner 
membrane proteins are recognized by SRP which, along with TF, scans nascent 
chains. SRP-dependent export involves delivery of the ribosome-nascent chain 
complex to FtsY and subsequent translocation through the SecYEG-SecDFYajC 
translocon. (B) The vast majority of preproteins have less hydrophobic signal 
sequence (lavender) and undergo Sec-dependent export. TF associates with the 
nascent polypeptide, halting cotranslational folding. As the chain grows, TF 
dissociates and the polypeptide is transferred to SecB or DnaK that maintain it in 
an extended conformation. Delivery to SecA and ATP-dependent translocation 
through SecYEG completes the process. (C) Preproteins with signal sequences 
containing the twin-arginine motif (cyan) are exported via the Tat-dependent 
pathway in a folded form. After cleavage of the signal sequence, partially folded 
periplasmic proteins may aggregate (1), undergo proteolysis (2) or reach a native 
conformation, possibly with the assistance of folding modulators (3). Cysteine 
pairs in proteins containing disulfide bonds are oxidized by DsbA (4) whereas 
incorrect disulfides are isomerized by DsbC (5). These oxidoreductases are 
reactivated by DsbB and DsbD, respectively. Black arrows show products obtained 
after each step, whereas blue arrows represent electron flow (15). ....................... 21
Figure 2.5 Schematic representation of the pathway from protein expression to purification 
using solubility tags. Four arbitrary tagged versions of the protein of interest are 
generated in E. coli. (A) After expression, some fusions will remain in the 
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insoluble fraction and be lost from the pathway. (B) Soluble fusions are purified by 
IMAC (immobilized metal affinity chromatography) using the attached His6 tag. A 
protease is then used to cleave the fusion tag from the partner protein. (C) Some 
fusions will not cleave efficiently, and will leave behind a mixture of cleaved and 
uncleaved proteins that cannot be easily separated. (D) Other fusions will cleave 
efficiently, but when separated from the solubility tag the partner protein will 
become insoluble and precipitate. (E) However, a well-behaved fusion will remain 
in solution and can be purified by a second IMAC step to remove the His6-tagged 
solubility tag and protease, leaving only the target protein in the flow through 
(IMAC FT) (76)...................................................................................................... 26
Figure 3.1 Result of TEM for immunogold labeling of displayed YFP on E. coli cell surface. 
The black dots represent the gold particles conjugated with the displayed YFP. 
Panel A/ JM109; Panel B/ JM109 (pESTKnYFP) induced with 0.1 mM IPTG.... 41
Figure 3.2 Characterization of YFP display on E. coli cell surface using JM109 
(pESTKnYFP) as the displaying host/vector system under various culture 
conditions. Panel A/ trypsin digestion; Panel B/ EDTA-sensitivity test; Panel C/ 
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insoluble fraction, 0.1 mM IPTG. The soluble fractions were also analyzed without 
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Figure 3.4 Result of TEM for immunogold labeling of displayed YFP on E. coli cell surface 
using JM109 (pESTKnYFP, pARSkp) as the displaying host/vector system. The 
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surface display using JM109 (pESTKnYFP, pARSkp) as the displaying host/vector 
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with a potential lipase gene (NCBI accession number YP_002233567) identified 
from the genomic sequence of Burkholderia cenocepacia J2315. Further DNA 
sequence analysis of the two ORFs showed 100% similarity (4 nucleotides being 
different and no gap), confirming the missing of a ‘STOP’ codon in the original 
PCR product of lip (1-6). Lipase genes from other Burkholderia sp. shared 70% to 
96% sequence identity with lip (1-6). It may be noted that lip (1-6) shared only 
92% and 93% sequence similarity to two other species of Burkholderia 
cenocepacia. The arrow represents the predicted cleavage site associated with the 
signal peptide (40 amino acids) using the SignalP 3.0 server 
(www.cbs.dtu.dk/services/SignalP/). However, the extracellular lipase purified 
from Burkholderia sp. HY-10 (215) was determined to have the N-terminal amino 
acid sequence of ‘ADTYAATRYPIILVHGLTGTDKYAG’ which is similar to the 
underlined amino acid sequence of ‘ADDYATTRYPIILVHGLTGTDKYAG’. 
This was determined as the N-terminal sequence of mature Lip for the subsequent 
cloning of the lip gene without its native signal peptide coding sequence (ll-lip).
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The term “genetic engineering” was first coined in Jack Williamson’s science fiction novel 
Dragon’s Island in 1951, about two years prior to James Watson and Francis Crick 
discovered that ‘the double helix DNA is the secret of life’; the medium for transmission of 
genetic information. The 1960s witnessed the “Green Revolution” when genetically 
improved seed was developed to meet food production targets in economically backward 
countries and earned the originator, Norman Borlaug, the Nobel Prize in 1970. Along with 
“recombinant DNA technology”, biotechnology has impacted all aspects of modern society 
in the twenty-first century including food, agriculture, health/medicine, pharmaceuticals, 
alternative bio-fuel sources, industrial enzymes, biodegradation and bioremediation, 
cosmetics, biosensors, bioinformatics, and advancement of knowledge. It has enabled 
scientists to extract and transfer specific genes from one species and overproduce in another 
host. Among the various expression systems such as yeast, insects, bacteria, and mammalian 
cells, the gram negative bacterium E. coli still remains as the most popular host for high level 
production of recombinant proteins from both prokaryotic and eukaryotic sources due to its 
many advantages (93, 173, 206). The past 25 years have seen enormous progress in the 
understanding of recombinant protein expression in E. coli including vast number of cloning 
vectors and mutant strains, improving mRNA stability, codon-optimization, coexpression of 
chaperones, post-translational modifications, use of secretory pathways, minimizing 
including bodies, improving solubility, and decreasing proteolysis (171).
Studies in our lab have focused on enhancing the functional expression of 
recombinant proteins in E. coli. While most of the proteins are expressed in the cytoplasm, 
extracytoplasmic expression such as periplasm, outer membrane, and extracellular medium 
can offer several advantages and the related technical issues have been emphasized (57). 
Penicillin acylase (PAC), the hetero-dimeric periplasmic protein with a unique 
posttranslational pathway (164) that formed insoluble inclusion bodies when expressed in E. 
coli (259), served as a model system, demonstrated that DegP, a periplasmic heat shock 
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protease with chaperone function at lower temperatures significantly improves pac
expression (162). Not only did its coexpression reduce the inclusion body formation, but it 
also improved the cell growth and the PAC activities significantly (196, 214). It was also 
discovered that arabinose-induction of lac derived promoters for pac expression significantly 
reduced the inclusion bodies, enhanced cell growth and improved PAC activities (195).
Microbial cell-surface display has been extensively explored due to its significant 
impact on various biotechnological and industrial applications, such as vaccine development, 
biosensor design, high-throughput screening of macromolecular libraries, and preparation of 
whole-cell biocatalysts (20, 159). The passenger protein is often expressed as a fusion with a 
carrier protein that serves as an anchoring motif on the outer membrane. Several studies have 
reported the use of various carrier domains, including lipoproteins, outer membrane proteins, 
autotransporters, porins, fimbria and flagella proteins, S-layer proteins, etc. (260). Up to now, 
most studies relevant to microbial cell-surface display focused on discovering novel carrier 
systems; however, another critical issue limiting display performance is physiological impact 
on the growing cells, has been seldom addressed. Cells with a high-level display tend to 
activate the extracytoplasmic stress pathways (2, 4, 232, 240) that sense and respond to 
perturbations within the cell envelope. The issue of concern is, how best to deal with this 
problem.
Any protein is rarely enriched when produced in the natural host; recombinant protein 
overproduction is frequently the sole applicable procedure. PalB (Lipase B from Pseudozyma 
antarctica previously known as Candida antarctica) is the most popular among the available 
lipases due to its interesting properties and important applications in organic synthesis and 
biotechnology (145). Our interest in PalB arises from its potential for biotransformation as 
opposed to chemical conversion of vegetable oils for biodiesel production. Previously PalB 
was produced in the heterologous hosts such as Aspergillus oryzae (122), Pichia pastoris 
(237), and Saccharomyces cerevisiae (313). Recent studies identified the disulfide bond 
formation as a serious impediment to producing bioactive PalB in E. coli cytoplasm. Though 
this issue was overcome by using the trxB mutant strain of E. coli (Origami) and N-terminal 
fusion tags, technical limitations related to protein aggregation, and impaired cell physiology 
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still prevailed. Furthermore, PalB was extremely unstable and highly susceptible to 
proteolysis when targeted to in the periplasm; the E. coli compartment with oxidizing
environment that favors disulfide bond formation. Although periplasm has fewer proteases 
than cytoplasm, proteolytic degradation is substantial and usually a major impediment to 
heterologous protein expression in E. coli. The functional expression of bioactive PalB 
resistant to proteolysis in E. coli is a major challenge for improving the bioprocess for 
recombinant PalB production.
PalB is an extracellular enzyme produced in Pseudozyma antarctica with three 
intermolecular disulfide bonds that determine the development of protein structure and 
bioactivity (287). The gram negative bacterium E. coli has very few mechanisms for 
extracellular secretion of proteins. Type I secretion system, known as the ABC transporter, 
secretes E. coli toxins and exoenzymes via a one-step process across both the cytoplasmic 
and outer membranes without a periplasmic intermediate (24). On the other hand, Type III 
secretion system represents a specific mechanism associated with the secretion of 
pathogenesis factors or flagellar proteins from the cytoplasm, bypassing the periplasm, 
directly to the exterior of the bacteria (278). Methodological approaches have also been 
developed to secrete periplasmic proteins to the culture supernatant of E. coli. They include 
(1) the use of leaky mutant host strains (233) and cell-wall-less L-form E. coli (105), (2) 
chemical or biochemical permeabilization of outer membrane (52, 251), and (3) coexpression 
of protein release factors such as bacteriocin release protein (BRP) (288), colicin E1 lysis 
protein (Kil), tolAIII and out genes (294). Given the technical limitations of intracellular 
production of PalB, its extracellular secretion appears to be a plausible exploration. Specific 
secretion of the foreign gene products to the extracellular medium also provides significant 
advantages in terms of least proteolysis, improved disulfide bond formation and protein 
folding, enhanced protein stability, and simpler downstream processing.
Lipases from Burkholderia are interesting enzymes due to their fine characteristics of 
thermal stability, alkaline pH and organic solvent tolerance, high activity for various 
substrates, and transesterification activity (215). However studies on overexpression of 
Burkholderia lipase are very rare in literature. Lipase gene in Burkholderia is described to be 
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present in an operon along with its lipase-specific foldase (Lif) (228). Attempts to express 
Burkholderia lipase in E. coli resulted in very low amounts of active soluble lipase, with the 
protein recovered as aggregates despite the coproduction of Lif. Active enzyme was 
recovered only by in vitro folding. Another study reported the expression of lipase in the 
form of inclusion bodies and the soluble protein variants were obtained by mutagenesis 
(104). The functional expression of Burkholderia Lip using various strategies available for 
heterologous protein expression in E. coli is worth exploring to identify the factors limiting 
its functional expression.
1.2 Research Objectives
The overall objectives of this thesis are as follows:
i. Investigation of the cell physiology and culture performance for E. coli cell-surface 
display by manipulation of a periplasmic chaperone Skp. Quantification of 
extracytoplasmic stress using lacZ reporter gene fusions with the promoters of degP, 
cpxP, and rpoH.
ii. Isolation of a stable PalB variant against intracellular proteolysis for improvement of 
protein production bioprocess.
iii. Functional expression of PalB by extracellular secretion to circumvent the limitations 
of intracellular misfolding and proteolysis.
iv. Exploration and systematic study of various strategies of heterologous protein 
expression in E. coli for achieving functional expression of lipase (Lip) from 
Burkholderia sp. C20.
1.3 Outline of the Thesis
This thesis consists of four manuscripts preceded by an introduction, literature review, and 
followed by conclusions. The scope of each chapter is listed as follows:
Chapter 1 gives an introduction to the thesis, including an overview of recombinant 
protein expression systems used in this thesis and the technical limitations. The hypothesis, 
objectives and the scope of the thesis are also given in this chapter.
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Chapter 2 reviews the previous progress on understanding recombinant protein 
production in E. coli, including gene expression systems, regulation at transcriptional and 
translational levels, targeting the gene to different compartments, protein folding and role of 
molecular chaperones, stress regulatory pathways, fusion protein technology, and optimal 
cultivation conditions for high-level protein production. A brief introduction to the proteins 
used as model systems in this research is also given in this chapter.
Chapter 3 investigates the physiological impact and culture performance of yellow 
fluorescent protein (YFP) cell-surface display in E. coli, the effect of coexpression of the 
periplasmic chaperone Skp, and the associated extracytoplasmic stress using lacZ reporter 
gene.
Chapter 4 describes the isolation of a stable PalB mutant resistant to intracellular 
proteolysis, the effect of DsbA chaperone coexpression in minimizing inclusion bodies, 
improving solubility, and bioactivity of the overexpressed protein.
Chapter 5 presents the characterization of extracellular secretion of PalB using the 
Type I α-hemolysin transporter, and the Type III modified flagellar apparatus. Soluble and 
bioactive PalB was secreted to the culture supernatant with minimum contamination from 
host proteins, while minimizing the effect of proteolysis, and having a negligible impact on 
cell physiology.
Chapter 6 describes the construction of Burkholderia Lip expression vectors and 
presents a systematic study of its expression in E. coli. The effect of targeting lip gene to 
various compartments, coexpression of folding factors, and fusions with soluble tags are 
investigated.
Chapter 7 presents the conclusions of this study, contributions of this research, and 




Heterologous protein expression has had a great impact on industrial applications, medicine 
and research. Earlier, the protein was isolated from their natural sources with low yields due 
to loss of protein and/or activity during complex purification steps and low expression levels 
in native organism, making them expensive and unattractive for large-scale applications.  
Itakura et al. reported the first heterologous production of a protein, a small peptide 
somatostatin (14 amino acids) in 1977 in Escherichia coli (129). The possibility to isolate the 
desired gene, overexpress in a heterologous host, and purify the pure protein has paved the 
way to investigate protein-protein interactions, enzyme kinetics, functional assays, structural 
analysis including crystallization, protein structure and NMR, antibody generation, and large 
scale production of biocatalysts and therapeutic proteins etc. The choice of an expression 
system for recombinant protein production depends on many factors including cell growth 
characteristics, gene expression levels, posttranslational modifications, regulatory issues 
concerning therapeutic proteins, process, design, scalability and other economic 
considerations (63), (121, 248). Among the various expression systems such as yeast, 
bacteria, insects, and mammalian cells; Escherichia coli still retains its popularity as the most 
versatile host because of its widely characterized genome, availability of an increasingly 
large number of cloning vectors, and mutant strains, its ability to grow rapidly, and reach
high density on inexpensive substrates (270), (173), (93). This was demonstrated first by Ely 
Lilly’s rDNA insulin, then by Monsanto’s bovine growth hormone (bGH). Iin spite of the 
extensive knowledge on recombinant protein production in E. coli, not every gene can be 
expressed in this organism. This may be due to the subtle features in the gene sequence, 
translational efficiency and stability of mRNA, misfolding and degradation of the protein by 
host proteases, host/protein toxicity, inability for posttranslational modifications required for 
eukaryotic proteins, limitations to facilitate extensive disulfide bond formation, and lack of 
proper secretion mechanisms for the efficient release of protein to the extracellular medium. 
Nevertheless, various strategies have been developed by researchers in the past for gene 
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expression in E. coli, including regulation at transcriptional and/or translational level, 
targeting the proteins to different compartments, protein folding and coexpression of 
molecular chaperones, misfolding and degradation within the cell, use of solubility 
enhancing fusion tags, and optimization of fermentation conditions. However, no strategy 
‘fits all’. Every protein is unique, various strategies are tailored together to achieve maximal 
production of bioactive protein without affecting the physiology of the growing cells.
2.1 Transcriptional and Translational Regulation
The typical prokaryotic expression vector (represented in Figure 1) consists of an inducible 
promoter, ribosome binding site, Shine Dalgarno sequence (SD), target gene, transcription 
terminator, a replication origin that determines the plasmid copy number, and an antibiotic 
resistance marker for plasmid selection and propagation. Depending on the application, the 
cDNA may be cloned into plasmids with 15-60 (pMB1/ColE1) copies to a few hundred 
copies per cell (pUC origin). The coexpression plasmids are selected for compatibility, for 
e.g. ColE1 derived plasmids combined with plasmids with p15A replicon (12). A strong 
tightly regulated promoter that can be induced in a simple and cost effective manner is 
usually desired to achieve high level protein synthesis. A promoter is a sequence of 
nucleotides that contains signals for the proper binding and subsequent activation of RNA 
polymerase to a form, capable of initiating the synthesis of RNA. Within or immediately 
adjacent to the promoter, there is an additional sequence of DNA sequence for the specific 
binding of repressor or activator proteins that can modulate the activity of the promoter. The 
gene of interest may be expressed under the control of such a regulatory element within the 
cell (118). When a promoter is used for high level protein expression in E. coli, it should be 
able to accumulate protein within the cell upto about 30% of the total cellular proteins. For 
large scale production, the cells should be able to grow to a high cell density. Tightly 
regulated promoters are used for expressing proteins that are toxic to the host cell. The 
overexpressed genes may result in misfolding of the proteins, decrease the cell growth rate, 
cause cell lysis, and result in the loss of the recombinant protein production. 
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For many years, E. coli lactose utilization operon discovered by Jacob and Monod in 
1964 has been the example of prokaryotic regulation. Therefore lac based promoters have 
been used extensively for the production of heterologous proteins in E. coli. Lactose is the 
natural inducer for lac derived promoter systems. Lactose after transglycosylation gets 
converted to allolactose which binds to the lac repressor to cause induction of the promoter. 
However it cannot be used in lacY- or lacZ- cells, where it cannot be transported into the cell 
or be converted to allolactose respectively. The strong induction by isopropyl-β-D-
thiogalactopyranoside (IPTG) for the (lac and trp) hybrid promoters tac (29) or trc (36) are 
widely used for basic research (Figure 2.1). However, the use of IPTG for the large-scale 
production of human therapeutic proteins is undesirable because of its toxicity (81) and cost. 
The lacI(Ts) gene encodes a thermosensitive lac repressor (1). Two different lac repressor 
mutants that are thermosensitive as well as IPTG inducible have also been reported (296). 
The activity of the phage pL promoter, a cold response promoter is found to be highest at 20 
°C, and declines as the temperature is raised (92). The promoter of the major cold shock gene 
cspA is also active at reduced temperatures (95). However these promoters can induce several 
heat shock and cold shock proteins within the cell. Still the most widely used promoters for 
large-scale protein production use thermal induction (pL) or chemical inducers (trp).When 
cold response promoters are used, protein folding will be only slightly affected at about 15 to 
20 °C, whereas the rates of transcription and translation will be substantially decreased. This 
in turn, will provide sufficient time for protein refolding, yielding active proteins, and 
avoiding the formation of inclusion bodies (209). The pH promoter has been reported to be 
very strong for recombinant proteins produced at levels of up to 40 to 50% of the total 
cellular protein and is another attractive option for high level gene expression (53). However 
this might be just atypical as protein synthesis depends on several other factors other than 
promoter strength.
Another lac derived promoter system is the pET vector system. Here the T7 RNA 
polymerase is under the control of the prophage (λDE3) encoding the IPTG-inducible lac
UV5 promoter (272). A single copy of RNA polymerase within the cell is sufficient for gene 
expression. However there are certain limitations. In many cases the overproduced protein 
9
cannot reach a biologically active conformation and tends to form insoluble inclusion bodies. 
In other cases high level of mRNA can be toxic to the cell. The leaky expression by T7 RNA 
polymerase may result in expression instability (266). The phoA promoter is induced by 
limitation of phosphate in the medium (187) and the trp promoter by the limitation of 
tryptophan (273). The araBAD (or PBAD) promoter is induced by the sugar L-arabinose. 
Although it is considered to be weaker than tac or trc promoter, in many cases it has been 
found to be better suited for protein overexpression (107). The PBAD promoter is usually 
characterized by fast induction, modulated induction, and tight repression by AraC. The tet
promoter is another system with very tight transcriptional regulation under the control of tet
repressor and convenient chemical induction by tetracycline or anhydrotetracycline (282). In 
this case the problems with host type genotype or influence of glucose through catabolite 
repression is avoided.
Figure 2.1 Schematic presentation of the salient features and sequence elements of a 
prokaryotic expression vector. Shown as an example, is the hybrid tac promoter (P) 
consisting of the 235 and 210 sequences, which are separated by a 17-base spacer. The 
arrow indicates the direction of transcription. The RBS consists of the SD sequence 
followed by an A1T-rich translational spacer that has an optimal length of 
approximately 8 bases. The SD sequence interacts with the 39 end of the 16S rRNA 
during translational initiation, as shown. The three start codons are shown, along with 
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the frequency of their usage in E. coli. Among the three stop codons, UAA followed by 
U is the most efficient translational termination sequence in E. coli. The repressor is 
encoded by a regulatory gene (R), which may be present on the vector itself or may be 
integrated in the host chromosome, and it modulates the activity of the promoter. The 
transcription terminator (TT) serves to stabilize the mRNA and the vector, as explained 
in the text. In addition, an antibiotic resistance gene, e.g., for tetracycline, facilitates 
phenotypic selection of the vector, and the origin of replication (Ori) determines the 
vector copy number (171).
Differences in the translation efficiencies of different mRNAs predominantly depend 
on the 5´end of the mRNA species. However there is no universal sequence for the efficient 
initiation of translation, nevertheless general guidelines have been suggested. Initiation of 
translation requires a Shine Dalgarno sequence of consensus 5´-UAAGGAGG-3´ (250)
complementary to the 3´ end of 16S rRNA, followed by an initiation codon. The most 
common and efficient one (two to three folds) is the AUG codon followed by GUG (8%), 
and rarely UUG (262) and AUU (41). Several translational enhancer sequences that 
markedly improve the expression of heterologous genes have been identified in the past. The 
g-10L sequence compared to the SD sequence caused a 40 to 340 fold increase in the 
expression of several genes (205). When placed upstream of SD for overexpression of lacZ, 
β-galactosidase activity increased by 110 folds (207). U-rich sequences upstream of 5´ 
untranslated region acted as translation enhancers for the expression of the E. coli atpE gene 
(177), human interleukin-2, human interferon beta (243), and RNaseD (312).  An interesting 
study by Sprengart et al. (258) demonstrated that sequences termed the downbox (DB), 
immediately downstream of the start codon also play an important role in the translation.  
Thus, in addition to the SD sequence and the start codon, other sequences in the mRNA also 
affect the translational efficiency. The mRNA stability can affect expression rates.  RNase E, 
RNase K, RNase II, RNase III, and polynucleotide phosphorylase (PNPase) are the common 
enzymes identified to participate in mRNA degradation (19). 5´ UTR regions of mRNAs (16)
and the stem-loop structures from the 3´ UTRs and intercistronic regions (117) are known to 
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stabilize mRNAs in E. coli. The 5´ UTR of ompA prolonged the half-life of a number of 
heterologous mRNAs. Wong and Chang demonstrated that the addition of 3´ UTR regions 
that can form stem loop structures to penicillinase (penP) and the human interleukin cDNA,
increased the half life of the mRNAs and enhanced the production of the corresponding 
polypeptides. They also suggested that gene expression might be enhanced by the use of host 
strains deficient in specific RNases, however mutant strains were often inviable (70).
2.2 Expressing Genes in Different E. coli Compartments
2.2.1 Cytoplasmic Expression
For most applications, it is desirable to achieve maximal production of the target protein in 
the cytoplasm where the nascent polypeptides are first synthesized, problems related to the 
formation of insoluble inclusion bodies is a significant barrier in the expression of genes in 
the cytoplasm. However the inclusion bodies offer certain advantages (50) as they facilitate 
the isolation of protein in high purity and concentration for refolding in vitro (239); the target 
protein is also protected from the proteases in the host. Proteins that are toxic to the cell when 
in the active form can also be produced first as inclusion bodies and then refolded separately 
(115). However, the protein folding in vitro is an arduous task and therefore not an attractive 
alternative. It is also not certain if the refolded protein would be able to regain its biological 
activity. The inclusion body formation of human T-cell receptor has been modeled on the 
parameters: charge average, total number of residues, turn forming residues, cysteine and 
proline fraction (1). 
Several strategies have been developed to minimize the formation of inclusion bodies 
in the cytoplasm. The most common approach is to reduce cultivation temperature during 
fermentation (244) thereby reducing the rate of transcription and translation. This also 
reduces the hydrophobic interactions that are responsible for protein misfolding. Several 
alternative to this end have been investigated; 1) using a cold inducible promoter (209), 2)
selection of suitable host strain (142), 3), supplementation of non-metabolizable sugars for 
improving the protein solubility (32), 4) alteration of pH (268) etc. The reducing 
environment of E. coli still poses a grave problem; the best example is of the protein alkaline 
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phosphatase which is active only in the periplasm (67). However the disulfide bonds can now 
be formed in the cytoplasm of a trxB mutant E. coli strain (68). These mutations inactivate 
the trxB gene that encodes thioredoxin reductase which contributes to the sulfhydril reducing 
potential of the cytoplasm (11). In a recent study from our lab, it was demonstrated that the 
Pseudozyma antarctica lipase B (PalB) was functionally expressed only in the cytoplasm of 
trxB and gor mutant E. coli strains Origami B(DE3) or by the coexpression of the disulfide 
bond chaperone DsbA, whereas it folded through the non productive pathway to form 
insoluble aggregates in the cytoplasmic expression of wild-type E. coli (305).
Any protein when expressed in the cytoplasm requires an initiation codon AUG (for 
Methionine). Although this extra amino acid might not affect the protein synthesized, but 
there are specific cases in which the extra Methionine had profound consequences. For 
example, the conformation of human hemoglobin is altered by an N-terminal Methionine 
residue (141). Moreover, the immunological properties of pharmaceutical proteins may 
change due to the presence of an extra amino acid residue. The coexpression of Methionine 
aminopeptidase that can remove the N-terminal Methionine is an alternative (119). Finally, 
the purification of recombinant protein from some 3000 gene pool (271) of intracellular 
proteins is another arduous task. 
2.2.2 Protein Targeting to Periplasm
In contrast to the cytoplasm, the periplasm offers several advantages for protein targeting. 
The oxidising environment of the periplasm that contains Dsb-enzymes catalyzing the 
formation of disulfide bonds facilitates the proper folding of the proteins, and the protein 
degradation in the periplasm is also less extensive (269). Only 5 % of the total cellular 
proteins are present in the periplasm (200); therefore  the recombinant protein can be 
efficiently concentrated and the purification is considerably less difficult. All the periplasmic 
proteins in E. coli require the secretion of their corresponding precursors across the 
cytoplasmic membrane mediated by a signal sequence. A wide variety of signal peptides, 
such as PelB (22), PhoA (281), OmpA (302), and SpA (189), have been adopted successfully 
as a genetic strategy to secrete recombinant proteins for expression in the periplasm or outer 
membrane of E. coli. The transport of proteins to the bacterial periplasm is an incompletely 
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understood process and the presence of a signal peptide does not always ensure efficient 
protein translocation through the inner membrane. For example, despite the correct cleavage 
of the signal peptide the T-cell receptor protein could not be detected in the periplasm (202). 
Coexpression of the periplasmic transport components like signal peptidase I (289), secE, 
and prlA4 genes (222), and use of prlF mutant strains (256) are certain strategies for 
improving the translocation of proteins. 
2.2.3 Extracellular Secretion
Secretion of recombinant proteins to the extracellular medium of E. coli has several 
advantages over intracellular expression. They include simpler downstream processing and 
purification, least proteolysis, improved protein folding and disulfide bond formation in the 
oxidizing environment outside the cell, enhanced solubility and bioactivity of the secreted 
protein, and N-terminus authenticity of the expressed polypeptide. Unfortunately very few 
proteins are secreted from E. coli due to the barrier from the outer membrane. The known 
secretion pathways in gram negative bacteria are Type I, II, III, IV, and V with varying 
mechanisms. The Type I, II, and III mechanisms are most commonly used in E. coli for 
secretion of toxins, degradative enzymes, and pathogenicity factors to the exterior of the cell. 
The Type II secretion system is the commonly known Sec-dependant translocation of 
the proteins from the cytoplasm across the inner membrane to the cell envelope. This class 
includes most of the periplasmic and outer membrane proteins that are synthesized as a 
propeptide in the cytoplasm with a cleavable signal peptide (discussed in periplasmic 
expression of proteins). Genetic strategies have been developed in the past to secrete the 
intracellular proteins extracellularly including the use of leaky mutant strains (233) and cell 
wall-less L-form E. coli (105), outer membrane permeabilization by chemical or biochemical 
agents including addition of magnesium, calcium, TritonX, EDTA, and lysozyme 
(enzymatic) (52, 251). Coexpression of protein release factors such as bacteriocin release 
protein (BRP) (288), colicin E1 lysis protein (Kil), tolAIII and out genes (294) have been 
successfully used to secrete recombinant proteins such as penicillin amidase, β-glucanase, β-
lactamase, phytase etc. However this approach leads to contamination by the host proteins 
and often deteriorates the growth of the producing cells. 
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The Type I secretion pathway comprises of the ABC family of transporters that secretes 
E. coli toxins from the cytoplasm to the exterior of the cell bypassing the periplasm with the 
help of ATP. E. coli α-hemolysin transporter is by far the most popular among the several 
Type I family secretion systems. The inner membrane protein HlyD trimer and HlyB form a 
complex with the help from ATP and interact with the outer membrane protein TolC to form 
the export conduit to transport the HlyA toxin/HlyA-fusion protein to the culture supernatant. 
It has been successfully used to secrete heterologous proteins, including single Ig domains 
(28), single chain Fv (79), and Shiga-like toxin Ile (286), that are otherwise hard to express 
intracellularly. Another study reported the modified flagellar apparatus for secretion of 
recombinant proteins including D1-D3 repeats from Staphylococcus aureus, the Peb1 
adhesin from Campylobacter jejuni, α-enolase from Streptococcus pneumonia, and the 
eukaryotic green fluorescent protein (170).
2.2.4 Bacterial Surface Display
Bacterial surface display is becoming an increasingly important research area for creating 
libraries of biomolecules that can be screened for desired properties, antibody production, 
bioadsorbents for removal of harmful chemicals and heavy metals, whole cell biocatalysts, 
vaccines, and biosensors. For a heterologous protein to be displayed on the outer membrane, 
it has be fused to a carrier protein that can insert into the outer membrane of E. coli, and a 
signal peptide that can translocate the fusion protein across the cytoplasmic protein.  The 
passenger protein may be fused with the carrier at the N-terminal, C-terminal, or as a 
sandwich fusion (Figure 2.2). The first example was the display of short gene fragments 
inserted into the genes for the Escherichia coli outer membrane proteins LamB, OmpA and 
PhoE, and the gene fusion products were found to be accessible on the outer surface of the 
recombinant bacteria (159). Since then, not only outer membrane proteins, but also E. coli
lipoproteins Lpp (84, 85) and TraT (45), lipoprotein pullulanase from Klebsiella pneumonia 
(147), E. coli adhesion protein AIDA-I autotransporter (134), EaeA intimin from pathogenic 
E. coli (297), fimbria proteins FimA and FiMH,  and flagellar protein FliC (298), have been 
employed to achieve heterologous surface display on E. coli. Functionally inactive esterase 
from Pseudomonas aeruginosa has been used to display lipases on the cell surface membrane 
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of E. coli (18). The ice nucleation protein from Pseudomonas syringae has been reported to 
accommodate large size heterologous protein for E. coli surface display (135) (150) (161). 
An interesting alternative is described by Hoischen et al. about a novel system that allows the 
display of recombinant proteins Staphylokinase protein on the cytoplasmic membrane using 
the L-form cells of E. coli (124). Cell-surface display has not been useful for high level gene 
expression to date. It has also been associated with deteriorated cell physiology resulting 
from outer membrane perturbation due to insertion of heterologous proteins.
Figure 2.2 Cell surface display systems in gram negative bacteria (A) surface display 
systems (B) cell surface display using ice nucleation protein (INP) (C) surface display 
using E. coli OmpC (159).
2.3 Recombinant Protein Folding and Misfolding
Protein misfolding and degradation are linked as catabolism is linked to anabolism to 
conserve the cellular resources. This process recycles improperly folded proteins into their 





reach its native conformation, premature termination of translation, or by environmental 
stress. To cope with this situation cells have evolved its own mechanism to favour folding of 
a new polypeptide, refold partially folded proteins, dissolve aggregates, and dispose damaged 
proteins. Molecular chaperones are a class of folding modulators that perform such a function 
in the cell (83). They are constitutively expressed in the cell but are sometimes up regulated 
by increase in temperature or other stress to the cell (including heterologous protein 
expression) (123). Therefore they are also referred to as heat shock or stress proteins. The 
mechanism of functioning of a chaperone is to bind to the nonpolar region that is buried 
within the core of a substrate (15). They target on hydrophobic amino acids that have basic 
residues in their vicinity. Therefore, although there is some degree of substrate specificity but 
generally they are less selective.
2.3.1 Folding in the Cytoplasm
The protein folding in the cytoplasm (Figure 2.3) is modulated by three chaperone systems: 
DnaK-DnaJ-GrpE, trigger factor (TF), and GroEL-GroES (112). The trans-conformation of 
peptide-proline (X-Pro) is energetically favoured over the cis-conformation in proteins. 
Therefore this rate limiting trans to cis isomerization is catalyzed by a class of proteins called 
peptydil prolyl isomerase (PPIases). TF is a cytoplasmic PPIase that binds to the ribosomes 
at the peptide exit site and are therefore related in the folding of short nascent chains (219). It 
has been reported that TF overexpression prevents the aggregation of endostatin, human 
oxygen regulated protein ORP150, and human lysozyme (198). However it should be noted 
that TF overproduction can cause cell filamentation. Longer nascent polypeptides are 
captured by DnaK. DnaJ is the cochaperone that ensures tight substrate binding by 
hydrolysing the DnaK bound ATP. The substrate pool for TF and DnaK pften overlap each 
other (69). GrpE catalyzes the substrate ejection by ADP/ATP exchange (153). They may be 
recaptured by DnaK-DnaJ for additional cycles of interaction or may be transferred to the 
GroEL-GroES system. GroEL is a large protein (800 kDa) and binds to both protein 
substrates and GroES. Like DnaK, GroEL favours hydrophobic and basic residues, and the 
trapped protein is able to fold in a hydrophilic environment within the molecule. The process 
does not involve dissolution of preformed recombinant inclusion bodies but is related to 
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improve folding of newly synthesized protein chains (112). However DnaK and GroEL can 
refold protein that can become unfolded by the environmental stress, when assisted by 
another class of chaperones called holdases. IbpA-IbpB, Hsp33 and Hsp31 are the identified 
holdases in E. coli (249). When the cell is under stress, these proteins bind the unfolded 
protein species and once the stress abates, transfer them to DnaK-DnaJ or GroEL-GroES. 
Thus they also prevent overloading on the folding chaperones. In previous studies from our 
lab, the cytoplasmic chaperones trigger factor, DnaK-DnaJ-GrpE, and GroEL-GroES 
individually or their cocktail was coexpressed with penicillin acylase (PAC) in the 
cytoplasm. Trigger factor could both solublize proPAC aggregates and increase PAC 
activity. However PAC activity was not simultaneously increased with proPAC solublization 
when GroEL-GroES or DnaK-DnaJ-GrpE was coexpressed (304). 
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Figure 2.3 Chaperone assisted protein folding in the cytoplasm of E. coli Trigger factor 
(TF) and DnaK/J engage solvent exposed hydrophobic amino acids of nascent 
polypeptides to shield them from both solvent and each other. The polypeptides 
released from TF or GrpE mediated DnaK/J release, either they attain a native 
conformation, recycles to DnaK/J, or transfers to the GroEL/ES chamber for folding at 
infinite dilution. In times of stress (red arrows), thermolabile proteins unfold and 
aggregate. IbpB binds partially folded proteins on its surface to serve as a reservoir of 
unfolded intermediates until folding chaperones become available and intercalates 
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within large aggregates. The holding chaperones Hsp33 and Hsp31 become important 
under oxidative and severe thermal stress, respectively. ClpB promotes the shearing 
and disaggregation of thermally unfolded host proteins and cooperates with DnaK-
DnaJ-GrpE to reactivate them once stress has abated. Recombinant proteins that miss 
an early interaction with TF or DnaK/DnaJ, that undergo multiple cycles of abortive 
interactions with folding chaperones or titrate them out, accumulate in inclusion bodies 
(green arrows) (15).
2.3.2 Periplasmic Folding Modulators
Unlike the cytoplasm, the bacterial periplasm is separated from the medium only by a porous 
membrane and is therefore directly affected by its variation. To date, certain groups of 
proteins are known to be involved in the protein folding in the periplasm. These include 
enzymes for formation and isomerization of disulfide bonds, PPIases, and foldases (Figure 
2.4). The rate limiting disulfide bond formation in the periplasm step (137) is catalyzed by a 
set of thiol disulfide reductases known as Dsb proteins. The DsbA which is maintained in 
oxidised state by the four cysteines in DsbB, transfer the disulfide bond to proteins. DsbC is 
known to correct the incorrect disulfide bonds in the proteins. DsbC is in turn maintained in 
the reduced state by DsbD at the expense of NADH oxidation in the cytoplasm.
DegP/HtrA is an ATP independent protease present in the periplasm. Transcription of 
degP is induced by heat shock and is essential for the survival of bacterial cells above 42 °C. 
However at lower temperatures it switches from protease function to chaperone function 
(257). In another study from our lab, the amount of inclusion bodies of periplasmically 
expressed PAC reduced significantly upon DegP coexpression (196). Not only did 
coexpression of degP improve the PAC activity significantly but it also improved the cell 
physiology by reducing the level of cell lysis, relieving the inhibition of cell growth. Unlike 
DegP, the DegP mutant could not suppress the physiological toxicity caused by PAC
overproduction. Neither could other periplasmic proteases DegQ or DegS had effect in 
reducing the physiological toxicity caused by pac overexpression. When degP was fused to 
lac Z on the λ attachment site of E. coli MC4100, it was expressed upon pac overexpression 
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which suggests that DegP is a heat shock protein induced in response to pac overexpression 
(214). 
The ATP independent Skp captures unfolded proteins when they emerge from the Sec 
translocation apparatus (113). However its primary function is to assist the folding and 
membrane insertion of outer membrane proteins. On the other hand, Skp has been shown to 
improve the folding of recombinant proteins or antibody fragments in the periplasm of E. coli
(31, 113, 160, 175). FkpA is known to exhibit both PPIase and chaperone function (10). They 
help in making the C-terminal domains of any protein accessible to prolyl bond 
isomerization. Outer membrane proteins are specific to SurA as it preferentially recognizes 
Ar-X-Ar motif (where Ar is an aromatic ring and X an amino acid residue) (25). SurA is a 
periplasmic protein required for the proper assembly of several outer membrane proteins.
The surA gene was discovered during the investigation of mutant E. coli cells that are able to 
survive in stationary phase (155). The amino acid sequence in SurA is similar to parvulin and 
therefore is considered a peptydil prolyl isomerase. On further investigation it was found that 
SurA is expressed in both exponentially growing and stationary phase cells and is required 
for growing at a higher pH, presumably to allow nascent outer membrane proteins to fold. 
Lack of SurA interferes with an early folding step in LamB maturation, negatively effects the 
expression of OmpC, OmpF and OmpA. surA- cells have a defective cell envelope with 
increased sensitivity to SDS and EDTA. It was also found that SurA binds to the peptide that 
has an Ar-X-Ar motif which is common in outer membrane proteins (25).
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Figure 2.4 Export and periplasmic folding pathways. Proteins destined for export can 
be translocated across the inner membrane in three different fashions. (A) Preproteins 
with highly nonpolar signal sequences (green) or transmembrane segments of inner 
membrane proteins are recognized by SRP which, along with TF, scans nascent chains. 
SRP-dependent export involves delivery of the ribosome-nascent chain complex to FtsY 
and subsequent translocation through the SecYEG-SecDFYajC translocon. (B) The 
vast majority of preproteins have less hydrophobic signal sequence (lavender) and 
undergo Sec-dependent export. TF associates with the nascent polypeptide, halting 
cotranslational folding. As the chain grows, TF dissociates and the polypeptide is 
transferred to SecB or DnaK that maintain it in an extended conformation. Delivery to 
SecA and ATP-dependent translocation through SecYEG completes the process. (C) 




exported via the Tat-dependent pathway in a folded form. After cleavage of the signal 
sequence, partially folded periplasmic proteins may aggregate (1), undergo proteolysis 
(2) or reach a native conformation, possibly with the assistance of folding modulators 
(3). Cysteine pairs in proteins containing disulfide bonds are oxidized by DsbA (4) 
whereas incorrect disulfides are isomerized by DsbC (5). These oxidoreductases are 
reactivated by DsbB and DsbD, respectively. Black arrows show products obtained 
after each step, whereas blue arrows represent electron flow (15).
2.4 Protein Degradation
Under prolonged or severe stress conditions, the above said chaperone-systems are unable to 
prevent protein aggregation. These protein aggregates are dealt with a set of molecules in E. 
coli. Among these are ClpA, ClpB, ClpX and ClpY. ClpB is known to solublize the 
aggregates while others are more or less involved in proteolysis (157). There are some less 
characterized proteins such as HtpG, HscA, HscC, and SlpA whose functions are unclear, but 
may play some role in reduction of protein misfolding (15). Though the periplasm contains 
fewer proteases than the cytoplasm, protein degradation by cell extracytoplasmic proteases is 
still considered as a serious impediment to the production of secreted proteins. DegP, Tsp, 
protease III, and OmpT are four common extracytoplasmic proteases. DegP is a periplasmic 
heat-shock protease (165, 263). The outer membrane protease OmpT specifically targets 
dibasic amino acid residues such as Arg-Lys and (74). Tsp has been shown to recognize and 
cleave C-terminal residues (254). The substrate specificity of Protease III is not known, 
though it can digest secreted fusion proteins (13).
2.5 Stress Regulatory Pathways in E. coli
Stress response pathways that sense protein misfolding, heat shock, or other cellular damage 
are highly conserved amongst living organisms (37, 231, 308). Both prokaryotic and 
eukaryotic cells synthesize a set of proteins called heat shock proteins (HSPs) to counteract 
the accumulation of damaged proteins (38, 91, 102, 311). Most HPSs are either proteases or 
chaperones for degrading or refolding misfolded proteins. In eukaryotic cells, protein 
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misfolding signals are sensed in the endoplasmic reticulum and transduced to the nucleus of 
the cell by a process called the unfolded protein response (UPR) (216). The stress response in 
the gram negative bacterium Escherichia coli has been compartmentalized into distinct 
cytoplasmic and extracytoplasmic sigma factors. The cytoplasmic stress response 
coordinated by the cytoplasmic sigma factor σ32 (103, 151) is well characterized with a set of 
chaperone members including DnaK/J and GroEL/ES (17, 264, 265). The stress response in 
the extracytoplasmic space (including the inner membrane, periplasm, and outer membrane) 
differs from the cytoplasmic one in that the stress signals are generated in the periplasm or 
outer membrane and transduced to the cytoplasm. For example, it can be induced by 
excessive amounts of unfolded/misfolded recombinant proteins in the periplasm, unfolded 
outer membrane proteins, heat shock, change in medium pH, etc. (23, 178, 184). The 
extracytoplasmic stress response is controlled by at least two different but partially 
overlapping stress regulons, i.e. the extracytoplasmic sigma factor σE (178, 230) and the Cpx 
two-component system (59). 
The σE stress regulon induces the expression of proteases, foldases, envelope 
localized chaperones, and genes involved in lipid biogenesis, etc. (62) and is essential not 
only for stress response but also for cell viability under abnormal growth conditions (56).
The σE regulon consists of several genes that can be categorized as periplasmic folding 
factors, degradases, outer membrane biogenesis, sensor proteins etc. It is encoded by the 
sigma factor rpoE or σE (238). Normally, σE is sequestered in its inactive state by the binding 
of an anti-sigma factor of RseA which is an inner membrane spanning protein with its 
periplasmic domain bound to RseB (a periplasmic protein that stabilizes RseA) and its 
cytoplasmic domain bound to σE (55, 56, 185). Upon experiencing heat shocks, RseA is 
rapidly degraded to release σE that can bind to RNA polymerase for transcription of the stress 
response genes in the regulon (3). Since RseA plays a central role in regulating the σE
pathway, studies have been conducted to identify the factors responsible for RseA 
degradation. It has been shown that DegS is a periplasmic serine protease responsible for the 
degradation of RseA (3, 6). Misfolded proteins bind to the PDZ domain of DegS to relieve its 
inhibited protease domain and to initiate the degradation of the periplasmic domain of RseA 
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(293). However, the cytoplasmic domain of RseA is still sufficient to inactivate σE (42). 
Another inner membrane protein, YaeL, is a member of the σE regulon and has been shown 
to degrade the cytoplasmic domain of RseA after its periplasmic domain is degraded by 
DegS (5). Several genes, including rpoH, degP, yaeL, and fkpA, etc., are regulated by σE. The 
rpoH gene comprises of three promoters: P1, P3, P4 (71). The promoters P1 and P4 are 
found to be active at exponential phase, however the transcription of rpoH is found to be 
completely dependent on P3 at higher temperatures. Studies on the regulation of rpoHP3 led 
to the identification of σE at higher temperatures (75, 295).
The Cpx envelope two-component regulatory system consists of a sensory inner 
membrane kinase (CpxA) and a cytoplasmic response regulator (CpxR) (120). CpxA has a 
periplasmic component and a cytoplasmic signaling domain. Upon detection of stress it 
autophosphorylates at a conserved histidine residue with the help of ATP. It then transfers 
this phosphate to an aspartate residue at the amino terminal of the CpxR. The CpxR-
phosphate then activates several proteins that are involved in the protein folding, degradation 
etc. in the cell envelope (232). The Cpx regulon is positively autoregulated and negatively 
feedback inhibited by a periplasmic protein CpxP. (60). CpxP is present in the periplasm 
under non stress conditions associated with the periplasmic component of CpxA. Thus the 
Cpx regulon remains in ‘shut down’ condition (58). However when cells encounter 
misfolded proteins/inclusion bodies in the periplasm, CpxP complexes with these protein 
aggregates. Once the protein aggregate-CpxP complexes are formed, they are available for 
proteolysis in the cells. Thus in the presence of misfolded protein aggregates, CpxP is titrated 
by DegP during the process of degradation of misfolded proteins (128). Once the CpxA-
CpxP complex is relieved, the Cpx stress regulatory pathway becomes positively regulated 
for the expression of several genes including degP and cpxP.
2.6 Fusion Protein Technology
Although recombinant protein expression and purification have been well addressed, they 
often exhibit variability in expression, solubility, stability, and functionality; thereby 
becoming difficult targets for large scale production and analyses. Although fusion tags were 
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first designed to facilitate affinity-purification of proteins, soon they were recognized as 
invaluable tools for improving the expression, solubility, and production of biologically 
active proteins, especially for difficult-to-express proteins. Although the reason for 
difficulties for expression and solubilization of certain proteins is not known, two factors that 
might contribute are the rate at which translation and protein folding occurs, which is must 
faster in E. coli as compared to other eukaryotic systems (299). Today, there are a number of 
common fusion tags namely maltose binding protein (MBP) (140), glutathione sepharose 
transferase (GST) (203), ubiquitin (Ub) (211), small ubiquitin-like modifier (SUMO) (172), 
thioredoxin (TRX) (154), disulfide bond enzymes (DsbA/C) (72), N-utilization substance 
(NusA) (66), seventeen kilodalton protein (Skp) (47), T7 protein kinase (T7PK) (47), 
solubility enhancing tag (SET) (314), Flag (Sigma) etc. that are used to express proteins in E. 
coli. MBP and GST have the advantage of affinity purification simultaneous to improvement 
in solubility and therefore are heavily used. While TRX, SUMO, NusA, and MBP have 
gained popularity as solubility enhancers, Skp and T7PK are used to produce hard-to-express 
proteins. The most probable reason for improved folding and stability of the fusion proteins 
are that the fusion partner efficiently reaches the native conformation as it emerges from the 
ribosome.
However all the fusion tags suffer from the same problem; none of them can equally 
improve the expression and solubility of all proteins. Although, the protein fusions can be 
directly used in many applications, the removal of fusion tags is necessary in other cases 
especially when large fusion tags have been fused. The fusion tag is removed in almost all 
cases with cleavage by a protease. The most common of them are TEV (139), thrombin, fXa, 
and EK (132). The principle concerns about the use of protease are the non-specific digestion 
of the target protein, incomplete cleavage, expensive proteases, and additional steps for 
protein purification. Another concern is the reversal of solubility upon removal of the fusion 
tag (192). The most widely accepted hypothesis for this phenomenon is that the proteins exist 
as soluble aggregates in solution that precipitate as soon as the solubilizing partner has been 
removed. On the other hand, addition of fusion tags has been reported to be associated with 
loss or alteration of protein’s biological activity, changes in protein conformation, and 
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toxicity of the target protein (76). Nevertheless, no other technology has been as effective as 
addition of fusion tags in improving the expression, solubility, biological activity, stability,
and purification of heterologous proteins.
                               
Figure 2.5 Schematic representation of the pathway from protein expression to 
purification using solubility tags. Four arbitrary tagged versions of the protein of 
interest are generated in E. coli. (A) After expression, some fusions will remain in the 
insoluble fraction and be lost from the pathway. (B) Soluble fusions are purified by 
IMAC (immobilized metal affinity chromatography) using the attached His6 tag. A 







will not cleave efficiently, and will leave behind a mixture of cleaved and uncleaved 
proteins that cannot be easily separated. (D) Other fusions will cleave efficiently, but 
when separated from the solubility tag the partner protein will become insoluble and 
precipitate. (E) However, a well-behaved fusion will remain in solution and can be 
purified by a second IMAC step to remove the His6-tagged solubility tag and protease, 
leaving only the target protein in the flow through (IMAC FT) (76).
2.7 Fermentation Conditions
Last, but not the least, the fermentation conditions often has significant impact on the 
metabolism of the growing cells and protein production. Nutrient composition, temperature, 
pH, and oxygen availability are important parameters that can affect the production levels 
and proteolytic activities. However high-cell-densities can often result in severe drawbacks 
including low oxygen levels, inefficient mixing, and heat generation to activate the stress 
response mechanism in the cells that induce the expression heat shock proteases in the cell 
and might result in proteolysis of the target protein (14, 74, 309). The translation of mRNAs 
is greatly affected by temperature as well as changes in the culture medium (130). 
Supplementation of sugars such as arabinose, sorbitol, and glycine causes many-fold increase 
in the solubility and activity of the produced proteins (26, 195). By using appropriate batch, 
fed-batch, and continuous culture fermentations, high cell densities upto 100g/L can be 
achieved, and therefore can be cost-effective for production of recombinant proteins (158).
2.8 Proteins Used in this Study
2.8.1 Green Fluorescent Protein
The 27 kDa green fluorescent protein (GFP) originally isolated from the jellyfish Aequoria 
victoria is the most commonly used tool as a biological marker in molecular biology, cell 
biology and medicine (223, 284). It has an excitation and emission maximum at 395 nm and 
509 nm respectively, which is the lower green portion of the visible spectrum. The fusion of 
protein to GFP does not alter its biological activity and therefore is highly useful as an 
expression reporter. It is highly stable to heat, alakaline pH, high pressure, photobleaching, 
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chaotropic and organic salts, and resistant to many proteases. It does not require a cofactor 
for development of activity, and is non-toxic in most cases (315). Many different GFP 
mutants have been engineered to meet the evolving needs of researchers. The first mutant 
reported was the Ser65Thr mutant of EGFP with increased fluorescence intensity and 
photostability (114). The mutant Phe64Leu of GFP folded with high efficiency. Later a series 
of mutations yielded the superfolder GFP that can fold rapidly even when fused to peptides 
with poor folding efficiency (277). Many colour mutants were derived including blue 
fluorescent protein (BFP with Tyr66His), cyan fluorescent protein (CFP with Tyr66Trp), and 
yellow fluorescent protein (YFP with Thr203Tyr), that find applications in fluorescence 
resonance energy transfer (FRET) experiments (284). Recently an infrared fluorescent 
protein was reported (252). Most fluorescent proteins absorb UV-visible range light, 
therefore the fluorescent protein in the infrared range allows more photos to travel without 
being bounced by electrons, thus more information can be derived from living specimens.
2.8.2 Lipase
Lipases have emerged as an important group of enzymes in the swiftly growing 
biotechnology industry due to its interesting properties and great potential for use in various 
industrial applications including food, detergent, cosmetics, and pharmaceuticals. They are 
ubiquitously present in plants, animals and microorganisms. Lipases are by and large 
produced from microbial soures including yeast, fungi, and bacteria.
2.8.2.1 Pseudozyma antarctica Lipase B
Lipase B (PalB) from Pseudozyma antarctica (originally known as Candida antarctica) 
belongs to the class of α/β hydrolases that have evolved divergently from various 
enantiomers, to catalyze reactions as various as hydrolysis of esters, thioesters, peptides, 
epoxides, and alkyl halides, or cleavage of carbon bonds in hydroxynitriles (125). The active 
site of PalB contains the catalytic triad, Ser105-His224-Asp187, common to all serine 
hydrolases. The active site lies buried in a cavity, but unlike most other lipases does not have 
a lid to cover the active site and does therefore not show interfacial activation (287). It is a 
triacylglycerol lipase and hydrolyzes triacyl glycerol to fatty acids, diacyl glycerol, monoacyl 
glycerol, and glycerol. It possesses a great regio- and stereo-selectivity, which is used in the 
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resolution of preparation of high priced pure enantiomers (46, 204). It shows a high stability 
in organic solvents, which together with its high stereoselectivity gives it properties which 
are difficult for many other catalysts to reach (145). Our interest in PalB arises from its 
potential as a biocatalyst for the production of biodiesel. The use of PalB as the target protein 
in this study significantly facilitates the experimental demonstration since it has a phenotype 
convenient for selection and screening purposes. Previously, recombinant PalB was 
expressed heterologously in fungi and yeasts, such as Aspergillus oryzae (122), Pichia 
pastoris (237), and Saccharomyces cerevisiae (313). Given the popularity of E. coli, 
functional expression of PalB in this bacterium was not demonstrated until recently (27, 167, 
303, 305, 306), but the expression performance stands improvement due to various technical 
limitations. Since there are three intramolecular disulfide bonds in PalB and their formation 
can potentially affect the development of protein structure and bioactivity, functional 
expression of PalB in the oxidative periplasm of E. coli was conducted (303, 306). However, 
heterologous PalB targeting in the periplasm appeared to be extremely sensitive to 
intracellular proteolysis, resulting in its fast and complete degradation. Such proteolysis 
could be prevented by expressing PalB with N-terminal fusion tags (306), or with 
coexpression of periplasmic chaperones (303), or in the oxidative cytoplasm of genetically 
modified E. coli (i.e. OrigamiTM strains) (305).
2.8.2.2 Burkholderia Lipase
The most important lipase-producing bacterial sources are Arthrobacter, Alacligenes, 
Bacillus, Chromobaterium, Burkholderia, and Pseudomonas (106). The fine characteristics 
of thermal stability, alkaline pH and organic solvent tolerance, high activity for various 
substrates, and transesterification activity make Burkholderia lipase an important biocatalyst 
(215) for a broad range of application in prospective industries like pharmaceuticals (80)and 
bioenergy production (201). Lipase gene in Burkholderia is described to be present in an 
operon along with its lipase-specific foldase (Lif) (228). Attempts to express Burkholderia
lipase in E. coli resulted in very low amounts of active soluble lipase, with the protein 
recovered as aggregates despite the coproduction of Lif. Active enzyme was recovered only 
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by in vitro folding. Another study reported the expression of lipase in the form of inclusion 
bodies and the soluble protein variants were obtained by mutagenesis (104).
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Chapter 3
Physiological Improvement to Enhance Escherichia coli
Cell-Surface Display via Reducing Extracytoplasmic stress
3.1 Introduction
The advent of recombinant DNA technology has revolutionized the strategies for protein 
production. Due to the well-characterized genome and techniques available for genetic 
manipulation, Escherichia coli serves as the most common host for gene expression. The 
expressed gene products can be targeted in various cellular compartments, including 
cytoplasm, inner membrane, periplasm, and outer membrane (57) or can be even secreted 
into extracellular medium (52, 90). Recently, microbial cell-surface display has been 
extensively studies due to its significant impact on various biotechnological and industrial 
applications, such as vaccine development, biosensor development, high-throughput 
screening of macromolecular libraries, and preparation of whole-cell biocatalysts (20, 159). 
To conduct cell-surface display in E. coli, a gene fusion needs to be constructed such 
that the gene product (i.e. precursor) expressed in the cytoplasm will consist of at least three 
major parts, i.e. signal sequence, passenger domain, and carrier domain. The signal sequence 
directs the precursor for its translocation into the periplasm. The carrier domain serves as a 
surface anchoring motif immobilized on the outer membrane. Depending on the type of 
anchoring motif, the passenger domain is linked to the carrier domain as an N-terminus, C-
terminus or sandwich fusion so that the displayed passenger is exposed to the extracellular 
environment with its native structure and function. Various outer membrane proteins, 
lipoproteins, fimbria proteins, flagella proteins, S-layer proteins, and autotransporter proteins 
have been shown to be effective in carrying passengers for E. coli cell-surface display (159).
Up to now, most studies related to microbial cell-surface display focused on 
discovering carrier systems and developing display vectors. However, another critical factor 
limiting display performance is the physiological impact, which has been seldom 
investigated. Cells with a high-level display tend to experience a stressful condition since the 
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outer membrane becomes fragile or even disintegrated upon frequent insertion of passenger-
carrier fusions. As a result, cells become sick and are subjected to growth arrest or even lysis. 
On the other hand, in order for the passenger to be exported across the outer membrane 
properly, the passenger-carrier fusion in the periplasm should be maintained in an unfolded 
or translocation-competent form (208). Premature folding or off-pathway misfolding of this 
fusion species in the periplasm could potentially mediate protein aggregation and induce 
periplasmic stress, resulting in poor display performance. Though the above physiological 
impacts are commonly observed particularly for E. coli, this bacterium is preferred to be used 
as a display host system due to its well-established genetic strategies and tools. Nevertheless, 
technical issues relevant to physiological impact could be further explored to improve display 
performance.
It is known that overexpression of foreign gene products in the extracellular 
compartment, such as periplasm or outer membrane, tends to generate local physiological 
stress. Recently, the responses to extracytoplasmic stress have gained much attention, 
particularly during the past decade. Specific stress-sensing and regulatory pathways of E
and Cpx, which are partially overlapping, have been well characterized (4, 62, 231, 240). The 
response to extracytoplasmic stress is primarily driven by the synthesis of a variety of stress-
responsive proteins expressing protease activity that degrades misfolded proteins and/or 
chaperone activity that renatures misfolded proteins. Up to now, several periplasmic proteins, 
including DegP (257), Skp (31, 113), SurA (156), FkpA (10, 30), DsbC (48), and substrate-
binding proteins (234), have been identified to have chaperone activities and could play a 
role to assist the folding and even targeting of extracytoplasmic proteins. As a practical
application, these periplasmic chaperones can be potential candidates to enhance cell-surface 
display via relieving extracytoplasmic physiological stress and/or via assisting periplasmic 
transport, folding, and targeting of passenger-carrier fusions. In addition, several periplasmic 
chaperones are known to be associated with outer membrane proteins for the transport in the 
periplasm and subsequent targeting onto the outer membrane (188). As such, cell-surface 
display of proteins could be possibly assisted by these periplasmic chaperones via a similar 
mechanism.
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In this study, the effect of coexpression of Skp, a characterized periplasmic chaperone 
in E. coli, on cell-surface display performance was investigated. EstA, an outer membrane 
esterase from Pseudomonas putida, and yellow fluorescent protein (YFP) were used as the 
carrier and passenger proteins, respectively. The use of YFP as a model protein facilitated the 
evaluation of display performance by measuring the fluorescence intensity of YFP-displaying 
cells. The study was conducted under two assumptions. First, the folding and targeting of 
passenger-carrier fusions are similar to those of carriers alone (i.e. outer membrane proteins). 
Second, the physiological stress occurring in the periplasm tends to limit the performance of 
E. coli cell-surface display and periplasmic chaperones can possibly offer a promise for 
resolving this technical problem. To the best of our knowledge, this is the first report 
demonstrating the potential applicability of genetic manipulation to enhance cell-surface 
display on E. coli via physiological improvement.
3.2 Materials and Methods
3.2.1 Bacterial Strains and Plasmids
Bacterial strains, plasmids, and oligonucleotides used in this study are summarized in Table 
3.1 and are briefly described below. DH5α and JM109 were used as the host for cloning and 
cell-surface display, respectively. P1 phage transduction was conducted to construct JM109-
derivatives with various promoter-lacZ fusions using SP594, SR1458 and SR1710 as the 
respective donor cells and JM109 as the recipient cell. To prepare the P1 phage lysate from 
the donor cell, 0.2 mL of an overnight LB (5 g/L NaCl, 5 g/L Bacto yeast extract, 10 g/L 
Bacto tryptone) culture of the donor strain was infected with the P1 phage. The P1-infected 
culture was immediately mixed with 2.5 mL of warm tryptone top agar (10 g/L Bacto 
tryptone, 5 g/L NaCl, 6.5 g/L Bacto agar, 5 mM CaCl2). This mixture was poured onto a 
fresh LB agar plate (15 g/L Bacto agar) with 5 mM CaCl2. The plate was incubated at 37 °C 
for approximately 4 h until the appearance of plaques. Then, 5 mL of LB medium with 5 mM 
CaCl2 was poured onto the plates for further overnight incubation at 4 °C. The P1-containing 
medium on top of the agar plate was collected and mixed thoroughly with 0.5 mL 
chloroform. After incubation at 37 °C for 30 min, the mixture was centrifuged at 6,000×g for 
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10 min. The supernatant was collected as the P1 phage lysate from the donor cell and was 
stored at -80 °C in 15 % glycerol. The P1 phage lysate was later used to infect the recipient 
cell. To do this, 25 mL of LB medium in an Erlenmeyer flask was inoculated with 1 mL of 
the recipient seed culture for cultivation at 37 °C and 200 rpm. The log phase culture 
(0.4~0.6 OD600) at 5 mL was centrifuged at 6,000×g for 10 min. After discarding the 
supernatant, the cell pellet was resuspended in 2 mL of P1-adsorption medium (5 mM CaCl2, 
10 mM MgCl2). An appropriate amount of the P1 phage lysate was added to the suspension. 
The bacterium-phage mixture was incubated at room temperature for 30 min. Then, the 
mixture was supplemented with 2 mL of LCTG broth (10 g/L tryptone, 5 g/L yeast extract, 
10 g/L NaCl, 1 g/L glucose, 2.5 mM CaCl2) for further incubation at room temperature for 2 
h. After incubation, the mixture was centrifuged at 6,000×g for 10 min. After discarding the 
supernatant, the cell pellet was resuspended in 0.2 mL of LCTG broth and the suspension 
with an appropriate dilution was plated on an LB agar plate with 80 μg/mL X-gal for blue-
white screening. The plate was incubated overnight at room temperature and then transferred 
to 37 °C incubation until blue colonies appeared. A few blue colonies were selected and 
restreaked on the LB plates with X-gal to ensure the maintenance of blue-color phenotype.
Molecular cloning was performed according to standard protocols (241). Restriction enzymes 
were purchased from New England Biolabs (Beverly, MA, USA). Polymerase chain reaction 
(PCR) was conducted in an automated thermal cycler (GeneAmp Thermocycler, Applied 
Biosystems, Foster City, CA, USA). Purification of plasmid DNA was performed using a 
spin-column kit purchased from Clontech (Palo Alto, CA, USA). Plasmid transformation was 
carried out using an electroporator (E. coli Pulser, Bio-Rad, Hercules, CA, USA) or a 
chemical method according to Chung and Miller (54). The plasmid, pESTKnYFP, was used 
to display YFP on E. coli cell surface. To construct the plasmid, the yfp gene was PCR-
amplified using pEYFP as the template, YFP-Sfi-Up and YFP-Sfi-Lo as the primers, and Pfu 
polymerase (Stratagene, La Jolla, CA, USA). The PCR product was purified and digested 
with SfiI, gel extracted and ligated to the SfiI digested fragment of pEST100-FScut to obtain 
pESTYFP. The KnR marker in pESTYFP was replaced by CmR. To do this, pACYC177 (44)
was first amplified in ER2925, a dcm mutant (213), to avoid the Dcm methylation at the two 
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StuI sites encompassing the KnR fragment. The purified plasmid was cleaved with StuI and 
the 1.3-kb DNA fragment containing the KnR gene was gel-extracted. Plasmid pESTYFP was 
digested with ScaI and the 6.6 kb DNA fragment was ligated with the 1.3-kb KnR cassette to 
form pESTKnYFP. Plasmid pARSkp was constructed by subcloning the BglII/HindIII 
fragment containing the skp gene from pHELP1 to similarly digested pAR3. Plasmid 
pESTKnYFP has a pBR322 replication origin and a KnR marker and is, therefore, compatible 
with pARSkp having a pACYC184 replication origin and a chloramphenicol-resistant (CmR) 
marker.
Table 3.1 Strains, plasmids, and oligonucleotides.
Strain and DNA Relevant genotype or phenotype Source and Reference#
E. coli
DH5α




Ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 glaT22 
mcrA dcm-6 hisG4 rfbD1 R(zgb210::Tn10) TetS endA1 
rpsL136 dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2
NEB (213)
JM109
F′ traD36 proA+B+ lacIq Δ(lacZ)Μ15/ Δ(lac-proAB) 
glnV44 e14- gyrA96 recA1 relA1 endA1 thi hsdR17
Lab stock (307)
JM1458 SR1458 (P1) × JM109, (PdegP-lacZ) This study
JM1710 SR1710 (P1) × JM109, (PrpoH-lacZ) This study
JM594 SP594 (P1) × JM109, (PcpxP-lacZ) This study
MC4100
F- araD139 Δ(argF-lac)U169 rpsL150 relA1 deoC1 
rbsR fthD5301 fruA25 λ-
CGSC (35)
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SR1458 MC4100 (PdegP-lacZ) S. Raina (230)
SR1710 MC4100 (PrpoH-lacZ) S. Raina (230)
SP594 MC4100 (PcpxP-lacZ)
T. J. Silhavy (Silhavy 
collection)
Plasmid
pACYC177 A cloning vector, Ori (pACYC184), KnR, CmR Lab stock (235)
pAR3 A cloning vector, ParaB, Ori (pACYC184), Cm
R J. Guttierez (221)
pARSkp ParaB ::skp, Ori (pACYC184), Cm
R This study
pEST100-FSCut Plac ::cut ::estA, Ori (pBR322), Cm
R H. Kolmer (18)
pESTKnYFP Plac ::yfp ::estA, Ori (pBR322), Kn
R This study
pESTYFP Plac ::yfp ::estA, Ori (pBR322), Cm
R This study
pEYFP Plac ::yfp, Ori (pBR322), Ap
R Clontech (210)
pHELP1 ParaB ::secB ::skp, Ori (pACYC184), Cm










# CCRC: Culture Collection and Research Center, Taiwan; NEB: New England Biolabs; CGSC: E. 
coli Genetic Stock Center
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3.2.2 Cultivation
Cells were revived by streaking the stock culture, stored at -80 C, on LB agar plates. The 
plate was incubated at 37 C for approximately 15 h. An isolated single colony was picked to 
inoculate 25 mL of LB medium, which was then incubated at 37 C and 200 rpm in a rotary 
shaker for approximately 15 h to form a seed culture. The medium was supplemented with 50 
g/mL kanamycin (Kn) or 34 g/mL chloramphenicol (Cm) when necessary. Erlenmeyer 
flasks containing 25 mL LB medium were inoculated with the seed culture and were shaken 
in a rotary shaker at 28 C and 200 rpm. When the cell density reached approximately 0.5 
OD600, the culture was supplemented with IPTG and/or arabinose for induction. The flask 
cultures were further shaken under the same conditions for another 4 h. All the cultivations 
were conducted at least in duplicate.
3.2.3 Cell Fractionation
The culture sample equivalent to 20 OD600 units was centrifuged at 6,000×g for 6 min at 4 °C 
to pellet the cells. After discarding the supernatant, the cell pellet was resuspended in 3 mL 
sodium phosphate buffer (0.05M, pH 7.5) and lysed by a French Press (ThermoIEC, 
Waltham, MA, USA). The cell lysate was further centrifuged for 15 min at 12,000×g and 4 
°C. The pellet containing insoluble proteins and cell debris was washed with phosphate 
buffer, resuspended in TE/SDS buffer (10 mM Tris HCl, pH 8.0, 1 mM EDTA, 1% SDS),
and heated to 100 C for 5 min for dissolution. The supernatant and pellet were analyzed 
with SDS-PAGE as the soluble and insoluble (i.e. membrane) fractions, respectively.
3.2.4 Analytical Methods
The culture sample was appropriately diluted with an isotonic saline solution for measuring 
cell density in OD600 with a spectrophotometer (DU
®520, Beckman Coulter, Fullerton, CA, 
USA). To measure the whole-cell fluorescence, the culture sample was centrifuged for 6 min 
at 6000×g and 4 °C and the cell pellet was resuspended with sodium phosphate buffer 
(0.05M, pH 7.5) to reach a final cell density of 0.5 OD600. The YFP fluorescence was 
determined with a spectrofluorometer (FP-6500, Jasco, Tokyo, Japan) using the excitation 
and emission wavelengths of 510 nm and 527 nm, respectively. 
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For immunogold labeling, the culture sample was centrifuged at 6000×g and 4 °C for 
6 min, and the cell pellet was resuspended to 0.5 OD600 with PBS buffer. A 100-μL drop of 
this cell suspension was placed on a sheet of parafilm. A formvar-coated nickel grid was 
placed, with the coating side facing down, on the drop surface of the cell suspension for 
approximately 10 min. The grid was blotted dry and placed on a drop of PBS with 0.3% skim 
milk powder as a blocking agent for 20 min. The grid was incubated in the blocking agent 
containing the primary antibody (i.e. anti GFP rabbit IgG from Clontech, diluted in 1/50) for 
1 h. The grid was washed with drops of the blocking agent for 3×2 min. The grid was 
incubated on a drop of the blocking agent containing the secondary antibody (i.e. goat anti-
rabbit IgG conjugated with gold from Sigma, diluted in 1/20) for 1 h. The grid was washed 
with drops of the blocking agent for 3×2 min and then with DI water for 4×2 min. The grid 
was stained with 2% aqueous uranyl acetate for 1 min and washed with DI water for 1 min. 
The grid was air-dried and observed under a transmission electron microscope (TEM; Philips 
CM10, Eidenhoven, Netherlands). All the steps were followed by intermediate blot drying of 
grids on a filter paper.
To conduct trypsin digestion, the culture sample was centrifuged for 6 min at 6000×g 
and 4 °C and the cell pellet was resuspended with the digestion buffer (200 mM Tris-HCl, 
150 mM MgCl2, pH 7.5) containing 2 mg/mL trypsin to reach a final cell density of 0.5 
OD600. The cells were then incubated at 37 °C for an hour and polymethyl sulfonyl fluoride 
(PMSF), a trypsin inhibitor, was added to a final concentration of 1 µM and the fluorescence 
intensity was measured
For EDTA and SDS sensitivity tests, EDTA and SDS at a final concentration of 2 
mM and 0.1%, respectively, were added to a 0.5-OD600 cell suspension in a sensitivity testing 
buffer (Tris-HCl 200 mM, pH 7.5). The cell suspension was incubated at 37 °C. Samples 
were taken at different time intervals and cell density was measured.
β-galactosidase assay was conducted using o-nitrophenyl-β-D-galactopyranoside 
(ONPG) as the substrate (182).
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed in a Mini-
PROTEANII electrophoresis cell (Bio-Rad, Hercules, CA, USA) using a 12.5% 
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polyacrylamide separating gel stacked by a 4% polyacrylamide stacking gel. The sample 
loading amount was 0.05 and 0.4 OD600-units for the soluble and insoluble fractions, 
respectively. Electrophoresis was conducted under a constant voltage of 200 V for 
approximately 1 h. The gel was stained with Coomassie blue and dried in a hood. The dried 
gel was then scanned. 
To conduct Western blotting, the proteins on the polyacrylamide gel were 
electroblotted to a PVDF membrane after SDS-PAGE using a Mini Trans-Blot Cell 
(BioRad, Hercules, CA, USA) according to a standard protocol (283). The electrophoretic 
transfer was conducted at a constant voltage of 100 V for 1 h. Protein-antibody hybridization 
was performed as described by Sambrook et al. (241). The primary antibody was anti-GFP 
rabbit IgG (Clontech, Mountain View, CA, USA) and the secondary antibody was goat anti-
rabbit IgG conjugated with horseradish peroxidase (HRP, Sigma, St. Louis, MO, USA). 
GFP-related polypeptides were detected by a colorimetric method using 3,3’-
diaminobenzidine tetrahydrochloride (DAB) as the substrate. The processed membrane was 
scanned.
3.3 Results
3.3.1 Cell Surface Display of YFP Results in Physiological Deterioration 
Using JM109 (pESTKnYFP) as the host/vector system for conducting cell-surface display of 
YFP under various IPTG inducer concentrations, the YFP display performance is 
summarized in Table 3.2. The control culture without IPTG supplementation had a cell 
density and a specific fluorescence intensity of 2.2 OD600 and 4.5 U/OD600/mL, respectively. 
While the specific fluorescence intensity was increased by more than two fold, indicating a 
certain level of YFP display, cell growth was significantly inhibited due to physiological 
deterioration (less than 0.5 OD600) and, as a result, the volumetric fluorescence intensity was 
even reduced for all the induced cultures. With such a rapidly deteriorating cell physiology, 
the specific fluorescence intensity was saturated at a low IPTG concentration 0.05 mM. The 
result of TEM (Figure 3.1) confirms that YFP was successfully displayed on E. coli cell 
surface though at a relatively low level. 
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Table 3.2 YFP display performance for JM109 (pESTKnYFP) under various culture 
conditions.
IPTG (mM) 0 0.05 0.1 0.5 1.0
Cell Optical Density
(OD600)
2.2±0.1 0.43±0.01 0.47±0.01 0.35±0.00 0.34±0.01
Specific Fluorescence Intensity
(U/OD600/mL)
4.5±0.2 15.2±0.6 15.1±0.2 13.1±0.2 13.8±0.2
Volumetric Fluorescence Intensity
(U/mL)
9.5±0.5 6.5±0.4 5.6±0.1 3.9±0.3 4.5±0.3
                                  
                                





                             
Figure 3.1 Result of TEM for immunogold labeling of displayed YFP on E. coli cell 
surface. The black dots represent the gold particles conjugated with the displayed YFP. 
Panel A/ JM109; Panel B/ JM109 (pESTKnYFP) induced with 0.1 mM IPTG. 
Various tests, including trypsin digestion and EDTA and SDS sensitivity, were 
conducted to characterize JM109 (pESTKnYFP) for YFP display on E. coli cell surface and 
the results are summarized in Figure 3.2. The fluorescence intensity for all the induced cells 
(except for the non-induced cells as a control) was significantly reduced after 1-h incubation 
for trypsin digestion (Figure 3.2A), implying that the expressed YFP was likely displayed on 
cell surface to which trypsin could access. All the induced cells were much more sensitive to 
either EDTA (Figure 3.2B) or SDS (Figure 3.2C) than non-induced cells, indicating that the 
outer membrane became more fragile upon IPTG-induction for YFP display. The result of 
Western blotting (Figure 3.3) shows that the expressed YFP was located in the insoluble 
fraction of the lysate and disappeared after trypsin digestion. All the above results indicate 
that YFP was displayed on E. coli cell surface upon IPTG-induction and cell physiology was 
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Figure 3.2 Characterization of YFP display on E. coli cell surface using JM109 
(pESTKnYFP) as the displaying host/vector system under various culture conditions. 






















































           
Figure 3.3 Result of Western blotting for YFP cell-surface display using JM109 
(pESTKnYFP) as the displaying host/vector system. Lane 1/ whole cell extract, no 
IPTG; Lane 2/ whole cell extract, 0.1 mM IPTG; Lane 3/ whole cell extract , 0.1 mM 
IPTG, with trypsin digestion ; Lane 4/ soluble fraction, 0.1 mM IPTG; Lane 5/ insoluble 
fraction, 0.1 mM IPTG. The soluble fractions were also analyzed without any 
hybridization signals (data not shown).
3.3.2 Skp Coexpression Highly Improves YFP Display Performance
Using JM109 (pESTKnYFP, pARSkp) as the host/vector system for conducting cell-surface 
display of YFP under various induction conditions, the YFP display performance is 
summarized in Table 3.3. Compared to the single-plasmid system, i.e. JM109
(pESTKnYFP), the YFP display performance was approximately the same for non-induced 
cultures. However, the presence of pARSkp significantly improved cell survival and growth 
1          2          3        4         5 
EYFP-EstA
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for IPTG-induced cultures (e.g. 0.47 vs. 1.4 OD600 for 0.1 mM IPTG), even without adding 
arabinose for Skp induction. With such improvement in cell physiology, the specific 
fluorescence intensity was either maintained at a similar level (i.e. 15.1 vs. 14.6 U/OD600/mL 
for cultures with 0.1 mM IPTG) or was increased by approximately 30% (i.e. 13.1 vs. 17.4 
U/OD600/mL and 13.8 vs. 18.2 U/OD600/mL for cultures with 0.5 and 1.0 mM IPTG, 
respectively), resulting in significant improvement in volumetric fluorescence intensity up to 
5 fold (e.g. 4.5 vs. 25.4 U/mL for cultures with 1.0 mM IPTG).
Table 3.3 YFP display performance for JM109 (pESTKnYFP, pARSkp) under various 
culture conditions.




2.2±0.2 1.4±0.2 1.4±0.0 1.4±0.1
Specific Fluorescence Intensity
(U/OD600/mL)
4.9±0.2 14.6±1.0 17.4±0.5 18.2±0.3
Volumetric Fluorescence Intensity
(U/mL)






















Compared to the cultures of either JM109 (pESTKnYFP) or JM109 (pESTKnYFP, 
pARSkp) induced with IPTG only, both cell growth and specific fluorescence intensity were 
increased when Skp was coexpressed through arabinose-induction (either at 0.5 or 5 mg/mL), 
resulting in a significant increase in volumetric fluorescence intensity for more than 15 fold 
(e.g. 4.5 for single-plasmid system with 1 mM IPTG vs. 70 U/mL for binary-plasmid system 
with 1 mM IPTG and 0.5 mg/mL arabinose). Note that, in contrast to the result of JM109 
(pESTKnYFP) cultures in which the display level was saturated with a low IPTG 
concentration, the specific fluorescence intensity for JM109 (pESTKnYFP, pARSkp) 
cultures increased monotonically with IPTG concentration up to 1 mM due to improved cell 
physiology. The result of TEM shows that the density of displayed YFP for JM109 
(pESTKnYFP, pARSkp) (Figure 3.4) was significantly higher than that for JM109 
(pESTKnYFP) (Figure 3.1B), implying an improved display performance with Skp 
coexpression. The result of Western blotting (Figure 3.5A) shows that the expressed YFP 
was still located in the insoluble fraction of the lysate upon Skp coexpression (Figure 3.5B) 
and the displayed level was significantly higher than that of JM109 (pESTKnYFP) (Figure 
3.3). The result of trypsin digestion (Figure 3.6A) suggests that YFP was displayed on the 
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cell surface. Figures 3.6B and 3.6C show that YFP-displayed cells with Skp coexpression 
were much less sensitive to both EDTA and SDS than YFP-displayed cells without Skp 
coexpression (Figures 3.2B and 3.2C), implying significantly improved cell physiology was 
obtained upon Skp coexpression.
       
Figure 3.4 Result of TEM for immunogold labeling of displayed YFP on E. coli cell 
surface using JM109 (pESTKnYFP, pARSkp) as the displaying host/vector system. The 
culture was supplemented with 0.1 mM IPTG and 0.5 mg/mL arabinose. Note that the 
density of the black dots, representing the gold particles conjugated with the displayed 
YFP, is significantly higher than that of JM109 (pESTKnYFP) under the same culture 
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A
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Figure 3.5 Result of Western blotting (Panel A) and SDS-PAGE (Panel B) for YFP cell-
surface display using JM109 (pESTKnYFP, pARSkp) as the displaying host/vector 
system. Panel A: Lane 1/ whole cell extract, no IPTG; Lane 2/ whole cell extract, 0.1 
mM IPTG; Lane 3/ whole cell extract, 0.1 mM IPTG, 0.5 mg/mL Arabinose; Lane 4/ 
whole cell extract, 0.1 mM IPTG, with trypsin digestion; Lane 5/ whole cell extract, 0.1 
mM IPTG, 0.5 mg/mL Arabinose, with trypsin digestion; Lane 6/ soluble fraction, 0.1 
mM IPTG; Lane 7/ soluble fraction, 0.1 mM IPTG, 0.5 mg/mL Arabinose; Lane 8/ 
insoluble fraction, 0.1 mM IPTG; Lane 8/ insoluble fraction, 0.1 mM IPTG, 0.5 mg/mL 
Arabinose. The soluble fractions were also analyzed without any hybridization signals 
(data not shown). Panel B: Lane 1/ Protein standard; Lane 2/ soluble fraction, no 
IPTG; Lane 3/ soluble fraction, 0.1 mM IPTG; Lane 4/ soluble fraction, 0.1 mM IPTG, 
0.5 mg/mL Arabinose; Lane 5/ insoluble fraction, no IPTG; Lane 6/ insoluble fraction, 
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Figure 3.6 Characterization of YFP display on E. coli cell surface using JM109 
(pESTKnYFP, pARSkp) as the displaying host/vector system under various culture 















































3.3.3 Skp Coexpression Reduces Extracytoplasmic Stress
To monitor extracytoplasmic stress responses to cell-surface display, three JM109-derived 
strains were constructed by transduction of a lacZ reporter gene fused with PdegP, PcpxP, and 
PrpoH, respectively, into JM109. Using these three strains, the results of YFP display 
performance for single-plasmid (i.e. pESTKnYFP) and binary-plasmid (i.e. pESTKnYFP and 
pARSkp) systems are summarized in Tables 3.4 and 3.5, respectively, and they are similar to 
the results for the corresponding display systems using wild-type JM109 (i.e. Tables 3.2 and 
3.3). Cells without Skp coexpression were subjected to growth arrest upon YFP display 
(Table 3.4), whereas growth was no longer inhibited and cell physiology was significantly 
improved upon Skp coexpression (Table 3.5).
Table 3.4 YFP display performance for JM109-derivatives harboring pESTKnYFP 
under various culture conditions: “–” and “+” represent “no induction” and “induction 
with 0.1 mM IPTG”, respectively.
JM1458/PdegP::lacZ JM594/PcpxP::lacZ JM1710/PrpoH::lacZ
IPTG – + – + – +
Cell Optical Density
(OD600) 2.4±0.0 0.88±0.05 2.1±0.1 1.2±0.1 2.4±0.0 0.86±0.02
Specific Fluorescence 
Intensity
(U/OD600/mL) 4.7±0.2 13.4±0.4 4.4±0.4 14.2±1.1 5.2±1.0 14.1±0.4
Volumetric Fluorescence 
Intensity
(U/mL) 10.9±0.4 11.8±1.0 9.0±0.6 16.9±2.0 12.7±2.5 12.1±0.4
% Cell Lysis 70 28 55
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Table 3.5 YFP display performance for JM109-derivatives harboring pESTKnYFP and 
pARSkp under various culture conditions: “–”, “+I”, and “+A” represent “no 
induction”, “induction with 0.1 mM IPTG”, and “induction with 0.5 mg/mL 
arabinose”, respectively.
JM1458/PdegP::lacZ JM594/PcpxP::lacZ JM1710/PrpoH::lacZ














11.2±1.2 16.5±1.0 42.8±3.1 11.1±0.6 19.3±2.8 49.9±3.2 9.9±0.7 13.5±0.4 42.5±2.2
% Cell Lysis 32 25 27 22 48 22
The results of stress response to YFP display for single-plasmid (i.e. pESTKnYFP) 
and binary-plasmid (i.e. pESTKnYFP and pARSkp) systems under various culture conditions 
are summarized in Figures 3.7A and 3.7B, respectively. All the degP, cpx, and rpoH
promoter activities were induced upon IPTG-induction for YFP display (Figures 3.7 and 3.8), 
implying that cells were experiencing extracytoplasmic stress and these stress responses were 
triggered via both Cpx and σE pathways. Note that, compared to the IPTG-induced single-
54
plasmid system [i.e. JM1458 (pESTKnYFP)], the degP promoter activity was significantly 
reduced in the presence of pARSkp even though Skp was not induced by arabinose 
supplementation (i.e. 1,100 vs. 498 Miller units). The degP promoter activity was further 
reduced upon adding arabinose for Skp coexpression (i.e. 175 Miller units). However, the 
cpx promoter activity appeared not to be affected by the presence of pARSkp, whether Skp 
was arabinose-induced or not. Compared to the IPTG-induced single-plasmid system [i.e. 
JM1710 (pESTKnYFP)], the rpoH promoter activity was slightly increased in the presence 
of pARSkp but without Skp induction (i.e. 649 vs. 823 Miller units), and was further 
increased upon Skp induction (i.e. 1,005 Miller units). 
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Figure 3.7 Promoter activities representing the extracytoplasmic stress in response to 
YFP display on E. coli cell surface under various culture conditions. Panel A/ JM109 
(pESTKnYFP); Panel B/ JM109 (pESTKnYFP, pARSkp).
3.4 Discussion
Displaying proteins on E. coli surface tends to seriously affect cell physiology, resulting in 
growth arrest and poor display performance. Up to now, no study has systematically 
investigated the factors contributing to such physiological deterioration though it is generally 
recognized that the outer membrane fragility caused by frequent export of carrier-passenger 
fusions could be a primary one. Developing strategies for in-depth understanding and 
suppression of the physiological impact caused by cell-surface display warrants more 
explorative effort. Since the mechanism for targeting of carrier-passenger fusions onto the 
outer membrane is believed to be similar to that of carriers alone (i.e. outer membrane 
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considered to enhance the display performance, including (1) polypeptide translocation 
across two membranes, (2) transport of carrier-passenger fusions in the periplasm, (3) 
prevention of spontaneous folding and maintenance of export-competent forms for carrier-
passenger fusions during the whole targeting process, and (4) blocking of the off-pathway 
processes that lead to aggregation, proteolysis, and perturbation of the constituents of the 
outer envelope and/or carrier-passenger fusions. Nevertheless, the physiological 
improvement cannot be convincingly demonstrated without cell physiology being properly
monitored. The global stress-response regulons (240) are identified as the cell’s natural 
defense system in response to physiological stress through regulating the synthesis of a 
variety of stress proteins expressing protease activity that degrades damaged proteins and/or 
chaperone activity that assists protein folding. As a practical application, these stress-
responsive proteins can be used not only as “sensors” for monitoring cell physiology but also
proper candidates to suppress the physiological stress. So far, three regulons, i.e. Cpx, σE, 
and Bae, have been discovered to be involved in sensing and suppressing extracytoplasmic 
stress (240), but only the first two are well characterized.
Among the stress proteins in response to extracytoplasmic stress, Skp is a 
characterized periplasmic chaperone that interacts with unfolded proteins translocated into 
the periplasm via Sec secretion system (184). In this study, coexpressing Skp to enhance YFP 
cell-surface display through improved cell physiology was successfully demonstrated. Cell 
growth was no longer inhibited and individual cells appeared to be more robust for 
displaying YFP on the surface. Cells with YPF display appeared to be less sensitive to EDTA 
and SDS and the density of surface-displayed YFP was highly increased upon Skp 
coexpression. It was reported that Skp plays a key role in proper biogenesis of the envelope 
by mediating the folding and targeting of several outer membrane proteins (39, 49, 65, 111, 
242). In this regard, folding and/or targeting of carrier-passenger fusions could be potentially 
facilitated by Skp. On the other hand, Skp has been shown to improve the folding of 
recombinant proteins or antibody fragments in the periplasm of E. coli (31, 113, 160, 175). 
Such an effect could also be useful to increase the solubility and prevent the premature 
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folding of periplasmic carrier-passenger fusions for their export and insertion on the outer 
membrane.
DegP is a periplasmic heat-shock protein with both protease and chaperone activities 
(257) and its production can be triggered via the Cpx (60) and/or σE pathways (75). CpxP is a 
periplasmic component of the Cpx regulon and is involved in the response to 
extracytoplasmic stress through an interaction with CpxA, which is another Cpx component 
acting as a membrane integral sensor (231). CpxP can suppress the toxicity caused by 
overexpression of envelope proteins and its production is only induced through the Cpx 
pathway (58). RpoH (also known as σH or σ32) is a heat-shock transcription factor regulating 
the expression of many heat-shock gene and its production is only induced through the σE
pathway (4). Fusions of the three stress-responsive promoters (i.e. PdegP, PcpxP, and PrpoH) with 
a lacZ reporter gene were constructed so that the expression level of β-galactosidase, the 
reporter gene product, could be assayed for determining the level of various extracytoplasmic 
stresses, e.g. the stress caused by misfolding of overproduced gene products in the periplasm 
(127). 
In this study, YFP display on E. coli cell-surface induced all the three promoter 
activities investigated (Figure 3.7), implying that cells experienced extracytoplasmic stress 
arising from cell-surface display. Cell growth was seriously arrested and poor display 
performance was obtained upon IPTG-induction (Table 3.4). The results suggest that the 
stress response was activated via both the Cpx and σE pathways. It was reported that the 
overexpression of envelope proteins can activate both the Cpx (255) and σE pathways (178). 
Furthermore, the σE pathways can be induced by perturbations to outer membrane protein 
folding (184). Cell-surface display of YFP with the use of an outer membrane protein as a 
carrier could possibly trigger the stress response via a mechanism similar to the above ones. 
It was reported that inner membrane anchoring is essential for DegP induction (186) and 
DegP is induced primarily to digest the accumulated misfolded proteins for cleaning the 
periplasm (138, 212). In that case, YFP display could possibly result in the misfolding of 
certain periplasmic protein(s) anchoring on the inner membrane and the protein misfolding 
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was then prevented by Skp coexpression. However, these misfolded protein(s) remains to be 
identified.
Interestingly, among these three promoter activities investigated here, only the degP
one showed a stress response consistent with the phenotypical cell physiology observed 
under various culture conditions for cell-surface display. Namely, the degP promoter activity 
was highly induced when cell growth was significantly arrested by YFP display without Skp 
coexpression (Figure 3.7), whereas the degP promoter activity was reduced when the growth 
arrest was released upon arabinose-induction for Skp coexpression (Tables 3.3 & 3.5, Figure 
3.8). The results suggest that the degP promoter activity could potentially serve as an 
effective “sensor” for monitoring extracytoplasmic stress and cell physiology during the 
course of cell-surface display. However, it is still uncertain via which of the Cpx and σE
pathways was the degP promoter activity triggered. The degP promoter activity was 
previously used for similar physiological monitoring when periplasmic proteins were 
overproduced (127, 214). In contrast, the other two promoter activities (i.e. cpxP and rpoH) 
were not reduced to reflect the phenotypical improvement of cell physiology when Skp was 
coexpressed and the induction of the two promoter activities appeared not to be affected by 
the presence of pARSkp (i.e. ~3 fold for PcpxP and ~12 fold for PrpoH), indicating that these 
two stress responses were not suppressed upon Skp coexpression. Note that a significant 
amount of the overexpressed Skp existed in an insoluble form (Figure 3.5B), which might 
cause other types of extracytoplasmic stress reflected as the non-reduced cpxP and rpoH
promoter activities upon Skp coexpression.
59
Chapter 4
Alleviation of Proteolysis to Enhance Recombinant Protein 
Production in Escherichia coli
4.1 Introduction
Given the availability of various host systems for recombinant protein production, bacterium 
Escherichia coli retains its popularity as the most common one. However, E. coli is a 
prokaryotic cell with several technical issues for heterologous expression of eukaryotic 
proteins, including host/protein incompatibility, codon bias, and lack of posttranslational 
processing abilities, etc. which can limit its practical applicability. Host/protein 
incompatibility appears to be rather critical since eukaryotic proteins heterologously 
expressed in E. coli are often recognized as foreign objects which can induce heat-shock 
responses and drive protease-mediated degradation. E. coli contains several proteases 
situated in various intracellular compartments, including the cytoplasm, periplasm, inner 
membrane, and outer membrane (98, 174). While these proteases normally play a pivotal role 
in maintaining cell physiology by clearing up abnormal proteins (94), they can potentially 
reduce the production yield by degrading heterologous recombinant proteins. Even though 
proteases are well characterized, the mechanisms associated with protein degradation and 
protein substrate specificity are incompletely understood. On the other hand, lack of proper 
posttranslational processing abilities, such as glycosylation, peptide splicing, and disulfide 
bond formation, can result in major structural disturbances which eventually lead to protein 
misfolding.
Cytoplasm is the compartment where all nascent proteins are first synthesized and most 
of them reside. There are at least five main heat-shock proteases, namely ClpAP, ClpXP, 
ClpYQ, Lon, and FtsH (97), that can be involved in degrading recombinant proteins in the 
cytoplasm. ClpAP and ClpXP are two-component proteases that share the common ClpP 
degradation subunit but have different regulatory units of ClpA and ClpX (99). While FtsH, 
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ClpAP and ClpXP are responsible for degradation of proteins with non-polar tails (116), 
ClpYQ and Lon proteases are more generic in their substrate specificity.
Alternatively, periplasm can be a proper destination for targeting of recombinant 
proteins due the following expression advantages (57, 180): (i) Downstream purification can 
be facilitated; (ii) Disulfide bonds can be formed in the oxidative periplasm; (iii) 
Recombinant proteins with an authentic N-terminus can be produced; and (iv) Recombinant 
proteins in the periplasm are less likely subjected to proteolytic attack. In addition, effective 
expression systems with optimal growth conditions can yield secreted proteins with an 
expression level as high as 30% of total cellular protein (89). Though the periplasm contains 
fewer proteases than the cytoplasm, protein degradation by cell extracytoplasmic proteases is 
still considered as a serious impediment to the production of secreted proteins. DegP, Tsp, 
protease III, and OmpT are four common extracytoplasmic proteases. DegP is a periplasmic 
heat-shock protease (165, 263). The outer membrane protease OmpT specifically targets 
dibasic amino acid residues (74). Tsp has been shown to recognize and cleave C-terminal 
residues (254). The substrate specificity of Protease III is not known though it can digest 
secreted fusion proteins (13). 
Herein, we used a case study for functional expression of a eukaryotic protein, i.e. lipase 
B (PalB) from Pseudozyma antarctica (previously known as Candida antarctica), in E. coli
to demonstrate molecular manipulation for alleviation of recombinant protein’s sensitivity 
toward intracellular proteolysis and to better understand the relation between proteolytic 
specificity and substrate protein sequence. PalB is an important industrial enzyme with 
justified applicability (9). The use of PalB as the target protein in this study significantly 
facilitates the experimental demonstration since it has a phenotype convenient for selection 
and screening purposes. Previously, recombinant PalB was expressed heterologously in fungi 
and yeasts, such as Aspergillus oryzae (122), Pichia pastoris (237), and Saccharomyces 
cerevisiae (313). Given the popularity of E. coli, functional expression of PalB in this 
bacterium was not demonstrated until recently (27, 167, 303, 305, 306), but the expression 
performance stands improvement due to various technical limitations. Since there are three 
intramolecular disulfide bonds in PalB and their formation can potentially affect the 
61
development of protein structure and bioactivity, functional expression of PalB in the 
oxidative periplasm of E. coli was conducted (303, 306). However, heterologous PalB 
targeting in the periplasm appeared to be extremely sensitive to intracellular proteolysis, 
resulting in its fast and complete degradation. Such proteolysis could be prevented by 
expressing PalB with N-terminal fusion tags (306) or with coexpression of periplasmic 
chaperones (303) or in the oxidative cytoplasm of genetically modified E. coli (i.e. 
OrigamiTM strains) (305). 
To alleviate the proteolysis limiting functional expression of PalB in E. coli, a stable 
PalB mutant variant against the proteolysis was derived in this study using error-prone 
polymerase chain reaction (ep-PCR) followed by screening on tributyrin agar plates. Based 
on sequencing analyses and site-directed mutagenesis experiments, two amino acid residues, 
i.e. Leu149 and Val223, were identified as “hot spots” for PalB stabilization. Functional 
expression of PalB in E. coli was significantly enhanced by using PalB mutants that can 
dodge periplasmic proteolysis, and was even further improved by coexpression of a 
periplasmic folding factor DsbA. While most studies in protein engineering were conducted 
primarily to identify mutant proteins with enhanced or novel bioactivities, this is an approach 
to derive protein variants with less susceptibility toward intracellular proteolysis so that 
protein manufacturing bioprocess can be improved. On the other hand, though it has been 
well perceived that the in vivo proteolytic specificity can be intrinsically determined by the 
sequence of protein substrate, experimental demonstration of this is rarely reported. The 
current study complements the lack of such experimental demonstration by showing that the 
proteolytic specificity of PalB heterologously expressed in E. coli can be drastically altered 
by simple amino acid substitutions.
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4.2 Materials and Methods
4.2.1 Bacterial Strains and Plasmids
Bacterial strains, plasmids, and oligonucleotides used in this study are summarized in Table 
4.1 and are briefly described below. BL21(DE3) was used as the host strain for PalB 
expression. 





F– ompT dcm lon hsdSB (rB
-, mB
-) gal λ(DE3[lacI ind1
sam7 nin5 lacUV5-T7 gene 1])
Novagen
Plasmid
pARDsbA ParaB::dsbA, Ori (pACYC184), CmR (303)
pARDsbC ParaB::dsbA, Ori (pACYC184), Cm
R (303)
pETG PT7-pelB::palB, Ori (pBR322), Ap
R (303)
pETGM-2
A pETG derivative containing two mutations of 




A pETG derivative containing a mutation of Leu149Gly 
in palB (by SDM with pETG and P104/P114) 
This study 
pETGM-4
A pETG derivative containing a mutation of Leu149Val 
in palB (by SDM with pETG and P103/P113)
This study 
pETGM-5 A pETG derivative containing a mutation of Leu149Ala This study 
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in palB (by SDM with pETG and P105/P115)
pETGM-6
A pETG derivative containing a mutation of Leu149Met 
in palB (by SDM with pETG and P106/P116)
This study 
pETGM-7
A pETG derivative containing a mutation of Leu149Ile 
in palB (by SDM with pETG and P107/P117)
This study 
pETGM-8
A pETG derivative containing a mutation of Val223Phe 
in palB (by SDM with pETG and P112/P122)
This study 
pETGM-9
A pETG derivative containing a mutation of Val223Met 
in palB (by SDM with pETG and P111/P121)
This study 
pETGM-10
A pETG derivative containing a mutation of Val223Ala 
in palB (by SDM with pETG and P110/P120)
This study 
pETGM-11
A pETG derivative containing a mutation of Val223Gly 
in palB (by SDM with pETG and P109/P119)
This study 
pETGM-12
A pETG derivative containing a mutation of Val223Ile 
in palB (by SDM with pETGM-2 and P136/P137, i.e. by 
reverting the mutation of Val149 to Leu in pETGM-2)
This study
Oligonucleotide DNA Sequence*
LB-P10 5'-GGCCATGGGTCTACCTTCCGGTTCGG-3' This study
LB-P11 5'-CTGAATTCTCAGGGGGTGACGATGCCGGAGCAGG-3' This study
P103 5'-CCTCTCGATGCAGTCGCGGTTAGTGCACCC-3' This study
P113 5'-GGGTGCACTAACCGCGACTGCATCGAGAGG-3' This study
P104 5'-CCTCTCGATGCAGGCGCCGTTAGTGCACCC-3' This study
64
P114 5'-GGGTGCACTAACGGCGCCTGCATCGAGAGG-3' This study
P105 5'-CCTCTCGATGCAGCCGCGGTTAGTGCACCC-3' This study
P115 5'-GGGTGCACTAACCGCGGCTGCATCGAGAGG-3' This study
P106 5'-CCTCTCGATGCCATGGCGGTTAGTGCACCC-3' This study
P116 5'-GGGTGCACTAACCGCCATGGCATCGAGAGG-3' This study
P107 5'-CCTCTCGATGCGATCGCGGTTAGTGCACCC-3' This study
P117 5'-GGGTGCACTAACCGCGATCGCATCGAGAGG-3' This study
P109 5'-GGGCCGCTGTTCGGGATCGACCATGCAGGC-3' This study
P119 5'-GCCTGCATGGTCGATCCCGAACAGCGGCCC-3' This study
P110 5'-GGGCCGCTGTTCGCGATCGACCATGCAGGC-3' This study
P120 5'-GCCTGCATGGTCGATCGCGAACAGCGGCCC-3' This study
P111 5'-GGGCCGCTGTTCATGATCGACCATGCAGGC-3' This study
P121 5'-GCCTGCATGGTCGATCATGAACAGCGGCCC-3' This study
P112 5'-GGGCCGCTGTTCTTTATCGACCATGCAGGC-3' This study
P122 5'-GCCTGCATGGTCGATAAAGAACAGCGGCCC-3' This study
P136 5′-CCTCTCGATGCACTGGCGGTTAGTGCACCC-3' This study
P137 5′-GGGTGCACTAACCGCCAGTGCATCGAGAGG-3' This study
* Italic: mutation nucleotides, underline: restriction site (silent mutation), bold: mutation codon
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The plasmid pETG contains the leader-less palB gene fused with the pelB signal 
peptide and the expression of pelB::palB is under the regulation of the T7 promoter (306). 
Other plasmids designated as pETGM-n (n = 2~12) are pETG derivatives containing various 
mutations in palB. The plasmids pARDsbA and pARDsbC respectively contain the dsbA and 
dsbC genes whose expression was under the regulation of the araB promoter. Molecular 
cloning was performed according to standard protocols (241). Restriction enzymes were 
purchased from New England Biolabs (Ipswich, MA, USA). Polymerase chain reaction 
(PCR) was performed in an automated thermal cycler (GeneAmp® PCR System 9700; 
Applied Biosystems, Foster City, CA, USA). Plasmid DNA was purified using a spin-column 
kit purchased from BD Biosciences Clontech (Palo Alto, CA, USA). Plasmid transformation 
was carried out according to Chung and Miller (54) or using an electroporator (Micropulser, 
Bio-Rad, Hercules, CA, USA). Error-prone PCR (ep-PCR) was conducted using GeneMorph 
II EZClone Domain Mutagenesis kit (Stratagene, Dedar Creek, TX, USA) with LB-P10 and 
LB-P11 as the primers and pETG as the template. Site-directed mutagenesis (SDM) was 
conducted using Quickchange Lightning Site-Directed Mutagenesis kit (Stratagene) with 
pETG or pETGM-2 as the template and various primer pairs (Table 4.1). The reaction 
mixtures were transformed into BL21(DE3) and selected on LB agar plates containing 1% 
tributyrin.
4.2.2 Cultivation
The protocol for shaker flask cultivation was described previously in Chapter 3. For 
bioreactor cultivations, the above described seed culture was used to inoculate a bench-top 
bioreactor (Omni-Culture, VirTis, Gardiner, NY, USA) containing 1-L working volume of 
LB medium with 10 L/L Antifoam 289 (Sigma, St. Louis, MO, USA). IPTG at 0.1 mM and 
arabinose at 0.2 g/L were added for induction purposes when the culture cell density reached 
~0.5 OD600. The bioreactor was purged with filter-sterilized air at 2 L/min for aeration. The 
culture pH was regulated at 7.00.1 by adding 3 N NH4OH or 3 N HCl using a combination 
of pH electrode (Mettler-Toledo, Switzerland), a pH controller (PC310, Suntex, Taipei, 
Taiwan), and two peristaltic pumps (101U/R, Watson Marlow, Falmouth, UK). The 
bioreactor was operated at 28 C and 650 rpm for approximately 8 h after induction.
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4.2.3 Analytical Methods
The protocols for various analyses are described in Chapter 3. PalB activity was qualitatively 
evaluated by the area and transparency of the halo formed on tributyrin agar plates. To 
conduct this, the soluble fractions of 50-L cell lysates were loaded on the plate incubated at 
37 °C overnight. On the other hand, PalB enzyme assay was conducted using a pH stat 
(Brinkman Metrohm 842 Titrando, FL, USA). An appropriate volume of the soluble fraction 
of cell lysates was added to 5 mL of 2% olive oil emulsion in water at 37 °C and the reaction 
solution was maintained at pH 8.0 by controlled addition of 0.02 N NaOH (279). One unit of 
enzyme activity is defined as the amount of enzyme required to liberate one mole of fatty 
acid per min.
Primary anti-PalB antibodies for probing PalB using Western blotting were raised in a 
rabbit intermittently immunized with the antigen of recombinant PalB expressed from A. 
oryzae (Sigma-Aldrich). It was further purified by SDS-PAGE and PalB used for 
immunization was obtained by polypepetide elution of the corresponding band in the 
polyacrylamide gel slice using an Electro-Eluter (Model 422; Bio-Rad).
4.2.4 Protein Localization
To prepare cell extracts corresponding to various intracellular compartments, cells equivalent 
to 20 OD600-units were centrifuged at 2 C and 6000g for 6 min. The cell pellet was washed 
with 10 mL Tris-HCl buffer (10 mM, pH 8.0) and resuspended in 10 mL Tris-HCl buffer (10 
mM, pH 8.0) with 0.5 M sucrose. The cell suspension was incubated with 25 µg/mL 
lysozyme for 20 min at room temperature. The lysozyme spheroplast was then diluted with 
equal volume of Tris-HCl buffer (10 mM, pH 8.0) with 1mM EDTA and incubated at room 
temperature for 20 min to obtain EDTA spheroplast. The cell suspension was divided into 
two halves and centrifuged at 6000×g for 6 min at 2 C. The supernatant containing the 
soluble periplasmic protein fraction was assayed for PalB activity.
The first half of the spheroplast pellet was resuspended in 2 mL Tris-HCl buffer (10 
mM, pH 8.0) with 10 mM MgCl2 and 0.3 M sucrose, and incubated with 0.1 mg/mL trypsin 
for 10 min at room temperature. Trypsin digestion was terminated by adding 5mM PMSF 
and the spheroplast suspension was centrifuged at 6000×g for 6 min at 2 C. The trypsin 
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digested spheroplast pellet and the second half of the spheroplast pellet were each 
resuspended in 2 mL Tris-HCl buffer (10 mM, pH 8.0), sonicated for 4 min, and then 
centrifuged at 4 C and 12,000g for 15 min. The supernatant containing the soluble 
cytoplasmic fraction was assayed for PalB activity. The pellet from the spheroplast without 
trypsin treatment contains the insoluble cytoplasmic and periplasmic inclusion bodies, 
whereas the pellet with trypsin digestion treatment only contains the insoluble cytoplasmic 
inclusion bodies. These pellets were solublized with TE/SDS buffer (10 mM Tris HCl, pH 
8.0, 1 mM EDTA, 1% SDS), heated at 100 °C for 5 min, and analyzed with SDS-PAGE and 
Western blotting.
4.3 Results
Results for functional expression of wild-type and various PalB mutants in the periplasm of 
E. coli are summarized in Figure 4.1 (tributyrin plate assay), Table 4.2 (enzyme assay), and 
Figure 4.2 (Western blotting), respectively. In all the expression constructs, the PelB signal 
peptide was used to drive the secretion of PalB into the periplasm and the expression of 
translational fusions of PelB and PalB variants was under the regulation of the T7 promoter 
with BL21(DE3) as the expression host.
The cell lysate of BL21(DE3) (pETG) culture sample (both un-induced and IPTG-
induced) did not have any detectable PalB activity (Table 4.2). Consistently, overnight 
incubation of the cell lysates on a tributyrin plate failed to produce any halos associated with 
tributyrin hydrolysis (Figure 4.1). Western blotting results revealed no PalB-related gene 
products in both soluble and insoluble fractions of the culture samples (Figure 4.2), 
excluding the possibility of protein misfolding as the reason for non-functional PalB 
expression. 
To identify more stable PalB variants, ep-PCR was conducted using pETG as the template 
and the PCR product was transformed into BL21(DE3). The transformants were screened on 
tributyrin agar plates for colonies expressing tributyrin hydrolytic activity. A colony 
developed a large size of halo. The harboring plasmid (designated as pETGM-2) of this clone 
was purified for sequencing analysis and two mutations, i.e. Leu149Val and Val223Ile, were 
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identified in the expressed mutant PalB (designated as M-2). A high PalB activity at 155 
U/L/OD600 was determined for the IPTG-induced culture sample of BL21(DE3) (pETGM-2), 
whereas no PalB activity was detected for the un-induced one (Table 4.2). Nevertheless, 
halos were clearly observed for both un-induced and IPTG-induced culture samples of 
BL21(DE3) (pETGM-2) (Figure 4.1). Note that the halo for IPTG-induced culture was 
significantly larger and more transparent than the un-induced culture. Western blotting 
results revealed PalB-related gene products in both soluble and insoluble fractions (Figure 
4.2). The bands were even visible for the un-induced culture sample, implying a potential 
expression issue of protein misfolding. It was however intriguing to observe such a dramatic 
effect on PalB stabilization and the enhancement of functional expression associated with 
these two simple mutations.
Table 4.2 Cultivation performance for the production of various PalB mutant 
derivatives.
Culture
Cell Density (OD600) Activity*
(U/L/OD600)
Mutation in 
PalBw/o IPTG w/ IPTG
BL21(DE3) (pETG) 3.1±0.0 3.3±0.1 ND None
BL21(DE3) (pETGM-2) 3.4±0.1 3.3±0.0 155
Leu149Val, 
Val223Ile
BL21(DE3) (pETGM-3) 3.2±0.1 3.3±0.0 ND Leu149Gly
BL21(DE3) (pETGM-4) 3.4±0.1 3.6±0.1 60 Leu149Val
BL21(DE3) (pETGM-5) 3.3±0.1 3.5±0.1 ND Leu149Ala
BL21(DE3) (pETGM-6) 2.7±0.1 3.0±0.1 ND Leu149Met
BL21(DE3) (pETGM-7) 3.5±0.0 3.2±0.0 38 Leu149Ile
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BL21(DE3) (pETGM-8) 3.0±0.0 3.6±0.0 50 Val223Phe
BL21(DE3) (pETGM-9) 2.9±0.1 2.8±0.0 ND Val223Met
BL21(DE3) (pETGM-10) 3.4±0.1 3.3±0.1 ND Val223Ala
BL21(DE3) (pETGM-11) 3.5±0.0 3.5±0.1 30 Val223Gly
BL21(DE3) (pETGM-12) 3.6±0.1 3.5±0.1 57 Val223Ile
* These activities represent IPTG-induced cultures. No activity was detected for all control cultures 
without IPTG induction. ND: Not detected
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Figure 4.1 Qualitative visualization of PalB activity using tributyrin plates for the 
expression of various PalB mutant derivatives. The number (n = 2~12) represents the 
PalB mutant (M-n) with the use of BL21(DE3) harboring the expression plasmid 
pETGM-n summarized in Tables 4.1 and 4.2. “G” represents the control experiment 
using BL21(DE3) harboring pETG. “C” and “I” represent the cultures respectively 
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Figure 4.2 Western blotting analysis of the culture samples for the expression of 
various PalB mutant derivatives. Both soluble and insoluble fractions are shown. 
The number (n = 2~12) represents the PalB mutant (M-n) with the use of 
BL21(DE3) harboring the expression plasmid pETGM-n summarized in Tables 1 
and 2. “G” represents the control experiment using BL21(DE3) harboring pETG. 
“C” and “I” represent the cultures respectively without and with IPTG induction.
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Using cultivated BL21(DE3) harboring pETGM-2, protein localization experiment was 
conducted to locate the expressed PalB mutant and the results are summarized in Figure 4.3. 
Approximately 76% (i.e. 125/165) of total PalB activity was localized in the periplasmic 
fraction and the rest resided in the cytoplasmic fraction. On the other hand, most of the 
protein band corresponding to the insoluble PalB mutant disappeared upon treating 
spheroplasts with trypsin (lane 6 vs. 7 in Figure 4.3), implying the presence of insoluble PalB 
mutant in the periplasm. The results suggested that the translocation of expressed PalB 
mutant mediated by PelB signal peptide was rather effective. Similar results of the 
localization experiment were obtained using cultivated BL21(DE3) harboring pETGM-4 
(data not shown).
PalB
1            2           3        4            5          6     7 
Soluble Insoluble
165 125 32 29
Figure 4.3 Western blotting analysis of the expressed PalB mutant (M-2) in 
various intracellular fractions of BL21(DE3) harboring pETGM-2. Lane1/ Total 
soluble fraction; Lane 2/ Soluble periplasmic fraction; Lane 3/ Soluble 
cytoplasmic fraction from the spheroplast without trypsin treatment; Lane 4/ 
Soluble cytoplasmic fraction from the spheroplast with trypsin treatment; Lane 5/ 
Total insoluble fraction; Lane 6/ Insoluble fraction from the spheroplast without 
trypsin treatment; Lane 7/ Insoluble fraction from the spheroplast with trypsin 
treatment. The numbers under lanes 1~4 represent the specific PalB activity (in 
U/L/OD600) of the corresponding fraction.
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Apparently, Leu149 and Val223 are two amino acids critically affecting PalB’s 
susceptibility to proteolysis in E. coli. To further understand this structural effect, site-
directed mutagenesis was conducted to introduce various single mutations to these two “hot 
spots”, including Leu149Gly (M-3), Leu149Val (M-4), Leu149Ala (M-5), Leu149Met (M-
6), Leu149Ile (M-7), Val223Phe (M-8), Val223Met (M-9), Val223Ala (M-10), Val223Gly 
(M-11), and Val223Ile (M-12) and their corresponding expression plasmids are listed in 
Table 4.1. Note that only hydrophobic amino acid residues were selected to avoid any major 
disturbances in the local protein structure associated with the mutagenesis. Among the five 
single mutations on Leu149, only Leu149Val (M-4) and Leu149Ile (M-7) resulted in slight 
improvement in functional expression, whereas the others behaved similar to the wild-type in 
hydrolyzing tributyrin (Figure 4.1). Among the five single mutations on Val223, only 
Val223Phe (M-8), Val223Gly (M-11), and Val223Ile (M-12) resulted in slight improvement 
in functional expression, whereas the others behaved similar to the wild-type (Figure 4.1). 
For the above single mutants with their tributyrin-hydrolyzing behavior similar to the wild-
type, neither PalB activity (Table 4.2) nor PalB-related gene product (Figure 4.2) was 
detectable.
Replacing Leu149 with Val or Ile had an effect in reducing PalB’s susceptibility to 
periplasmic proteolysis and Val appeared to be more effective than Ile (Table 4.2; 60 
U/L/OD600 for M-4 vs. 38 U/L/OD600 for M-7). Similarly, replacing Val223 with Phe, Gly or 
Ile had a similar PalB stabilization effect with Ile as the most effective one (Table 4.2; 50 
U/L/OD600 for M-8, 30 U/L/OD600 for M-11, and 57 U/L/OD600 for M-12). While it was 
unsurprising to observe individual improvement associated with the single mutants of 
Leu149Val (M-4) and Val223Ile (M-12), the two mutations appeared to have a synergistic 
effect in reducing PalB’s susceptibility to proteolysis (Table 4.2: 155 U/L/OD600 for M-2). 
Note that, similar to the double mutant M-2, PalB-related gene products were detected in the 
insoluble fraction of cell lysate of the single mutants expressing PalB activity, implying that 
protein misfolding could be another limiting step for functional expression of PalB in E. coli. 
Various periplasmic folding factors, including DegP, FkpA, SurA, Skp, DsbA, and 
DsbC were coexpressed with M-2 for potential alleviation of PalB misfolding in E. coli. 
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Using shaker-flask cultivations for preliminary investigation, only DsbA and DsbC had a 
slightly improving effect on functional expression of PalB (data not shown). We then 
conducted bioreactor cultivations to characterize this effect and the results are summarized in 
Figure 4.4. There was neither PalB activity nor PalB-relevant polypeptides for the control 
culture of BL21(DE3) (pETG), even for the culture sample taken at 1-h after IPTG-
induction; implying the expressed gene product was extremely unstable. Functional 
expression of PalB for another control culture of BL21(DE3) (pETGM-2) was improved and 
the specific PalB activity reached 465 U/L/OD600, which was much higher than that of 
shaker-flask cultivation (i.e. 155 U/L/OD600) possibly due to a better cell growth environment 
in the bioreactor. Interestingly, coexpression of DsbA significantly boosted functional 
expression of PalB and the specific PalB activity was more than 2-fold that of the control 
culture of BL21(DE3) (pETGM-2) (Figure 4.4B) with a slight reduction in the amount of 
insoluble PalB (lane 6 vs. 8 in Figure 4.4C). On the other hand, the cultivation performance 
of BL21(DE3) (pETGM-2, pARDsbC) was rather similar to that of the control culture of 
BL21(DE3) (pETGM-2), suggesting that the improving effect associated with DsbC 
coexpression was minimal.
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Figure 4.4 Bioreactor cultivation performance for functional expression of PalB using 
various host/vector systems. Panel A: Time profiles of cell density; Panel B: Time 
profiles of the specific PalB activity [Note that there was no detectable activity for 
BL21(DE3) (pETG) culture samples]; Panel C: Western blotting analysis of the final 
samples of the four cultures. Both soluble and insoluble fractions are shown. Lane 1/5 
BL21(DE3) (pETG); Lane 2/6 BL21(DE3) (pETGM-2); Lane 3/7 BL21(DE3) (pETGM-
2, pARDsbC); Lane 4/8 BL21(DE3) (pETGM-2, pARDsbA).
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While many studies based on rational mutagenesis, directed evolution, and gene shuffling are 
conducted to derive mutant PalBs with improved enzyme properties, such as thermostability, 
bioactivity or enantioselectivity (217, 218, 236, 267), this is a similar protein engineering 
approach to improve recombinant protein production through identification of mutant PalB 
variants with less sensitivity toward in vivo proteolysis when being overexpressed. 
Theoretically, functional expression of mutant PalB variants in the periplasm could be further 
enhanced with proper disulfide bond formation in this oxidative compartment.
The results of no detectable PalB activity and PalB-related gene product for BL21(DE3) 
(pETG) suggest that either translation of the pelB::palB fusion gene was ineffective or the 
translated gene product was degraded. The latter was more plausible since translation of 
pelB-free palB or other palB fusions was rather effective (303, 306) and there were not many 
rare codons in palB which would otherwise impede translation (data not shown). Our 
previous results showed that the wild-type PalB was subjected to potential proteolysis in the 
periplasm (303). Interestingly, the wild-type PalB was less degradable when being expressed 
in the cytoplasm which contains more proteases than the periplasm (305) or being expressed 
with N-terminal fusion tags in the periplasm (306).
Since intracellular proteolysis of recombinant proteins is a rather common technical 
issue, approaches to overcome this limitation have been extensively explored. These include 
the use of protease-deficient mutant strains as the expression host (179, 290), growth of 
production cells at a lower temperature (51), coexpression of folding factors (291, 303), 
protein fusion technology (33, 73, 108), elimination of protease cleavage sites (96, 247, 290), 
modification of the hydrophobicity of target proteins (136, 191), and manipulation of 
cultivation conditions (14, 158). While genetic elimination of proteolytically sensitive 
sequences without impacting target protein’s bioactivity appears to be technically attractive, 
there is no effective prediction or identification of these potential protease cleavage sites. 
Our present results suggest that Leu149 and Val223 are two amino acids critically 
affecting PalB’s susceptibility toward periplasmic proteolysis in E. coli. Such proteolytic 
sensitivity was significantly alleviated by replacing Leu149 with Val or Ile and/or replacing 
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Val223 with Phe, Gly or Ile, but was unchanged when replacing Leu149 with Gly, Ala or 
Met and replacing Val223 with Met or Ala. Note that Leu149 is located at the entrance of the 
partially formed lid of the protein structure, whereas Val223 is situated near one of the 
catalytic triad His226 in the active site. However, these amino acid substitutions with 
positive effects were expected to convert the overall protein conformation into a less 
proteolytically sensitive form without changing the enzyme mechanism or kinetics. In 
addition, only hydrophobic amino acids were selected for mutagenesis to avoid major 
disturbances in the local protein structure. It was interesting to observe positive effects by 
replacing Val223 with either a bulky Phe or a small Gly, though replacing Val223 with Ile 
had the best improving effect; implying that the molecular size of the amino acid was not a 
critical factor associated with the proteolytic sensitivity. Note that, though the cultivation 
performance for functional expression of PalB was significantly improved with the use of the 
double mutant species (i.e. Leu149Val and Val223Ile), protein bands corresponding to PalB 
were present in the insoluble fraction, implying that the improved functional expression was 
limited by another limiting step of protein misfolding.
The majority of the expressed PalB mutants (e.g. M-2 and M-4), either soluble or 
insoluble, was detected in the periplasm, implying translocation mediated by PelB signal 
peptide was effective. However, it was a bit surprising that certain PalB activity was detected 
in the reductive cytoplasm which is supposedly unsuitable for disulfide bond formation. 
Interestingly, functional expression of PalB M-2 variant was significantly enhanced upon the 
coexpression of DsbA, but not DsbC. The results suggest that the initiation but not 
isomerization associated with disulfide bond formation in the periplasm became limiting. The 
chaperone activity associated with DsbA could also assist the folding of the expressed PalB 
double mutant. It was previously reported that functional expression of PalB in the oxidative 
cytoplasm of E. coli Origami strains could be limited by disulfide bond formation (305).
Although many proteases have been identified in E. coli, their proteolytic mechanisms, 
recognition sequences, and substrate specificity remain incompletely characterized. This 
study appears to identify new protease-sensitive sequences since further investigation of the 
amino acid sequence near Leu149 and Val223 (i.e. Leu146-Asp147-Ala148-Leu149-Ala150-
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Val151-Ser152 and Pro220-Leu221-Phe222-Val223-Ile224-Asp225-His226) did not reveal any sites 
previously reported as proteolytically sensitive. However, proteolytically sensitive sequences 
might not be specific to certain proteases and various factors affecting protease binding, 
secretion, folding, solubility or steric hindrance, e.g. neighboring domains or amino acids 
(190), can contribute to the sensitivity of potential proteolytic sites, making such sequence 
manipulation for alleviation of proteolysis more difficult. Since the proteolytic sensitivity of 
PalB remained unchanged when replacing Leu149 or Val223 with several other amino acids, 
a protease-recognition pattern other than amino acid sequence might be involved in PalB 
degradation.
Mutant E. coli strains deficient in a selection of genetic loci associated with protein 
degradation were constructed to enhance the production of labile recombinant proteins (13, 
179). Since BL21(DE3) used in this study is deficient in ompT encoding an envelope 
protease OmpT which cleaves periplasmic proteins at dibasic amino acid sequences such as 
Arg-Lys (101), OmpT was not responsible for PalB degradation. Precise identification of the 
protease(s) responsible for PalB degradation could assist the construction of proper mutant 
strains for functional expression. Nevertheless, the specific alleviation of target protein’s 
sensitivity toward intracellular proteolysis proposed herein offers an alternative to enhance 
recombinant protein production since the knockout in protease genes can potentially impair 
the physiology, growth properties, and even viability of the production strains and 
subsequently affect recombinant protein yield.
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Chapter 5
Enhancing Functional Expression of Heterologous Lipase 
B in Escherichia coli by Extracellular Secretion
5.1 Introduction
Escherichia coli retains its popularity as the most versatile host for recombinant protein 
production due to many expression advantages (93, 173, 206). Given the extensive
knowledge associated with heterologous protein expression in E. coli, technical limitations 
are still encountered, particularly including posttranslational processing, protein misfolding 
and aggregation, proteolysis, and recombinant protein toxicity (171). 
Cytoplasm is the intracellular compartment where all nascent proteins are first 
synthesized and most of them reside. However, it might not serve as a suitable destination for 
recombinant protein production because of the liability to protein proteolysis (274), the 
inability to form disulfide bonds (225), the tendency to protein misfolding (149), and the 
complicated downstream processing (271). These drawbacks can be potentially overcome by 
secretion of foreign gene products to the periplasm or extracellular medium (181). 
All the periplasmic and outer membrane proteins in E. coli require the secretion of their 
corresponding precursors across the cytoplasmic membrane. The major mechanism driving 
such translocation is the Sec-dependant Type II secretion pathway, which is mediated by a 
cleavable signal peptide at the N terminus (52). A wide variety of signal peptides, such as
PelB (22), PhoA (281), OmpA (302), and SpA (189), have been adopted successfully as a 
genetic strategy to secrete recombinant proteins for expression in the periplasm or on the 
outer membrane of E. coli. 
By contrast, very few E. coli proteins are known to be extracellularly secreted due to the 
presence of another secretion barrier of the outer membrane. Type I secretion system, known 
as the ABC transporter, secretes E. coli toxins and exoenzymes via a one-step process across 
both the cytoplasmic and outer membranes without a periplasmic intermediate (24). On the 
other hand, Type III secretion system represents a specific mechanism associated with the 
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secretion of pathogenesis factors or flagellar proteins from the cytoplasm, bypassing the 
periplasm, directly to the exterior of the bacteria (278).
Despite of limited natural mechanisms for protein secretion in E. coli, genetic strategies 
have been developed to release recombinant proteins extracellularly, including (1) the use of 
leaky mutant host strains (233) and cell-wall-less L-form E. coli (105), (2) chemical or 
biochemical permeabilization of outer membrane (52, 251), and (3) coexpression of protein
release factors such as bacteriocin release protein (BRP) (288), colicin E1 lysis protein (Kil), 
tolAIII and out genes (294). However, these approaches on the basis of permeabilizing cells 
are limited to the release of periplasmic proteins (which are typically exported from the 
cytoplasm via Type II secretion system) and often deteriorate the physiological condition of 
producing cells. Consequently, the recombinant protein yield is hampered. Type I or III 
secretion systems, therefore, appear to be an alternative by which extracellular production of 
proteins can be performed with minimum physiological impact. In fact, several proteins, that 
are otherwise hard to be expressed intracellularly, have been functionally expressed and 
extracellularly secreted via the hemolysin (Type I) system (28, 79, 286) and the flagellar 
(Type III) system (21, 64, 220, 253). 
PalB, a lipase B from Pseudozyma antarctica (previously known as Candida 
antarctica), is an important industrial enzyme with wide applications (9). Herein, we are 
exploring another strategy for functional expression of recombinant PalB, namely 
extracellular secretion via Type I and III systems (Figure 5.1). Previously, PalB was 
expressed heterologously in fungi and yeasts, such as Aspergillus oryzae (122), Pichia 
pastoris (237), and Saccharomyces cerevisiae (313). Given the popularity of E. coli, 
functional expression of PalB in this host was not demonstrated until recently (27, 167, 303, 
305, 306). Since there are three intramolecular disulfide bonds in PalB and their formation 
can potentially affect the development of protein structure and bioactivity, functional 
expression of PalB in the oxidative periplasm of E. coli appears to be a rational approach. 
However, heterologous PalB targeting in the periplasm was highly unstable and subjected to 
proteolysis (303). Cytoplasmic expression of PalB in the reducing cytoplasm of wild-type E. 
coli suffered ineffective disulfide bond formation. Though this technical issue could be 
82
circumvented by the expression in the oxidative cytoplasm of genetically modified E. coli
(i.e. OrigamiTM), protein misfolding remained problematic (305).Given the above limitations 
in disulfide bond formation and protein misfolding, extracellular secretion appears to be a 
plausible exploration. In this study, using the hemolysin secretion apparatus, PalB-HlyA 
protein fusion was extracellularly produced with relatively fast secretion and high PalB 
activities. On the other hand, though PalB secreted via the flagellar system is an intact 
protein, the secretion was not initiated until 24 h after cultivation. Both two protein secretion 
systems posed minimum physiological impact on producing cells.

























Figure 5.1 Extracellular secretion of heterologous PalB in E. coli via Type I and Type 
III secretion systems. Panel A/ The hemolysin (Type I) secretion system belongs to the 
ABC transporter family which recognizes the C-terminal amino acids of hemolysin 
toxin HlyA for protein secretion without requiring an N-terminal signal peptide (100). 
The inner membrane proteins, i.e. HlyB and HlyD trimer, form an assembly with 
concurrent ATP hydrolysis (79, 88) to interact with the outer membrane protein TolC 
(148). A hydrophilic channel connecting the two membranes forms as an export conduit 
through which the recombinant PalB fused to the 23 kDa C-terminal of HlyA is co-
exported extracellularly. Panel B/ The E. coli flagellar (Type III) secretion system can 
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flagellar assembly component proteins (183). In order to conduct recombinant protein 
secretion using this system, the flagellar protein gene fliC is replaced by the target gene 
of interest (palB in this study) flanked by the untranslated regions (UTR) of the fliC
gene, i.e. the 173 bp promoter sequence of fliCMG1655 at 5´ end and 321 bp terminator 
sequence of fliCMG1655 at the 3´ end (170). The exact nature of the secretion signals still 
remains unknown. One model suggests that the secretion could be cotranslational using 
the 5´UTR region of mRNA as the signal (8); whereas another model describes the 
secretion as posttranslational using a protein sequence as a signal (168).
5.2 Materials and Methods
5.2.1 Bacterial Strains and Plasmids
Bacterial strains, plasmids, and oligonucleotides used in this study are summarized in Table 
5.1 and are briefly described below. DH5α was used as the host strain for molecular cloning. 
BL21(DE3), DH5α, HB101, JM109 and MC4100 were used as the expression hosts for PalB 
secretion studies using the hemolysin transporter. MKS12 was used as the host strain for 
PalB secretion studies using flagellar system.
The protocol for molecular cloning is described in Chapter 3. The plasmid 
pEHLYAPalB was used for extracellular secretion of PalB-HlyA fusion via the hemolysin 
system. The palB gene was PCR-amplified with Pfu (Stratagene, La Jolla, CA, USA) as the 
PCR polymerase, pPCRscriptPalB-L as the template, and P10 and pEHREV as the primers. 
The amplified DNA fragment was digested with NcoI/EagI and ligated with similarly 
digested pEHLYA2-SD to form pEHLYAPalB. The plasmid pVDL9.3 was used for the 
production of HlyB and HlyD. The plasmid p5´3´UTRPalB was used for extracellular 
secretion of PalB via the E. coli flagellar system. The PvuI/SacI fragment of p5´UTR was 
subcloned into pMCS3´UTR to form p5´3´UTR containing the 173-bp 5´- fliCMG1655
promoter sequence and the 321-bp 3´- untranslated region (UTR) of the fliCMG1655 gene. The 
palB gene was PCR-amplified with Pfu as the PCR polymerase, pPCRscriptPalB-L as the 
template, and P10 and P22 as the primers. The amplified DNA fragment was digested with 
NcoI/SacI and ligated to similarly digested p5´3´UTR to form p5´3´UTRPalB.
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Table 5.1 Strains, plasmids, and oligonucleotides.
Strain Relevant Genotype Source & Reference 
BL21(DE3)
F– ompT dcm lon hsdSB (rB
-, mB
-) gal λ(DE3[lacI
ind1 sam7 nin5 lacUV5-T7 gene 1])
(224)
DH5α
F'/(80 dlac Δ(lacZ)M15) Δ(lacZYA-argF)U169 
deoR recA1 endA1 hsdR17 (rK
-, mK




F- hsdS20 leuB6 recA13 ara-14 proA2 lacY1 thi-1 
galK2 rpsL20 xyl-5 mtl-1 supE44 -
(34)
JM109
recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi-1 








Deletion of 1407 bp fliD gene and 1497 bp fliC gene 




173 bp promoter sequence of fliCMG1655 in PvuI-ScaI 




321 bp 3′UTR DNA sequence of fliCMG1655 in ScaI-
EcoRI site of pBR322, TcR
(170)
p5′3′UTR
173 bp promoter sequence of fliCMG1655 in PvuI-ScaI 









pPCRscriptPalB-L PCR cloning of palB, ApR This lab





pEHREV 5'-ACGGAGCTCGAATTCGGCCGGGGTGACGAT-3' This study
* Italic: mutation nucleotides, underline: restriction site 
5.2.2 Cultivation
The protocol for shaker flask experiment and bioreactor cultivation is described in Chapter 3 
and Chapter 4. 
5.2.3 Analytical Methods
The protocol for various analyses is described in Chapter 3 and Chapter 4. The culture 
supernatant and intracellular soluble fraction were analyzed for PalB activity.  
5.3 Results 
For the extracellular secretion of PalB from E. coli, the plasmid pEHLYAPalB containing the 
palB-hlyA gene fusion (encoding the protein fusion of PalB and the 23 kDa C-terminal of 
HlyA whose expression was regulated by the lac promoter) was constructed. Using JM109 
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harboring pEHLYAPalB and pVDL9.3 for shaker flask cultivation, the culture performance 
is summarized in Figure 5.2. PalB bioactivity associated with the extracellular secretion of 
PalB-HlyA was visualized on tributyrin agar plates (Figure 5.2A), indicating that HlyA can 
functionally mediate PalB secretion without affecting its proper folding. Two cultivation 
temperatures, i.e. 28 °C and 37 °C, were used. While cell growth for the two cultures was 
similar (Figure 5.2B), the 37 °C one had a higher specific PalB activity (128 vs. 83 
U/L/OD600 in Figure 5.2C). Therefore, all subsequent cultivations were performed at 37 °C. 
Western blotting was also conducted to probe PalB-HlyA at approximately 58 kDa in both 
the extracellular and intracellular (soluble) fractions. While the PalB-HlyA band was
detected in both fractions (Figure 5.2D), PalB activity was measurable only in the 
extracellular fraction (Figure 5.2A and 5.2C) but not the intracellular one (data not shown), 
implying that the secretion of PalB could assist proper protein folding to attain its bioactive 
form. Note that, for the later extracellular culture samples at 20 and 24 h, another PalB-
related band with a molecular weight less than the expected size of 58 kDa was probed by
PalB antibodies, implying that a possible proteolysis might have occurred on a specific 
cleavage site. Upon comparing the PalB activity with the band intensity, both extracellular 
bands appeared to be bioactive. 









                 



















































Figure 5.2 Shaker flask cultivation of JM109 (pEHLYAPalB, pVDL9.3): The 
cultivation was conducted at 28 °C and 37 °C. IPTG at 0.5 mM was used for induction. 
Panel A/ Qualitative visualization of PalB activity using tributyrin agar plates. Panel B/ 
Time profiles of cell density. Panel C/ Time profiles of specific PalB activity. Panel D/ 
Western blotting analysis of the extracellular and soluble intracellular fraction of 
culture samples.
The effect of the inducer concentration on the secretion of PalB-HlyA is shown in 
Figure 5.3. The control experiment without IPTG induction had a specific PalB activity of 25
U/L/OD600 due to the expression leakage associated with the lac promoter. The PalB activity 
increased monotonically with the IPTG concentration up to 0.5 mM, at which the 
expression/secretion was optimal (Figure 5.3B). Further increase in the inducer concentration 
had either no or adverse effect on the culture performance. Note that the doublet bands were 
still observable for all the later extracellular culture samples (Figure 5.3C). Nevertheless, the 
inducer concentration had no effect on cell growth (Figure 5.3A), implying that the 
D
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expression and secretion of PalB-HlyA posed a minimum physiological impact on producing
cells.
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Figure 5.3 Effect of the inducer concentration on the culture performance for PalB-
HlyA expression and secretion using JM109 (pEHLYAPalB, pVDL9.3): The cultivation 
was conducted at 37 °C with various IPTG concentrations. Panel A/ Time profiles of 
cell density. Panel B/ Time profiles of specific PalB activity. Panel C/ Western blotting 
analysis of the extracellular fraction of culture samples. 
C
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Five E. coli hosts, i.e. BL21(DE3), DH5α, HB101, JM109 and MC4100, were used to 
observe any host effect and the results are summarized in Figure 5.4. While the specific PalB 
activity was the highest with the use of MC4100 or DH5α as the expression host (Figure 
5.4B), the latter suffered poor growth (Figure 5.4A) which negatively impacted the overall 
culture performance. On the other hand, recombinant HB101 had the lowest specific PalB
activity (Figure 5.4B). Note that no secretion was observed for recombinant BL21(DE3)
(data not shown) though it is often considered an effective host for recombinant protein 
production. The results suggest the importance of selecting a proper host strain for the 
extracellular production of PalB using the hemolysin secretion system. Interestingly, the 
doublet bands on the Western blot for the late culture samples of recombinant JM109 and 
DH5α were similar in pattern since the two bands had a comparable intensity (Figure 5.4C). 
On the other hand, the lower band of the doublet for the late recombinant HB101 culture 
samples was minor, whereas the upper band of the doublet for recombinant MC4100 culture 
samples was minor (Figure 5.4C). Note that the high PalB activities associated with the late 
recombinant MC4100 culture samples support the previous argument that both bands could 
represent a bioactive species.
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Figure 5.4 Effect of the host cell on the culture performance for PalB-HlyA expression 
and secretion: Various E. coli hosts, including DH5α, HB101, JM109, and MC4100, 
harboring pEHLYAPalB and pVDL9.3 were used. The cultivation was conducted at 37 
°C with 0.5 mM IPTG. Panel A/ Time profiles of cell density. Panel B/ Time profiles of 




Extracellular secretion for functional expression of PalB was also explored in a 
bioreactor and the cultivation results using JM109 (pEHLYAPalB, pVDL9.3) are 
summarized in Figure 5.5. With the cultivation at 28 °C, the specific PalB activity was 
increased by 50% at 130 U/L/OD600 as compared to the shaker flask culture in which the 
maximum PalB activity was 83 U/L/OD600. On the other hand, only a slight improvement 
was observed in the secretion of PalB-HlyA for the bioreactor culture at 37 °C when 
compared to the shaker flask culture at the same temperature (i.e. 142 U/L/OD600 vs. 128 
U/L/OD600). While PalB-HlyA was effectively produced and secreted within 9 h of 
bioreactor cultivation at 37 °C, the secreted protein appeared to be rather unstable and the 
PalB activities declined after 9 h. The results imply that a lower cultivation temperature at 28 
°C might be favored for bioreactor cultivation which appears to have a better ambience for 
faster secretion and production of PalB-HlyA.
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Figure 5.5 Bioreactor cultivation of JM109 (pEHLYAPalB, pVDL9.3): The cultivation 
was conducted at 28 °C and 37 °C. IPTG at 0.5 mM was used for induction. Panel A/ 
Time profiles of cell density. Panel B/ Time profiles of specific PalB activity. Panel C/ 
Western blotting analysis of the extracellular fraction of culture samples.
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The modified flagellar secretion apparatus was also explored for the extracellular 
secretion of recombinant PalB using the plasmid p5´3´UTRPalB. The expression of PalB was
under the regulation of the fliC promoter. Using E. coli MKS12, whose flagellin-related
genes of fliC and fliD are deleted, as a host, the results of shaker flask cultivation are 
summarized in Figure 5.6. Consistent to the previous observation (170), protein secretion
was not significantly observed until 24 h of cultivation. Hence, culture samples were 
collected during 24 and 48 h for analysis. Compared to the hemolysin system, the flagellar
system appears to be less effective in terms of the secretion level though the intact PalB 
rather than a PalB protein fusion was secreted. The cultivation was conducted at both 28 °C 
and 37 °C with a rather similar culture performance in terms of cell growth (Figure 5.6B) and 
the secretion level (Figure 5.6C). Western blotting was conducted to probe the expressed 
PalB in both the extracellular and intracellular (soluble) fractions. While the PalB-related 
band at 35 kDa was observed in both fractions, PalB activity was present only in the 
extracellular fraction (Figure 5.6D). The results suggest that extracellular secretion could 
assist proper folding for functional expression of PalB.





























































Figure 5.6 Shaker flask cultivation of MKS12 (p5´3´UTRPalB): The cultivation was 
conducted at 28 °C and 37 °C. Panel A/ Qualitative visualization of PalB activity using 
tributyrin agar plates. Panel B/ Time profiles of cell density. Panel C/ Time profiles of 
specific PalB activity. Panel D/ Western blotting analysis of the extracellular and 
soluble intracellular fraction of culture samples.
Culture performance for extracellular secretion of PalB was enhanced upon bioreactor 
cultivation and the results are summarized in Figure 5.7. Compared to the shaker flask 
cultivation at 37 °C, the corresponding bioreactor culture had not only a higher cell density 
(5.8 vs. 3.2 OD600) but also a higher specific PalB activity (70 vs. 54 U/L/OD600), resulting in 
a significant enhancement in the volumetric PalB activity. There was also a slight 
improvement for bioreactor cultivation at 28 °C due to a higher cell density compared to the 
shaker flask cultivation. Note that the secretion of PalB did not appear to pose any adverse 
effect on cell physiology based on the profile of cell growth.
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Figure 5.7 Bioreactor cultivation of MKS12 (p5´3´UTRPalB): The cultivation was 
conducted at 28 °C and 37 °C. Panel A/ Time profiles of cell density. Panel B/ Time 
profiles of specific PalB activity. Panel C/ Western blotting analysis of the extracellular 
fraction of culture samples.
5.4 Discussion
Though PalB has wide industrial applications, its functional expression in E. coli suffered 
various technical limitations. In our lab, various strategies were explored to express 
heterologous PalB in the cytoplasm, periplasm, and cell surface of E. coli with protein 
misfolding and intracellular proteolysis as the major expression issues (303, 305, 306). 
Hence, extracellular secretion appears to be a plausible alternative for exploration. In this 
study, functional expression of heterologous PalB in E. coli was achieved by extracellular 
secretion via two Sec-independent pathways, i.e. the α-hemolysin (Type I) and the modified 
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flagellar (Type III) secretion systems. Bioactive and rather pure PalB was obtained in the 
extracellular medium with minimum contamination by the host proteins.
Since PalB has three disulfide bonds critical for developing the protein structure and 
biological activity, the absence of the PalB activity for the intracellular fraction of culture 
samples suggests that the intracellularly expressed polypeptides could be maintained in an 
unfolded or partially folded state presumably for preparing extracellular export. It was 
previously demonstrated that single chain Fv fragments secreted by the hemolysin transporter 
retained the antigen binding activity, which is associated with the formation of correct 
disulfide bridges, upon the extracellular accumulation (79). However, the trxB mutant of E. 
coli with an oxidizing cytoplasm had an inhibitory effect on the HlyA-dependant secretion of 
proteins with disulfide bonds (78). These observations suggest that proper disulfide bonds 
formed upon either protein translocation through the export conduit or protein exposure to 
the oxidative environment outside the cell.
One of the advantages of the hemolysin transporter demonstrated in this study lies in its 
fast and efficient secretion of PalB-HlyA with no interference in the folding and activity of 
PalB from the HlyA moiety. The hemolysin transporter has been competitive for the 
secretion of small heterologous polypeptides, such as single Ig domains (28), single chain Fv 
(79), and Shiga-like toxin IIeB (286). Apparently, the large size of PalB-HlyA with more 
than 500 amino acids did not affect its effective secretion, as demonstrated herein.
Though the hemolysin transporter is able to export the target protein extracellularly, it 
has at least two drawbacks. First, the secreted protein remains fused to HlyA and, depending 
on the application, an additional cleavage step might be required to obtain the native target
protein. Second, coexpression of HlyB and HlyD secretion component proteins is required to 
mediate the secretion (7, 276). The simultaneous overexpression of the target protein fusion 
(i.e. PalB-HlyA) and transport component proteins might lead to an extra physiological 
burden on producing cells, resulting in relatively poor cell growth observed herein.
It is interesting to observe another protein species, with its size a bit smaller than the 
expected size of PalB-HlyA, in the extracellular fraction of culture samples after prolonged 
cultivation. Apparently, the secreted PalB-HlyA was subjected to extracellular proteolysis. In 
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addition to intracellular proteases, cell envelope proteases can also mediate the proteolysis of
recombinant proteins heterologously expressed in E. coli. For example, the outer membrane 
protease OmpT was shown to specifically degrade several recombinant proteins incubated 
with intact E. coli K-12 (101). It was also applied for the proteolysis of secreted proteins 
fused with HlyA (110). OmpT acts on dibasic residues (176) and is present in all the E. coli
hosts used herein except BL21(DE3). The PalB-related band with a lower molecular weight 
could possibly represent the OmpT-degradation product of PalB-HlyA. Nevertheless, it 
seems that the extracellular proteolysis did not affect the PalB activity, particularly for the 
culture of recombinant MC4100 in which most of secreted PalB-HlyA was digested but 
without losing the PalB activity (Figure 5.4C). Such proteolysis was almost negligible for the
bioreactor cultivation at 28 °C (Figure 5.5C), implying that it could be associated with high 
cultivation temperature. 
Type III secretion systems were originally identified when conducting studies on 
pathogenesis of bacteria whose invasion mechanism involves the injection of bacterial 
proteins into host cells (87, 126). The structural and regulatory components of the flagellum 
comprise the secretion apparatus, a Type III secretion system that secretes the flagellum from 
the cytoplasm directly to the exterior of the cell (183). Several proteins from evolutionarily 
distant sources, including Peb1 from Campylobacter jejuni (220), D1-D3 repeats from 
Staphylococcus aerus (253), α-enolase from Streptococcus pneumoniae (21), and the 
eukaryotic green fluorescent protein (64) were successfully expressed in E. coli and 
extracellularly secreted using the flagellar secretion system. However, these studies also 
reported that there were polypeptides highly expressed intracellularly but hardly secreted, as 
well as those expressed at low levels but still secreted extracellularly.
While PalB secretion was achieved by the modified flagellar secretion system herein, 
the secretion rate was rather slow and the expression/secretion level was relatively low 
possibly due to the lack of a strong promoter. Majander et al. (170) reported that different 
target proteins have varying levels of protein yield which could be associated with the 
similarity of the target protein sequence to flagellin and in turn the efficiency of transcription 
and translation of the target protein gene. On the other hand, the secretion rate might be 
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influenced by posttranslational folding since the flagellar subunits are secreted in an unfolded 
form (261) and fold only as they assemble (310). However, such secretion mechanism could 
be advantageous for functional expression of PalB which requires the formation of three 
disulfide bonds for proper folding. Extracellular secretion of PalB apparently made disulfide 
bond formation more effective and proteolysis less susceptible, unlike our previous 
explorations with intracellular expression (303, 305, 306). Given the slow secretion rate and 
relatively low PalB expression levels, the major advantage of the flagellar system is that the
intact PalB, instead of PalB protein fusion as mediated by the hemolysin system, could be 
extracellularly secreted. This has a critical impact on biotechnological applications with 
respect to not only functional expression of PalB but also simpler downstream purification 
and recovery.
It is also noteworthy, in both cases, that the extracellular secretion of PalB protein 
products posed a minimum physiological impact on producing cells since the cell growth 
profile was hardly affected by heterologous protein expression and cell lysis was not 
observed during the cultivation. Also, the expression/secretion performance appears to be 
enhanced by bioreactor cultivation as compared to the shaker flask cultivation, presumably 
due to the controlled environment conducive to producing cells. The extracellularly secreted 
PalB products were not subjected to major proteolysis and loss of bioactivity, which was 
previously observed upon intracellular expression (303). While the secretion of PalB 
products was effective, both of the two secretion systems had a technical issue of low 
expression which could be improved by using a strong promoter system.
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Chapter 6
Enhancing the Functional Expression of Heterologous 
Burkholderia Lipase in Escherichia coli
6.1 Introduction 
Lipases are an important biocatalyst for industrial applications (246). Microbial cells 
including bacteria, fungi, and yeasts are the major sources of lipases with various enzymatic 
activities (e.g. hydrolysis, esterification, transesterification, alcoholysis, acidolysis, and 
chemo, regio, enantio-selective synthesis), enzyme properties (e.g. pH and temperature 
stability), and substrate specificities (131). Recent interest in lipases arises particularly from 
their applications as a potential biocatalyst for biodiesel production (197). Many microbial 
lipases have been isolated, sequenced and expressed (43, 61, 133, 285, 305). Among them, 
Burkholderia lipases have certain features of thermal stability, alkaline pH and organic 
solvent tolerance, transesterification activity, and high substrate selectivity, making it an 
attractive industrial enzyme (80, 201, 215). Hence, there is a motivation in developing an 
economically feasible bioprocess for their overproduction. 
The Gram-negative bacterium Escherichia coli is still recognized as the most popular 
host for high-level production of recombinant proteins from both prokaryotic and eukaryotic 
sources (173). While the major expression steps of transcription and translation have to be 
effective to achieve high-level production, it is not uncommon that the recombinant protein 
yield is limited by posttranslational events, such as disulfide bond formation, solubility, 
misfolding, proteolysis, and even the toxicity to host cells (171). The expressed recombinant 
protein can be targeted in various intracellular compartments, including the cytoplasm and 
periplasm, displayed on the cell surface or secreted into the extracellular medium. The 
oxidative environment of the extracytoplasmic compartments is conducive for disulfide bond 
formation (90). Extracellular secretion often yields recombinant proteins in the culture 
medium with minimum contamination from host cell proteins (181). The recombinant 
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proteins can be displayed on the E. coli cell surface for specific applications, such as whole-
cell biocatalysts and high throughput peptide library screening (159).
E. coli has several folding modulators to assist the folding of nascent polypeptides, 
particularly during stressful conditions. These folding modulators, including trigger factor, 
DnaK/J-GrpE, and GroEL/ES in the cytoplasm and Dsb-family chaperones, DegP, FkpA, 
Skp, and SurA in the periplasm, can be potentially useful for the high-level production of 
heterologous proteins in a bioactive conformation in the cytoplasm or periplasm (15). 
Alternatively, fusion tags, originally developed for protein purification with affinity 
chromatography, are an effective tool to enhance the functional expression, solubility, 
bioactivity, and stability of the partner protein (275). The N-terminal tags can potentially 
enhance the translational initiation and, therefore, are more popular (109). Several solubility-
enhancing tags have been successfully used to produce hard-to-express heterologous proteins 
in E. coli (76). 
Given the recognized industrial applicability of Burkholderia lipase, there are very 
few reports regarding its production so far. One of them is the cloning and heterologous 
expression of the Burkholderia cepacia lipase gene in E. coli (229). However, the 
recombinant lipase was predominantly expressed as insoluble inclusion bodies even with the 
coexpression of lipase-specific foldase (Lif) which is a natural lipase folding modulator. 
Another study reported the mutagenesis and screening approach to obtain soluble variants of
Burkholderia lipase for functional expression (104). In the current study, we explored various 
genetic strategies for the functional expression of a lipase from Burkholderia sp. C20 (Lip) in 
E. coli. The Burkholderia strain was originally isolated from the food waste and could 
potentially have novel lipases with the transesterification activity for biodiesel production 
(166).
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6.2 Materials and Methods
6.2.1 Bacterial Strains and Plasmids
Bacterial strains, plasmids, and oligonucleotides used in this study are summarized in Table 
1. DH5α was used as the host strain for molecular cloning. JM109, BL21(DE3), and Origami 
B(DE3) were used as the host strain for Lip expression. The protocols for molecular cloning 
are described in Chapter 3. 
The lip gene was PCR-amplified using the primer pair P1 and P2, and Burkholderia sp. 
C20 chromosomal DNA as the template. The primer pair P1 and P2 was designed based on 
the sequence of the lipA gene of Burkholderia multivorans (NCBI Accession number 
NC_010805-1). The amplified lip gene was cloned to pPCRscriptSK(+) to obtain 
pPCRscriptLip and the DNA sequencing result is given  in Figure 6.1A. The lip gene with 
the native signal peptide was PCR-amplified using P20/P21 primer pairs on pPCRscriptLip 
template, digested with NcoI/EcoRI and ligated to similarly digested pTrc99A to obtain 
pTrcLip. The leaderless(ll) lip gene (without the native signal peptide) was PCR-amplified 
using the primers P58/P21 and pPCRscriptLip template, digested with NcoI/EcoRI and 
ligated to similarly digested pTrc99A to obtain the plasmid pTrcLipll. In addition, PCR was 
performed using pPCRscriptLip as the template and the primer pairs of P131/P27, P58/P27, 
and P58/P59, respectively. The PCR products were digested respectively with SfiI, NcoI/SfiI 
and NcoI/SacI and ligated to similarly digested pESTYFP, pEHLYA2-SD and 
pETM80/pETM82 to construct pESTLipll, pEHLYALipll and pllDsbCLipll/pDsbCLipll. 
The NcoI/EcoRI DNA fragment from pTrcLipll was subcloned into pET20b(+) and pENTR4 
to obtain pETLipll and pENTRLipll, respectively. The lip-containing DNA in pENTRLipll 
was subcloned into pGGWA, pMGWA, pHNGWA, pXGWA, pDest-555, pDest-556, 
pETM-50, and pETM-52 using the Gateway cloning technology (Invitrogen); resulting in 
pGSTLipll, pMBPLipll, pHisNusALipll, pTRXLipll, pT7PKLipll, pSkpLipll, pDsbALipll, 
and pllDsbALipll, respectively. The plasmids pAR3GRO, pARDegP, pARDsbA pARDsbC, 
pARFkpA, pARllDsbA, pARllDsbC, pARSurA and pARSkp respectively contain the 
groEL/ES, degP, dsbA, dsbC, fkpA, lldsbA, lldsbC, surA and skp genes whose expression was 
under the regulation of the araB promoter. The plasmid pG-KJE8 contains the dnaK/J-grpE 
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and groEL/ES genes respectively fused with araB and zt-lp promoters. pG-TF3 contains the 
tig and groEL/ES genes respectively fused with araB and zt-lp promoters. All chaperone 
gene(s)-expression plasmids contain a chloramphenicol-resistant (CmR) marker and, 
therefore, are compatible with all Lip-expression vectors containing an Ampicillin-resistant 
(ApR) marker.
Table 6.1 Strains, plasmids, and oligonucleotides.
Strain Relevant Genotype Source & Reference
E. coli
BL21(DE3)
F– ompT dcm lon hsdSB (rB
-, mB
-) gal λ(DE3[lacI ind1
sam7 nin5 lacUV5-T7 gene 1])
Novagen (224)
DH5α
F'(80 dlac Δ(lacZ)M15) Δ(lacZYA-argF)U169 deoR 
recA1 endA1 hsdR17 (rK
-, mK




recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi-1 
mcrA ∆lac-proAB) F′[traD36 proAB＋ lacIq lacZ∆M15]
Lab stock  (307)
Origami B(DE3)
F–ompT hsdSB(rB- mB-) gal dcm lacY1 ahpC (DE3) 





Isolated from the food waste of a food processing plant (166)
Plasmid
pAR3GRO ParaB::groEL/ES, CmR Lab stock (221)
110
pAR3KJ ParaB::dnaK/J::grpE, Cm
R Lab stock (221)
pARDegP ParaB::degP, CmR Lab stock (214)
pARDsbA ParaB::dsbA, CmR Lab stock (303)
pARDsbC ParaB::dsbC, Cm
R Lab stock (303)
pARFkpA ParaB::fkpA, Cm
R Lab stock (301)
pARllDsbA ParaB::lldsbA, CmR Lab stock (305)
pARllDsbC ParaB::lldsbC, CmR Lab stock (305)
pARSkp ParaB::skp, Cm
R Lab stock (193)
pARSurA ParaB::surA, Cm
R Lab stock
pDest-555 Ptac::6×his::T7PK, ApR Deb K. Chatterjee (47)
pDest-556 Ptac::6×his::skp, ApR Deb K. Chatterjee (47)
pHisperiMBP Ptac::6×his::mbp, Ap
R D. Waugh (192)
pDsbALipll PT7::dsbA::6×his::lipll, ApR This study
pDsbCLipll PT7::dsbC::6×his::lipll, KnR This study
pETM-50 PT7::dsbA::6×his, ApR EMBL
pETM-52 PT7::lldsbA::6×his, ApR EMBL
pETM-80 PT7::dsbC::6×his, ApR EMBL (72)
pETM-82 PT7::lldsbC::6×his, ApR EMBL (72)
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pENTR4 Entry vector, attL1-rrNB-attL2, KnR Invitrogen
pENTRLipll lipll gene containing entry vector, KnR This study




R Lab stock (193)
pESTLipll Plac::phoAsignal::lipll::estA, CmR This study
pET20b(+) PT7::pelB, ApR Lab stock
pETLipll PT7::pelB::lipll, Ap
R This study
pG-KJE8 ParaB::dnaK/J::grpE, Pzt-lp::groEL/ES, Cm
R T. Yura (198)
pG-TF3 ParaB::tig, Pzt-lp::groEL/ES, CmR T. Yura (198)





pHNGWA PT7::6×his::nusA, ApR D. Busso (40)
pHisNusALipll PT7:: 6×his::nusA::lipll, Ap
R This study
pllDsbALipll PT7::lldsbA::6×his::lip, ApR This study
pllDsbCLipll PT7::lldsbA::6×his::lip, KnR This study






PCR cloning vector, ApR Stratagene
pPCRscriptLip PCR cloning of lip, ApR This study
pSkpLipll PT7::skp::lip, ApR This study
pT7PKLipll PT7::T7PK::lipll, ApR This study
pTF16 ParaB::tig, Cm
R T. Yura (198)
pTrcLip Ptrc::lip, Ap
R This study
pTrcLipll Ptrc::lipll, ApR This study
pTRXLipll PT7:: trx::lipll, Ap
R This study
pXGWA PT7::trx, Ap
R D. Busso (40)
Oligonucleotides
P1 5'-ATGGCCAGATCGATGCGTTCCAGGGTGGTG-3' This study
P2 5'-TCAGACGCCCGCGAGCTTCAACCGGTTCGC-3' This study
P20 5'-CCGCCCATGGCCAGATCGATGCGTTCCAGG-3' This study





P27 5'-CACCGCGGTGGCGGGAGCTCAAGCCCCGCC-3' This study
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P58 5'-GCGGCAACCGCCATGGCCGACGACTATGCG-3' This study





* Italic: mutation nucleotides, underline: restriction site
6.2.2 Cultivation
The protocol for cultivation is described in Chapter 3. After induction, the Erlenmeyer flasks 
were further shaken at the same conditions for another 4h at 28 ⁰C, or 24h at 15 ⁰C. All the 
shaker-flask cultivations were conducted at least in duplicate.
6.2.3 Analytical Methods
The protocols for various analyses are described in Chapter 3 and Chapter 4. Lip activity was 
qualitatively evaluated by the area and transparency of the halo formed on 1% tributyrin agar 
plates. To conduct this, soluble fractions and extracellular fractions of 50-L were loaded on 
the plate and incubated at 37 °C overnight. On the other hand, Lip enzyme assay was 
conducted using a pH-stat (Brinkman Metrohm 842 Titrando, FL, USA). An appropriate 
volume of the soluble fraction of cell lysates was added to 5 mL of 2% tributyrin emulsion in 
water at 55 °C and the reaction solution was maintained at pH 9.0 by controlled addition of 
0.02 N NaOH (279). One unit of enzyme activity is defined as the amount of enzyme 
required to liberate one mole of fatty acid per min.
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1-6_complete      ATGGCCAGATCGATGCGTTCCAGGGTAATGGCAGGGGCAGTGGCATGCGC
NC_010805-1     (1) ATGGCCAGATCGATGCGTTCCAGGGTGGTGGCAGCAGCAGTGGCGTGCGC
                     
1-6_complete        GATGAGCGTCGCGCCGTTCGCGGGGACGACCGCGCTGACGACGCTCGCGA
NC_010805-1    (51) GATGAGCGCCGCGCCGTTCGCGGGAACGACCGCGTTGATGACGCTCGCGA
                     
1-6_complete         CGACGCACGCGGCGATGGCGGCAACCGCGCCCGCCGACGACTATGCGACG
NC_010805-1   (101) CGACGCGCACGGCGCTCGCCGCGATTGCGCCGGCCGACGATTACGCGGCG
1-6_complete         ACGCGCTATCCGATCATTCTCGTGCACGGGTTGACCGGCACCGACAAGTA
NC_010805-1   (151) ACGCGCTATCCGATCGTCCTCGTGCACGGGCTCACGGGCACCGACAAGTA
                     
1-6_complete         CGCGGGCGTACTCGATTACTGGTACGGCATCCAGGAAGACCTGCAACAGC
NC_010805-1   (201) CGCGGGCGTGCTCGAGTACTGGTACGGCATCCAGGAAGACCTGCAGCGGC
                     
1-6_complete         ATGGCGCGACCGTCTACGTCGCGAACCTGTCGGGCTTCCAGAGCGACGAC
NC_010805-1   (251) ACGGTGCGACGGTGTATGTCGCGAACCTGTCGGGATTCCAGAGCGACGAC
                     
1-6_complete         GGCCCGAACGGGCGCGGCGAACAGCTGCTGGCTTACGTGAAGACGGTGCT
NC_010805-1   (301) GGTCCGAACGGACGCGGCGAACAGCTGCTCGCATACGTGAAGCAGGTGCT
                     
1-6_complete         CGCCGCGACCGGCGCGACCAAGGTCAATCTCGTCGGTCACAGCCAGGGCG
NC_010805-1   (351) GGCCGCGACCGGCGCGACGAAGGTCAATCTGATCGGTCATAGCCAGGGCG
                     
1-6_complete         GGCTGACGTCGCGCTATGTCGCGGCCGTCGCGCCCGATCTCGTCGCGTCG
NC_010805-1   (401) GTCTCACGTCGCGCTACGTGGCGGCCGTCGCGCCGGATCTCGTCGCGTCG
                     
1-6_complete        GTGACGACGATCGGCACGCCGCATCGCGGCTCCGAGTTCGCCGACTTCGT
NC_010805-1   (451) GTGACGACGATCGGCACTCCGCATCGCGGCTCGGAGTTCGCGGACTTCGT
                     
1-6_complete         GCAGGACGTGCTCGCGTACGATCCGACCGGACTGTCGTCGACGGTGATCG
NC_010805-1   (501) GCAGAGCGTGCTTGCGTACGACCCGACCGGGTTGTCGTCGTCGGTGATCG
1-6_complete         CCGCGTTCGTCAATGTATTCGGAATCCTGACGAGCAGCAGCCACAACACG
NC_010805-1   (551) CCGCGTTCGTCAATGTGTTCGGCATCCTGACGAGCAGCAGCCACAACACG
                     
1-6_complete         AACCAGGACGCACTCGCGTCGCTGAAGACGCTGACGACCGCGCAGGCCGC
NC_010805-1   (601) AACCAGGACGCGCTCGCCGCACTGACGACGCTGACGACCGCGCAGGCCGC
                     
1-6_complete         CACCTACAACCAGAACTATCCGAGCGCGGGCCTCGGCGCTCCCGGCAGTT
NC_010805-1   (651) GACCTACAACCGGAACTTTCCGAGCGCGGGTCTCGGTGCACCGGGCAGCT
                     
1-6_complete         GCCAGACCGGCGCGCCGACGGAAACCGTCGGCGGCAACACGCATCTGCTG
NC_010805-1   (701) GCACGACCGGTGCGTCGACGGAAACCGTCGGCGGCAATACGCATCTGCTG
                     
1-6_complete         TATTCGTGGGCCGGCACGGCGATCCAGCCGACGCTGTCGCTGTTCGGCGT
NC_010805-1   (751) TACTCGTGGGCCGGCACCGCGATTCAGCCGACGAATTCGGCGTTCGGCGT
                     
1-6_complete         GACGGGGGCGACGGATACGAGCACCGTTCCGGTCGTCGATCCGGCGAACG
NC_010805-1   (801) CACGGGCGCGAGCGACACGAGCACGATTCCGGTCATCGATCCGGCCAATG
                     
1-6_complete         TGCTCGACCTGTCGACGCTCGCGCTGTTCGGCACGGGCACGGTGATGATC
NC_010805-1   (851) CACTCGATGCGTCGACGCTCGCGCTGCTCGGCACGGGCACCGTGATGATC
                     
1-6_complete         AACCGCGGTTCGGGCGAGAACGACGGGCTCGTGTCGAAGTGCAGCGCGCT
NC_010805-1   (901) AATCGCGGCTCGGGGCAGAACGACGGACTCGTGTCGAAGTGCAGCGCGCT
                     
1-6_complete         GTACGGCAAGGTGCTGAGCACGCGCTACAAGTGGAACCATATCGACGAGA
NC_010805-1   (951) GTACGGACAGGTGCTCGGCACGCACTTCAAATGGAATCATCTCGACGAGA
                     
1-6_complete         TCAACCAGCTGCTCGGCGTGCGCGGCGCGTATGCGGAAGACCCGGTCGCG
NC_010805-1  (1001) TCAATCAGTTGCTCGGCGTGCGCGGTGCGTATGCGGAAGATCCGGTCGCG
                     
1-6_complete        GTGATCCGCACGCATGCGAACCGGTTGAAGCTCGCGGGCGGGTGA




           
          
1                                               50
Translation of 1-6_complete    (1) 
MARSMRSRVMAGAVACAMSVAPFAGTTALTTLATTHAAMAATAPADDYAT
Translation of NC_010805-1    (1) 
MARSMRSRVVAAAVACAMSAAPFAGTTALMTLATTRTALAAIAPADDYAA
51                                             100
Translation of 1-6_complete   (51) 
TRYPIILVHGLTGTDKYAGVLDYWYGIQEDLQQHGATVYVANLSGFQSDD
Translation of NC_010805-1   (51) 
TRYPIVLVHGLTGTDKYAGVLEYWYGIQEDLQRHGATVYVANLSGFQSDD
101                                            150
Translation of 1-6_complete  (101) 
GPNGRGEQLLAYVKTVLAATGATKVNLVGHSQGGLTSRYVAAVAPDLVAS
Translation of NC_010805-1  (101) 
GPNGRGEQLLAYVKQVLAATGATKVNLIGHSQGGLTSRYVAAVAPDLVAS
151                                            200
Translation of 1-6_complete  (151) 
VTTIGTPHRGSEFADFVQDVLAYDPTGLSSTVIAAFVNVFGILTSSSHNT
Translation of NC_010805-1  (151) 
VTTIGTPHRGSEFADFVQSVLAYDPTGLSSSVIAAFVNVFGILTSSSHNT
201                                            250
Translation of 1-6_complete  (201) 
NQDALASLKTLTTAQAATYNQNYPSAGLGAPGSCQTGAPTETVGGNTHLL
Translation of NC_010805-1  (201) 
NQDALAALTTLTTAQAATYNRNFPSAGLGAPGSCTTGASTETVGGNTHLL
251                                            300
Translation of 1-6_complete  (251) 
YSWAGTAIQPTLSLFGVTGATDTSTVPVVDPANVLDLSTLALFGTGTVMI
Translation of NC_010805-1  (251) 
YSWAGTAIQPTNSAFGVTGASDTSTIPVIDPANALDASTLALLGTGTVMI
301                                            350
Translation of 1-6_complete  (301) 
NRGSGENDGLVSKCSALYGKVLSTRYKWNHIDEINQLLGVRGAYAEDPVA
Translation of NC_010805-1  (301) 
NRGSGQNDGLVSKCSALYGQVLGTHFKWNHLDEINQLLGVRGAYAEDPVA
351          363
Translation of 1-6_complete  (351) 
VIRTHANRLKLAGG




Figure 6.1 A) Nucleotide sequence analysis of the open reading frame (ORF) of the lip
gene amplified by PCR using the genomic DNA of Burkholderia sp. C20 as the template 
and the primer pair of P1 and P2 (denoted as ‘1-6’). The sequences of the primers P1 
and P2 were determined based on terminal sequences of the 1095-bp lipase gene (lipA) 
on the chromosome 2 of Burkholderia multivorans ATCC 17616 (NCBI accession 
number NC_010805, region 699394~700488). The sequences of lip (1-6) and lipA
(denoted as ‘NC_010805’) have been aligned to share a sequence similarity of 87.9%. 
The stop codon ‘TGA’ at the 3’ end of 1-6 in the figure was originally ‘GCT’ in the 
amplified DNA, which was replaced with a ‘STOP’ codon for further cloning 
experiments. B) The translated amino acid sequences of the lip gene (denoted as 
‘translation of 1-6 complete’) and lipA gene (depicted as ‘translation of NC-010805_1’) 
have been aligned to share a sequence identity of 85.6% and a sequence consensus of 
89.5%. The 1-364 amino acid sequence of lip gene (1-6) was subjected to the BLAST 
query (www.ncbi.nlm.nih.gov). A sequence identity of 99% (362/364) and 100% positive 
(364/364) was observed with a potential lipase gene (NCBI accession number 
YP_002233567) identified from the genomic sequence of Burkholderia cenocepacia
J2315. Further DNA sequence analysis of the two ORFs showed 100% similarity (4 
nucleotides being different and no gap), confirming the missing of a ‘STOP’ codon in 
the original PCR product of lip (1-6). Lipase genes from other Burkholderia sp. shared 
70% to 96% sequence identity with lip (1-6). It may be noted that lip (1-6) shared only 
92% and 93% sequence similarity to two other species of Burkholderia cenocepacia. 
The arrow represents the predicted cleavage site associated with the signal peptide (40 
amino acids) using the SignalP 3.0 server (www.cbs.dtu.dk/services/SignalP/). However, 
the extracellular lipase purified from Burkholderia sp. HY-10 (215) was determined to 
have the N-terminal amino acid sequence of ‘ADTYAATRYPIILVHGLTGTDKYAG’ 
which is similar to the underlined amino acid sequence of 
‘ADDYATTRYPIILVHGLTGTDKYAG’. This was determined as the N-terminal 
sequence of mature Lip for the subsequent cloning of the lip gene without its native 
signal peptide coding sequence (ll-lip).
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6.3 Results
Seven scenarios (i.e. A1, A2, B, C, D, E, and F summarized in Figure 6.2) for the functional 
expression and targeting of a lipase from Burkholderia sp. C20 (Lip) in E. coli are compared. 
Figure 6.2 Various expression strategies adopted in this study for the production and 
targeting of Lip in E. coli. A1/ Secretion of Lip into the extracellular medium: The lip
gene containing the native signal peptide is expressed under the regulation of the trc
promoter. The native signal peptide is responsible for the extracellular secretion of Lip 
(denoted as LipA1). A2/ Secretion of Lip into the periplasm: The lip gene without its 
native signal peptide coding sequence (ll-lip) is fused with the pelB signal sequence and 



































signal peptide is responsible for the translocation of Lip to the periplasm (denoted as 
LipA2). B: Periplasmic expression of Lip fusions: Lip is N-terminally fused with various 
expression enhancing tags (i.e. DsbA, DsbC, and HisperiMBP) and the Fu::ll-lip gene 
fusions are expressed under the regulation of the T7 or tac promoter. The signal 
peptides of DsbA, DsbC, and MBP are respectively responsible for the translocation of 
Fu-Lip to the periplasm (denoted as Fu-LipB). C/ Surface display of Lip: Lip is C-
terminally fused with an inactive variant of EstA from Pseudomonas aeruginosa and the 
ll-lip::estA fusion is expressed under the regulation of the lac promoter. The signal 
peptide of PhoA is responsible for exporting Lip-Fu (denoted as Fu-LipC). D/ 
Cytoplasmic expression of Lip: The ll-lip gene is expressed in the cytoplasm under the 
regulation of trc promoter (denoted as LipD). E/ Cytoplasmic expression of Lip with an 
N-terminal fusion tag: Lip is N-terminally fused with various expression enhancing tags 
(i.e. DsbA, DsbC, GST, MBP, NusA, Skp, T7PK, and TRX) and the Fu::ll-lip gene 
fusions are expressed in the cytoplasm under the regulation of the T7/tac promoter 
(denoted as Fu-LipE). F/ Secretion of a Lip fusion into the extracellular medium: Lip is 
C-terminally fused with HlyA and the ll-lip::hlyA gene fusion is expressed under the 
regulation of the lac promoter. Lip-HlyA is extracellularly secreted via the α-hemolysin 
transporter (denoted as Lip-FuF). 
The culture performance of Lip expression using JM109 (pTrcLip) (i.e. scenario A1) 
is summarized in Figure 6.3. Visible halos were observed on tributyrin plates (Figure 6.3A) 
for the extracellular medium samples of the IPTG-induced culture with the lipase activity up 
to 55 U/L (expression system 1 in Figure 6.3C), but not for the soluble intracellular fraction. 
The results imply that bioactive Lip was expressed and secreted into the extracellular 
medium under the direction of the native signal peptide which is recognized by E. coli. The 
extracellular expression posed no adverse physiological impact on the bacterial cell growth 
(Figure 6.3B). Since Burkholderia lipase is translocated across the inner membrane while 
being unfolded via the Sec secretion system prior to the secretion into the extracellular 
medium (86), folding factors in the cell envelope were coexpressed to investigate their effect 
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on Lip expression and the results are summarized in Figure 3 as well. Among the folding 
factors investigated, Skp significantly increased the lipase activity by 36% to 75 U/L (#7 in 
Figure 6.3C); whereas DegP had an adverse effect with neither halos being present on 
tributyrin plates nor a measurable lipase activity (#6 in Figure 6.3C). 
                







































                 
Figure 6.3 Culture performance of Lip expression (scenario A1) using (1) JM109 
(pTrcLip), (2) JM109 (pTrcLip, pARFkpA), (3) JM109 (pTrcLip, pARDsbA), (4) 
JM109 (pTrcLip, pARDsbC), (5) JM109 (pTrcLip, pARSurA), (6) JM109 (pTrcLip, 
pARDegP), (7) JM109 (pTrcLip, pARSkp). Panel A/ Qualitative visualization of lipase 
activity on tributyrin agar plates. Panel B/ Cell density. Panel C/ Lipase activity. ‘C’, 
‘I’, and ‘A’ represent the cultures ‘without induction’, ‘with IPTG induction’, and 
‘with arabinose induction’, respectively. ‘E’ and ‘L’ represent the ‘extracellular 
fraction’ and ‘soluble lysate fraction’, respectively.
The culture performance for Lip expression in the cytoplasm of E. coli (i.e. scenario 
D) is described in Figure 6.4. Among the three hosts investigated, i.e. JM109, BL21(DE3), 
and Origami B(DE3), the halo associated with tributyrin hydrolysis was visualized only for 
the culture sample of recombinant Origami B(DE3) and the lipase activity appeared to be 
extremely low (#2 in Figure 6.4A). However, neither lipase activity was measurable by pH 
stat nor the protein band corresponding to Lip overexpression was identifiable by SDS-


























two possible expression issues, i.e. ineffective translation or protein degradation. Several 
cytoplasmic chaperones including GroEL/ES, Trigger factor, DnaK/J-GrpE, and the Dsb-
chaperones were coexpressed to investigate their possible effect on the cytoplasmic
expression of Lip. Visible halos developed on tributyrin agar plates were slightly visible only 
for BL21(DE3) (pTrcLipll, pAR3GRO) and BL21(DE3) (pTrcLipll, pG-KJE8) (#4 and #5 in 
Figure 6.4A), but however not for recombinant Origami B(DE3) (data not shown). Again, the 
lipase activity was not measurable by pH stat and the Lip band was not identifiable by SDS-















                     
Figure 6.4 Culture performance of Lip expression (scenario D) using (1) JM109 
(pTrcLipll), (2) Origami B(DE3) (pTrcLipll), (3) BL21(DE3) (pTrcLipll), (4) 
BL21(DE3) (pTrcLipll, pAR3GRO), (5) BL21(DE3) (pTrcLipll, pG-KJE8). Panel A/ 
Qualitative visualization of kipase activity on tributyrin agar plates. Panel B/ Cell 
density. ‘C’ ‘I’ ‘A’ and ‘Tc’ represent the cultures ‘without induction’, ‘with IPTG 
induction’, ‘with arabinose induction’, and ‘with tetracycline induction’, respectively. 
The culture performance for Lip expression in the periplasm of E. coli (i.e. scenario 
A2) is summarized in Figure 6.5. Using the cell lysate of the BL21(DE3) (pETLipll) culture 
sample with IPTG induction, a halo was visualized on tributyrin agar plates (Figure 5A) and 
a lipase activity up to 50 U/L was measured (Figure 6.5C). A protein band corresponding to 
Lip at 35 kDa were visualized upon the SDS-PAGE analysis, but most of the expressed Lip 
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misfolding. Neither lowering the cultivation temperature to 15 °C nor the coexpression of 
periplasmic chaperones improved the solubility or lipase activity (data not shown). 
                                        
                                                    


















































                                         
Figure 6.5 Culture performance of Lip expression (scenario A2) using BL21(DE3) 
(pETLipll). Panel A/ Qualitative visualization of lipase activity on tributyrin agar 
plates. Panel B/ Cell density. Panel C/ Lipase activity. Panel D/ SDS PAGE analysis of 
the soluble and insoluble fractions of culture samples. ‘C’ and ‘I’ represent the cultures 





Given the poor culture performance for the cytoplasmic expression of Lip, eight N-
terminal fusion tags, i.e. DsbA, DsbC, GST, MBP, HisNusA, Skp, T7PK, and TRX, were 
used to construct various translational fusions with Lip for their respective expression in the 
cytoplasm (i.e. scenario E). The culture performance for the expression of these Lip fusions 
in BL21(DE3) and Origami B(DE3) is summarized in Figure 6.6. In general, 28 °C appeared 
to be a better cultivation temperature than 15 °C (Figure 6.6A). Halos with a higher intensity 
were observed for T7PK-Lip, DsbA-Lip and DsbC-Lip fusions (#1, #7 and #8 respectively in 
Figure 6.6A) using BL21(DE3) as the expression host and for T7PK-Lip, Skp-Lip, MBP-Lip, 
and HisNusA-Lip (#1, #4, #5, and #6 respectively in Figure 6.6A) using Origami (DE3) as 
the expression host. GST-Lip fusion hardly had any lipase activity (#3 in Figure 6.6A) no 
matter which host was selected. The majority of the overexpressed Lip fusions aggregated as 
insoluble inclusion bodies (insoluble fraction in Figures 6.6D and 6.6G). In general, the 
lipase activity assayed by pH stat in general correlated with the solubility of Lip fusion 
proteins. Among the eight fusion tags investigated in recombinant BL21(DE3), T7PK, DsbA, 
and DsbC were effective in solubilizing Lip (Lanes 1, 7, and 8 in the soluble fraction of 
Figure 6.6D) and the Lip activities of T7PK-Lip, DsbA-Lip, and DsbC-Lip fusions were 
assayed to be 105 U/L, 135 U/L and 85 U/L, respectively (Figure 6.6C). On the other hand, 
both lipase activity (Figure 6.6C) and protein bands corresponding to TRX-Lip, GST-Lip, 
Skp-Lip, and MBP-Lip (Lanes 2, 3, 4, and 5 in Figure 6.6D) were minimally detected in the 
soluble fraction even though halos can be slightly visualized on tributyrin plates for TRX-
Lip, and Skp-Lip (Figure 6.6A). Though HisNusA-Lip fusion had a visible protein band in 
the soluble fraction (Lane 6 in Figure 6.6D) and showed a faint halo on the tributyrin plate 
(Figure 6.6A), its lipase activity was hardly detected by pH stat (Figure 6.6C). Among the 
seven fusion tags investigated in recombinant Origami B(DE3), the lipase activities of T7PK-
Lip, Skp-Lip, MBP-Lip, HisNusA-Lip fusion proteins were assayed to be 92 U/L, 55 U/L, 25 
U/L, and 35 U/L (Figure 6.6F), respectively, whereas the other fusions had no detectable 
lipase activities with faint halos on tributyrin plates. Note that the lipase activity of Skp-Lip 
was detected by both pH stat and a visible halo on the tributyrin plate though the protein 
band corresponding to Skp-Lip was hardly detectable (Lane 4 in Figure 6.6G). In general, the 
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expressed fusions had a higher protein solubility in Origami B(DE3) than BL21(DE3) 
(Figures 6.6D vs. 6.6G), implying that the enhancement in the protein solubility could be 
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Figure 6.6 Culture performance of Lip expression (scenario E) using an E. coli host 
harboring (1) pT7PKLipll, (2) pTRXLipll, (3) pGSTLipll, (4) pSkpLipll, (5) 
pMBPLipll, (6) pHisNusALipll, (7) pllDsbALipll, (8) pllDsbCLipll. Panel A/ Qualitative 
visualization of lipase activity on tributyrin agar plates. The right and left halves of
each plate represent the culture samples respectively using BL21(DE3) (denoted as ‘B’) 
GG
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and Origami B(DE3) (denoted as ‘O’) as the expression host. The upper half and lower 
halves of each plate represent the cultivation temperatures of 28 °C and 15 °C, 
respectively. Plate 7 corresponds to recombinant BL21(DE3) only since Origami 
B(DE3) is not compatible with the kanamycin-resistant plasmid pllDsbCLipll. Panel B 
& E/ Cell density. Panel C & F/ Lipase activity. Panel D & G/ SDS PAGE analysis of 
the soluble and insoluble fractions of culture samples. Various Lip protein fusions have 
been indicated. Note that Panels B, C, and D represent the cultures using BL21(DE3) as 
the expression host, and Panels E, F, and G represent the cultures using Origami 
B(DE3) as the expression host. ‘C’ and ‘I’ represent the cultures ‘without induction’ 
and ‘with IPTG induction’, respectively.
Similarly, three N-terminal fusion tags, i.e., HisperiMBP, DsbA, and DsbC, were 
used to construct various translational fusions with Lip for their respective expression in the 
periplasm (i.e. scenario B). The culture performance for the expression of these Lip fusions 
in BL21(DE3) is summarized in Figure 6.7. Though visible halos developed on tributyrin 
plates for these Lip fusions (Figure 6.7A), their lipase activities were undeterminable by pH 
stat. Apparently, these fusion tags were incompetent in solubilizing the expressed Lip since 
almost all the Lip fusions were detected in the insoluble fraction as inclusion bodies (Figure 
6.7C). 















                                                        
Figure 6.7 Culture performance of Lip expression (scenario B) using (1) BL21(DE3) 
(pDsbA-Lipll), (2) BL21(DE3) (pDsbC-Lipll), (3) BL21(DE3) (pHisperiMBP-Lipll). 
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half and lower halves of each plate represent the cultivation temperatures of 28 °C and 
15 °C, respectively. Panel B/ Cell density. Panel C/ SDS-PAGE analysis of the soluble 
and insoluble fractions of culture samples. Various Lip protein fusions have been 
indicated. ‘C’ and ‘I’ represent the cultures ‘without induction’ and ‘with IPTG 
induction’, respectively. 
Given the above technical limitations associated with intracellular expression in E. 
coli and the fact that Lip is an extracellular lipase in the original Gram-negative bacterium 
Burkholderia, extracellular secretion of Lip appears to be a plausible approach. To do this, a 
translational fusion of Lip with the 23 kDa C-terminal of HlyA was constructed for 
extracellular secretion of Lip-HlyA via the Hly-transporter (i.e. scenario F). The secretion 
was assisted by HlyB and HlyD which were coexpressed from the plasmid pVDL9.3. Using 
JM109 harboring pEHLYALipll and pVDL9.3, the culture performance for the expression 
and secretion of Lip-HlyA is summarized in Figure 6.8. Visible halos were developed on 
tributyrin agar plates for the extracellular medium samples (Figure 6.8A), but not the 
intracellular fractions; indicating that HlyA can mediate the secretion of bioactive Lip. 
Lipase activity up to 95 U/L was obtained in the 24-h IPTG-induced culture sample without 
affecting cell growth (Figure 6.8C). Note that the samples of the control cultures without 
IPTG induction also developed a visible halo owing to the leaky expression associated with 
the lac promoter, but its lipase activity was very low compared to that of the IPTG-induced 
culture (Figure 6.8C). The Hly-transporter appeared to be more effective than using the 
native signal peptide of Lip for achieving functional Lip secretion in the growth medium of 
E. coli (95 U/L in Figure 6.8C vs. 55 U/L in Figure 6.3C). However, Lip secreted with the 
use of the native signal peptide is an intact Lip as opposed to the Lip-HlyA fusion secreted 
via the Hly-transporter.
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Figure 6.8 Culture performance of Lip expression (scenario F) using JM109 (pEHLYA-
Lipll) Panel A/ Qualitative visualization of lipase activity on tributyrin agar plates. 






















































‘without induction’ and ‘with IPTG induction’, respectively. ‘E’ and ‘L’ represent the 
‘extracellular fraction’ and ‘soluble lysate fraction’, respectively.
Finally, displaying Lip on the E. coli cell surface using the carrier protein of EstA*, 
which is an inactive variant of esterase from Pseudomonas aeruginosa (18), was explored 
(scenario C) and the culture performance of JM109 harboring pESTLipll is summarized in 
Figure 6.9. Upon the qualitative analysis of the lipase activity on tributyrin agar plates, halos 
were observed for both the whole cell and the extracellular fraction, whereas no halo was 
visible for the soluble intracellular lysate (Figure 6.9A). The presence of the lipase activity in 
the extracellular fraction suggests Lip detachment from the cell membrane and/or a potential 
cell lysis. The whole cells harvested from the IPTG-induced culture yielded a lipase activity 
up to 25 U/L upon conducting the lipase assay by pH stat (Figure 6.9C), confirming the 
functional display of Lip on the E. coli cell surface.














        
Figure 6.9 Culture performance of Lip expression (scenario C) using JM109 (pEST-
Lipll) Panel A/ Qualitative visualization of lipase activity on tributyrin agar plates. 
Panel B/ Cell density. Panel C/ Lipase activity. ‘C’ and ‘I’ represent the cultures 
‘without induction’ and ‘with IPTG induction’, respectively. “Ce”, “E”, and “L” 
represent the ‘cell’, ‘extracellular fraction’, and ‘soluble lysate fraction’, respectively, of 
culture samples.
                
6.4 Discussion
Functional expression of recombinant proteins in E. coli can be potentially limited by 
disulfide bond formation. In this study, it appears that Lip expression in the oxidative 
cytoplasm of Origami B(DE3) slightly developed the lipase activity, as opposed to the 
cytoplasmic expression of Lip in the reductive cytoplasm of BL21(DE3) which has no lipase 
activity (Figure 6.4). The results suggest certain disulfide bond(s) could be critical for 












































bridge, which is conserved in lipases from Gram-negative bacteria, is required for protein 
stabilization against heat denaturation and proteolysis (144, 152, 199). Such conserved 
cysteine residues of Cys190 and Cys270 exist in the mature Lip. In addition to disulfide bond 
formation, ineffective translation or proteolysis could also contribute to the poor Lip yield 
associated with the cytoplasmic expression. Coexpression of GroEL/ES, which assists the 
folding of de-novo proteins and the refolding of misfolded proteins (77, 112), had a slightly 
positive effect in developing the lipase activity in BL21(DE3). The low expression yield 
could be partially alleviated with the use of fusion tags and high-level expression was 
achieved for all the Lip fusions except Skp-Lip. Though lipase activity was detected for 
several Lip fusions, the majority of the expressed Lip fusions aggregated as insoluble 
inclusion bodies in the cell, implying another expression issue of protein misfolding. It is 
interesting to observe that the functional expression of the Lip fusion with DsbA was 
achieved in BL21(DE3), but not in Origami B(DE3); whereas the functional expression of 
Lip fusions with MBP, Skp, and HisNusA was achieved in Origami B(DE3), but not in 
BL21(DE3). T7PK was reported to be effective in producing hard-to-express proteins in E. 
coli (47) and it was the only fusion tag achieving the functional expression in both 
BL21(DE3) and Origami B(DE3).
Similarly, the majority of the heterologously expressed Lip, either non-fused Lip or 
Lip fusions, in the periplasm of E. coli formed inclusion bodies though the periplasm is an 
oxidative compartment suitable for disulfide bond formation. The first step for the secretion 
of extracellular lipase in Burkholderia is protein translocation across the cytoplasmic 
membrane to the periplasm via the Sec secretion system and the export occurs concurrently 
with the removal of the N-terminal signal sequence while maintaining a partially folded and 
near native conformation for the secreted lipase (86). Further transport of proteins across the 
outer membrane into the extracellular medium can be mediated by the Xcp secreton, which is 
a complex machinery comprising of at least 12 different proteins and well conserved in the 
Gram-negative bacteria species such as Pseudomonas and Burkholderia (280). Though the 
expressed Lip was targeted to the periplasm of E. coli via the Sec secretion system, the 
presence of insoluble Lip aggregates, even under the situation with the coexpression of 
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periplasmic folding factors, suggests that proper folding of Lip was prevented in the 
periplasm. Interestingly, the expression of Lip with its native signal peptide produced active 
enzyme in the extracellular medium of E. coli, implying that extracellular secretion assists 
the proper folding of Lip. Apparently, the signal peptide of Burkholderia Lip is recognized 
by E. coli for the extracellular secretion of Lip even though no Xcp-secreton-like system has 
been reported for E. coli. Technically, it will be interesting to explore the use of the Lip 
signal peptide for the extracellular secretion of recombinant proteins since most of the signal 
peptides adopted in E. coli are primarily for the secretion of recombinant proteins into the 
periplasm (143, 169, 189, 245). The extracellular expression of Lip was further improved by 
Skp coexpression. Skp is a cell envelope chaperone that helps maintaining an intermediate 
folded conformation for outer membrane proteins to be competent for export and insertion 
onto the outer membrane (39). It was demonstrated to be effective in improving the folding 
of recombinant antibody fragments in the periplasm (31) and the display of recombinant 
proteins on the cell surface (193). The improved extracellular expression of Lip associated 
with Skp coexpression might be due to the prevention of premature Lip folding in the 
periplasm so that the subsequent export across the outer membrane was facilitated.
Since extracellular secretion appears to be an effective approach for the functional 
expression of Lip, another strategy of using the α-hemolysin transporter for extracellular 
secretion was successfully explored in this study. The extracellular secretion was conducted 
through the construction of a Lip-HlyA fusion whose translocation across the inner and outer 
membranes in E. coli is mediated by an export conduit which is assembled by the Hly-
transport component proteins of HlyB, HlyD (88) and the outer membrane protein TolC (7). 
No signal peptide is required for such direct secretion of Lip-HlyA from the cytoplasm to the 
cell exterior without a periplasmic intermediate (276). It was reported that functionally active 
single chain Fv antibodies with correct disulfide bonds were secreted via the Hly-transporter 
(79), whereas the activity was demolished when an E. coli mutant defective in thioredoxin 
reductase was used as the host for the secretion (78); suggesting that proper disulfide bonds 
could be formed during the protein transport through the export conduit or in the oxidative 
culture medium. Such a feature might be helpful in terms of forming the disulfide bridge of 
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Cys190-Cys270 in Lip-HlyA which is required for stabilizing the active protein (144). 
Comparing the two secretion strategies, both of them posed a minimum physiological impact 
on cell growth, but the one via the Hly-transporter appeared to produce a higher lipase 
activity. However, a Lip-HlyA fusion was produced and, as a result, an additional protein 
cleavage step would be required to obtain the native Lip. On the other hand, the native Lip 
was produced through the secretion based on the native signal peptide.
Finally, Lip was functionally expressed on the E. coli cell surface using EstA*, an 
inactive variant of EstA from Pseudomonas aeruginosa, as a carrier protein. EstA has been 
shown to be properly localized on the outer membrane upon heterologous expression in E. 
coli and, as a result, it can serve as a carrier for the functional display of several lipolytic 
enzymes from Fusarium solani, Bacillus subtilis, and Serratia marcescens on the E. coli cell 
surface (18). Since the N-terminal extracellular domain of EstA is intact in this design, the 
passenger protein fused to the carrier can be relatively large, fully exposed on top of the 
carrier protein, and placed far from the lipopolysaccharide layer as compared to other 
displaying systems. In this study, whole cells with the expressed Lip-EstA* were found to 
have the lipase activity, implying the functional expression of Lip on the cell surface. 
However, the lipase activity was also detected in the extracellular medium, suggesting some 
of the displayed Lip was released. The release of the displayed Lip could be possibly due to 
the proteolytic attack by certain outer membrane protease, such as OmpT (101), or the 
release of the whole Lip-EstA* fusion into the medium since EstA is not a native E. coli
protein and the integration of EstA with the outer membrane might not be firm enough. The 
E. coli cells with bioactive Lip being expressed on the outer membrane can be used as a 
whole-cell biocatalyst though the displaying performance could be further improved.
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Chapter 7
Original Contributions and Recommendations
7.1 Original Contributions
7.1.1 Periplasmic Chaperone Skp Reduces Extracytoplasmic Stress and 
Improves Cell Surface Display in E. coli
Cell physiology seriously deteriorated when yellow fluorescence protein (YFP) was 
displayed on E. coli cell surface, resulting in growth arrest, cell lysis, and poor display 
performance. Coexpression of Skp, a periplasmic chaperone known to be associated with 
several outer membrane proteins for their targeting onto the outer membrane, was 
demonstrated to be effective to restore the deteriorated cell physiology. Upon Skp 
coexpression, cells with YFP display became less sensitive to EDTA and SDS, implying cell 
physiology was improved. Display performance was highly enhanced due to the increased 
specific fluorescence intensity without growth arrest and cell lysis. Results of transmission 
electron microscopy (TEM) indicated that the density of surface-displayed YFP was highly 
increased upon Skp coexpression. Cells with YFP display experienced a high level of 
extracytoplasmic stress, as reflected by the induced promoter activities of three stress-
responsive genes, i.e. degP and rpoH. The extracytoplasmic stress reflected by the degP
promoter activity appeared to correlate well with the phenotypical cell physiology observed 
under various culture conditions for cell-surface display. The gene fusion of PdegP::lacZ was 
therefore proposed to be a suitable “sensor” for monitoring extracytoplasmic stress and cell 
physiology during the course of E. coli cell-surface display.
7.1.2 Stabilization of Proteolytically Sensitive Periplasmic Recombinant PalB 
Expression in E. coli
Using a eukaryotic protein of lipase B (PalB) from yeast Pseudozyma antarctica as the target 
protein for heterologous expression in E. coli, we experimentally demonstrated that the 
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proteolytic specificity can be intrinsically determined by the sequence of protein substrate 
and can be drastically altered by simple amino acid substitutions. Intracellular proteolysis has 
been recognized as one of the key factors limiting recombinant protein production, 
particularly for eukaryotic proteins heterologously expressed in the prokaryotic expression 
systems of E. coli. However, both the rationale as why these eukaryotic proteins often fall 
into the proteolytic category and the molecular mechanism associated with such proteolysis 
remain incompletely understood. Two proteolytically sensitive amino acid residues, i.e. 
Leu149 and Val223, were identified to critically affect PalB’s susceptibility to proteolysis in
E. coli. Functional expression was significantly enhanced with the use of PalB mutant 
derivatives that can dodge the proteolysis. While the majority of expressed PalB double 
mutant was localized in the periplasm, the functional expression appeared to be limited by 
protein misfolding. Coexpression of a periplasmic folding factor of DsbA could alleviate the 
limitation and, as a result, functional expression of the PalB double mutant was significantly 
enhanced. The study offers an alternative genetic strategy in molecular manipulation to 
enhance recombinant protein production in E. coli.
7.1.3 Efficient Secretion of Active PalB in the Extracellular Medium of E. coli
To overcome the technical problems related to insolubility in the cytoplasm and protein 
instability associated with proteolysis in the periplasm in Escherichia coli, PalB secretion 
from the cytoplasm to the bacterial culture medium without a periplasmic intermediate was 
investigated in this study. The methods are based on the E. coli α-hemolysin transport system 
(Hly) and the modified flagellar Type III secretion apparatus (TTSS) that can export proteins 
of interest from the cytoplasm directly to the exterior of the cell. Cultivation conditions 
including inducer strength, temperature and suitable host strain for optimal PalB-HlyA 
secretion were identified using shaker flask experiments for hemolysin transporter. PalB 
accumulated in the extracellular medium was functionally active with appropriate disulfide 
bridges formed and the secretion was non toxic to the growing cells. However, the secretion 
intermediates in the intracellular fraction of culture samples were non-bioactive even though 
they were soluble, suggesting that the extracellular secretion did mediate the development of 
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PalB activity. Proteolysis of the recombinant PalB-HlyA did not affect PalB activity as PalB 
was likely intact. Pure PalB secretion, unlike PalB-HlyA fusion protein; was achieved using 
the modified flagellar secretion system; however the secretion was slow with lower specific 
PalB activities but effective cell growth. 
7.1.4 Cloning and Functional Expression of Burkholderia Lip in E. coli
Functional expression of lipase (Lip) from Burkholderia sp. C20 in E. coli was explored. 
Active Lip was expressed in the trxB and gor mutant Origami B(DE3) cytoplasm, suggesting 
the importance of disulfide bond formation for Lip expression. While overexpression 
limitation related to low protein limits was observed, coexpression of GroEL/ES folding 
chaperone was found to be enhancing cytoplasmic Lip expression. Though high yields of 
overexpressed Lip were attained during periplasmic expression, most of the polypeptides 
formed insoluble inclusion bodies. Fusion tag technique was also explored by constructing 
several Lip fusions for the evaluation of their expression performance. While cytoplasmic 
overexpression limitation was overcome by using Lip fusions except with Skp, the fusion 
tags T7PK, DsbA, and DsbC were the most effective in boosting the solubility and biological 
activity of the expressed Lip. On the other hand, Lip fusions expressed in the periplasm 
aggregated to form non-native protein. To overcome the technical limitations related to 
intracellular Lip expression, extracellular secretion was explored. Biologically active Lip was 
secreted to the E. coli culture medium using its native signal peptide; coexpression of the 
periplasmic chaperone Skp that assists the folding of periplasmic and outer membrane 
proteins translocated using the Sec-pathway, improved the secretion performance of Lip. 
Enhanced secretion of bioactive Lip fused to HlyA; from the cytoplasm to the culture 
supernatant without a periplasmic intermediate was conducted by α-hemolysin transporter. 
Lip fused to the carrier EstA was functionally displayed on the outer surface of E. coli and 
the whole cells were verified to possess enzymatic Lip activity.
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7.2 Recommendations
1. The extracellular lipase (Lip) in Burkholderia requires the help of a specific lipase-
folding-chaperone (Lif) that is encoded in its operon for appropriate folding and 
secretion of the mature protein. Lif maintains Lip in a partially folded conformation 
competent required for secretion of Burkholderia lipase using the Xcp secreton. The 
lif gene may be isolated by PCR-amplification from the genomic DNA of 
Burkholderia sp. C20. It will be interesting to investigate the coexpression of lif with 
the various constructs of Lip described in Chapter 6, to improve the solubility and 
minimize the inclusion bodies of Lip in E. coli. The coexpression of Lif can be 
targeted to cytoplasm or periplasm depending on the cytoplasmic or extracytoplasmic 
expression of Lip in E. coli.
2. The extracellular proteins including lipase in gram negative bacteria such as 
Burkholderia and the related species Pseudomonas are secreted by the Type II 
secretion pathway, also called the main terminal branch (MTB) of the general 
secretory pathway (GSP), more specifically the Xcp-secreton (226). These proteins 
are translocated in two steps across the bacterial cell envelope. After translocation of 
the signal peptide-bearing exoproteins across the cytoplasmic membrane, a step 
similar to the Sec-mediated transport of proteins in Escherichia coli (227), the 
exoproteins are transported from the periplasm across the outer membrane. The 
secretion by Xcp secreton requires the products of at least 12 xcp genes namely 
xcpAPQRSTUVWXYZ located in the cell envelope (82). XcpP and/or XcpQ 
determine this secretion specificity, based on their results from Erwinia (163). It is 
worth investigation whether the coexpression of the XcpP and XcpQ can improve the 
secretion of Burkholderia Lip in E. coli. 
3. Based on the analysis by SignalP software, the cleavage site of the signal peptide 
from Burkholderia Lip was found to be located between the 40th and 41st amino acid 
residue. However the N-terminal sequencing analysis of the extracellular lipase from 
Burkholderia sp HY-10 starts at the 45th amino acid (described in Chapter 6). 
Therefore the Lip polypeptide might be present as a propeptide after translocation 
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across the cytoplasmic membrane of gram negative bacteria and might possibly 
contain recognition features for folding and secretion. The majority of the 
periplasmically expressed Lip in E. coli was found to form insoluble aggregates. It 
would be worth exploration to express the propeptide rather than the mature peptide 
of Lip in E. coli periplasm to investigate the effect on Lip folding and solubility.
4. Lipase expression is an excellent system for high throughput screening due to the 
possibility of identification of clones expressing active enzyme on tributyrin 
hydrolysis agar plates. Soluble versions of Lip in E. coli may be generated by random 
mutagenesis. Promising clones might be identified; the plasmid DNA isolated from 
the clones can be sequenced to identify the ‘hot spot’ amino acid residues in the 
sequence of Lip. They can be manipulated further by site directed mutagenesis to 
investigate the importance of the recognized amino acids in the structure and 
functional expression in E. coli. Similar methodology may be applied to the 
cytoplasmic expression of Lip in E. coli to identify mutants that have enhanced 
expression with respect to efficient translation and/or resistance to proteolysis.
5. Several other genes (six) named as putative lipase or esterase were isolated from the 
genomic DNA of Burkholderia sp. C20 based on the chromosome sequence of other 
Burkholderia species (NCBI) and cloned in various vectors for cytoplasmic and 
extracytoplasmic expression in E. coli. It would be exciting to identify any novel 
lipolytic enzymes present in Burkholderia sp. C20 and overexpress them in E. coli.
6. Apart from the many interesting applications of PalB, recent interests have arisen due 
to its potential for biotransformation for biodiesel production as opposed to the 
chemical conversion of oils. However this process requires the overproduction of the 
enzyme in a cost effective manner. The improvement in the bioprocess of functional 
overexpression of PalB mutant in E. coli might provide an effective alternative for 
large-scale production of PalB as opposed to the rather expensive preparations of 
PalB from Novazym (Novozymes A/S) and Chirazyme (Roche Molecular 
Biochemicals) (145). The pure protein preparation of PalB mutant can be compared 
with the standard PalB (from Novazym).
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7. A few other clones, with halos of intensities relatively lower than the double mutant 
of PalB (Leu149, Val223) were identified. It is worthwhile to investigate the relevant 
mutations present in those clones responsible for the enhanced expression in E. coli. 
Although it has been known widely that the protein sequence determines their 
susceptibility to proteolysis and a number of proteases in E. coli have been identified, 
their substrate specificity or recognition sequences have not been explored properly. 
Identification of the proteolytically sensitive sequences of PalB described in Chapter 
4 should be used to identify any novel protease or the substrate specificity of the 
existing proteases. Such information can be used for the construction of potential 
mutant strains in E. coli deficient in proteases, which would be useful for expression 
of eukaryotic proteins.
8. PalB expressed in the extracellular medium which has minimum contamination from 
host proteins, could be concentrated and/or purified to be used in the preparation of 
immobilized enzymes.
9. In our previous studies (193), the degP promoter activity was found to be a suitable 
marker for probing the level of extracytoplasmic stress that cells encountered under 
various culture conditions for surface display and periplasmic expression of 
recombinant proteins. However, the rpoH promoter activity failed to show such 
correlation, particularly for the culture conditions in which extracytoplasmic stresses 
appeared to be partially relieved when DegP was coexpressed (194). Since rpoH is a 
member of the σE pathway whose expression is associated with RseA degradation, the 
degradation could possibly be mediated by periplasmic proteases other than DegS. It 
has been reported that DegP, DegQ, and DegS are homologous periplasmic serine 
proteases with a conserved catalytic triad of Ser-His-Asp (146, 292). Hence, DegP 
and DegQ could be alternative proteases for RseA degradation. It would be very 
interesting to investigate if these periplasmic proteases could share an overlapping 
biological function of RseA degradation to induce the rpoH promoter activity under 
stressful conditions associated with the display of a recombinant protein on the cell 
surface of E. coli. 
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Appendix A
Protocols for Molecular Cloning
A1. Genomic DNA Isolation from Burkholderia sp. C20
(DNeasy® Tissue Kit, Qiagen) 
1. Harvest Burkholderia sp. C20 from 1 ml of overnight culture (at 30 °C, 220 rpm) by 
centrifuging for 10 min at 5000 × g, at room temperature. Discard the supernatant.
2. Resuspend the cells in 600 μl of 1 M sorbitol buffer. Add 200 units lyticase and 
incubate at 30 °C for 30 min.
3. Spin down spheroplasts at 300 × g for 10 min. 
4. Resuspend the spheroplasts in 180 μl of Buffer ATL. Add 20 μl of proteinase K, 
vortex, and incubate at 55 °C in a shaking water-bath until the cells are completely 
lysed.
5. Vortex for 15 s. Add 200 μl of Buffer AL to the sample, vortex, and incubate at 70 °C 
for 10 min.
6. Add 200 μl of ethanol (96~100%) to the sample, and vortex.
7. Pipette the mixture from Step 6 into the DNeasy Mini-spin column placed in a 2 ml 
collection tube. Centrifuge at 6000 × g for 1 min. Discard the flow-through with the 
collection tube.
8. Place the DNeasy column in a new 2 ml collection tube, add 500 μl of Buffer AW1, 
and centrifuge at 6000 × g for 1 min. Discard the flow-through with the collection 
tube.
9. Place the DNeasy in a new 2 ml collection tube, add 500 μl of Buffer AW2, and 
centrifuge at 15000 × g for 5 min to dry the DNeasy membrane. Discard the flow-
through with the collection tube.
10. Place the DNeasy column in a clean 1.5 ml microcentrifuge tube, and pipette 200 μl 
of Buffer AE directly onto the membrane. Incubate at room temperature for 1 min, 
and then centrifuge at 6000 × g for 1 min to elution of the genomic DNA.
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A2. Plasmid DNA Isolation from E. coli (Qiaprep Spin Miniprep Kit, 
Qiagen)
1. Resuspend pelleted bacterial cells in 250 µl Buffer P1 (containing RNase) and 
transfer to a micro-centrifuge tube.
2. Add 250 µl Buffer P2 (Lysis buffer) and mix thoroughly by inverting the tube 
gently 4–6 times. 
3. Add 350 µl Buffer N3 (Neutralization buffer) and mix immediately and 
thoroughly by inverting the tube 4–6 times. 
4. Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top 
microcentrifuge. A compact white pellet will form.
5. Apply the supernatants from step 4 to the QIAprep spin column by decanting 
or pipetting.
6. Centrifuge for 30–60 s. Discard the flow-through.
7. Wash the QIAprep spin column by adding 0.5 ml Buffer PB and centrifuging 
for 30–60 s. Discard the flow-through. This step is necessary to remove trace 
nuclease activity when using endA+ strains such as the JM series, HB101 and 
its derivatives, or any wild-type strain, which have high levels of nuclease
activity or high carbohydrate content. 
8. Wash QIAprep spin column by adding 0.75 ml Buffer PE (containing ethanol) 
and centrifuging for 30–60 s.
9. Discard the flow-through, and centrifuge for an additional 1 min to remove 
residual wash buffer.
10. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, add 50 µl Buffer EB (10 mM Tris·Cl, pH 8.5) or water to the center of 
each QIAprep spin column, let stand for 1 min, and centrifuge for 1 min.
A3. DNA Restriction Digestion
1. For analytical purposes, set up the reaction mixture in microfuge tube as follows:
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# The restriction enzymes have to be diluted with the appropriate Diluent buffer to a 
final concentration of 1 U/µl. * For most of the commercial enzymes, 1 Unit of 
enzyme is defined as the amount required to digest 1µg of DNA (e.g.  DNA, check 
with source) in one hour at 37 0C. 
2. Mix the ingredients by pulse-spinning the microfuge tubes.
3. Incubate the reaction solution at 37C (or other recommended temperature for 
specific restriction enzymes) for at least 1 hr.
4. Inactivate restriction enzyme by heating at 65C (or other recommended temperature 
for specific restriction enzymes) for 15 min (optional).
A4. DNA Ligation Reaction
1. Digest the plasmid DNA and the insert DNA with the appropriate restriction 
enzymes. If necessary, isolate the desired fragments by gel elctrophoresis, gel 
extraction and purify by ethanol precipitation.







DI Water x µL
Reaction Buffer 10X 1X      1 µL
DNA 50-200ng/µL 10~30ng/µL      y µL
Restriction Enzyme 1U/µL # ~1 U *    ~1 µL *
Total                                                                        10 µL
Component Amount Volume used (µL)
Insert DNA 0.1-1µg * x
Vector DNA 0.05-1µg * y
10X Ligation Buffer - 1.0
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ended to use equimolar amount of vector and insert DNA for cohesive end ligation. 
(Molecular cloning-Maniatis). 
@ One Weiss Unit is defined as the amount of enzyme that catalyzes the exchange of 1 
nmole of P32 from pyrophosphate into ATP in 20 minutes at 37 0C. One Weiss Unit 
corresponds to 60 cohesive end units as defined by New England Biolabs. (Molecular 
cloning-Maniatis)
3. Mix the components in a pulse spinner.
4. Incubate the reaction mixture 1-4 hours at 16 0C or overnight at room 
temperature. 
A5. DNA Transformation using Chemical Method (54)
TSB (Transformation and Storage Buffer): Stored at 4C
LB broth containing 10% PEG, 5% DMSO and 20 mM Mg+2 (10 mM MgCl2 and 10 mM 
MgSO4)
TSBG: TSB + 20 mM Glucose, stored at 4C
Stock solution
Preparation of 1 M MgCl2
Dissolve 1.904 g MgCl2 (MW = 95.2) into 20 mL DI water and autoclave for 15 min.
Preparation of 1 M MgSO4
Dissolve 2.408 g MgSO4 (MW = 120.4) into 20 mL DI water and autoclave for 15 min.
Preparation of 2 M glucose
1. Dissolve 36 g glucose into 100 mL DI water and autoclave for 15 min.
2. Store it at 4C.
Preparation of TSB (or TSBG)
T4 DNA Ligase Enzyme 0.1 Weiss Units @ 0.2 µL 
Deionised Water To make up the reaction volume to 10 µL. 
Total 10
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1. Mix 93 mL LB broth, 10 g PEG, and 5 mL DMSO.
2. Autoclave the mixture for 15 min.
3. Aseptically add 1 mL of 1 M MgCl2 and 1 mL of 1M MgSO4.
4. *For TSBG, aseptically add 1 mL of 2 M glucose.
5. Store both buffers at 4C.
Procedures
Preparation of competent cells
1. Inoculate 5 mL of LB with a colony. Grow the culture at 37C.
2. Inoculate 100-1000 L of the LB culture to another new LB (say, 25 mL). Grow the 
culture to the early log phase (OD600 = 0.3-0.6).
3. Collect 1 mL of culture in each microfuge tube and centrifuge at 0 4C, 4000g for 5 min.
4. Discard the supernatant and resuspend the pellet in 1/10 volume of TSB (100L). Sit on 
ice for about 10 min and ready to be used.
5. *The competent cells can be stored at -70C.
Transformation
1. For 0.1 mL of the competent cells in TSB in a microfuge tube, add 0.1 g of plasmid 
DNA.
2. Sit on ice for 5-30 min (Heat shock is not necessary).
3. Add 0.9 mL of TSBG.
4. Incubate at 37C with shaking (200 rpm) for 60-90 min to allow the expression of the 
antibiotic resistance gene.
5. Plate 200 L on the appropriate plates for selection of transformants.
A6. DNA Transformation using Electroporation (Modified from 
Electroporation Manual, BioRad)
Preparation of Electrocompetent Cells
1. Inoculate 100 ml of L-broth with 1/100 volume of a fresh overnight E. coli culture.
2. Grow the cells at 37 °C shaking at 200 rpm to an OD600 of approximately 0.5–0.7 .
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3. Chill cells on ice for ~20 min. For all subsequent steps, keep the cells as close to 0 °C 
as possible (in an ice/water bath) and chill all containers in ice before adding cells. To 
harvest, transfer the cells to two cold 60-ml centrifuge bottles and spin at 6000 x g for 15 
minutes at 4 °C.
4. Carefully pour off and discard the supernatant. It is better to sacrifice the yield by 
pouring off a few cells than to leave any supernatant behind.
5. Gently resuspend the pellet in 50 ml of ice-cold 10% glycerol each. Centrifuge at 6000 
x g for 15 minutes at 4 °C; carefully pour off and discard the supernatant.
6. Resuspend the pellet in 50 ml of ice-cold 10% glycerol, transfer to one 60-ml bottle. 
Centrifuge at 6000 x g for 15 minutes at 4 °C; carefully pour off and discard the 
supernatant.
7. Resuspend the pellet in ~4 ml of ice-cold 10% glycerol. Transfer to two 2-ml sterile 
microfuge tubes. Centrifuge at 6000 x g for 15 minutes at 4 °C; carefully pour off and 
discard the supernatant.
8. Resuspend the cell pellet in a final volume of 400µl of ice-cold 10% glycerol. The cell 
concentration should be about 1–3 x 1010 cells/ml.
This suspension may be frozen in aliquots (40µl each in a sterilized 1.5ml microfuge 
tube) on dry ice and stored at -80 °C. The cells are stable for at least 6 months under these 
conditions.
Electroporation
1. Thaw the cells on ice. For each sample to be electroporated, place a 1.5 ml microfuge 
tube and either a 0.1 or 0.2 cm electroporation cuvette on ice.
2. In a cold, 1.5 ml polypropylene microfuge tube, mix 40 µl of the cell suspension with 
1 to 2 µl of DNA (DNA should be in deioned water). Mix well and incubate on ice 
for ~1 minute. (Note: it is best to mix the plasmids and cells in a microfuge tube since 
the narrow gap of the cuvettes prevents uniform mixing.).
3. Set the MicroPulser to “Ec1” when using the 0.1 cm cuvettes. Set it to "Ec2" or "Ec3" 
when using the 0.2 cm cuvettes. See Section 4 for operating instructions.
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4. Transfer the mixture of cells and DNA to a cold electroporation cuvette and tap the 
suspension to the bottom. Place the cuvette in the chamber slide. Push the slide into 
the chamber until the cuvette is seated between the contacts in the base of the 
chamber. Pulse once.
5. Remove the cuvette from the chamber and immediately add 1 ml of SOC medium to 
the cuvette. Quickly but gently resuspend the cells with a Pasteur pipette. (The period 
between applying the pulse and transferring the cells to outgrowth medium is crucial 
for recovering E. coli transformants (Dower et al., 1988). Delaying this transfer by 
even 1 minute causes a 3-fold drop in transformation. This decline continues to a 20-
fold drop by 10 minutes.
6. Transfer the cell suspension to a 17 x 100 mm polypropylene tube and incubate at 37 
°C for 1 hour, shaking at 225 rpm.
7. Check and record the pulse parameters. The time constant should be close to 5 
milliseconds. The field strength can be calculated as actual volts (kV) / cuvette gap 
(cm).
8. Plate on selective medium.
Solutions and Reagents for Electroporation
1. L-Broth: 10 g Bacto tryptone, 5 g Bacto yeast extract, 5 g NaCl; dissolve in 1.0 L 
water. Autoclave. 100ml
2. 10% (v/v) Glycerol: 12.6 g glycerol (density = 1.26 g/cc) in 90 ml of water. 
Autoclave or filter sterilize. 200ml
3. SOC: seperately autoclave,
(1) 2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM NaCl, 2.5 mM KCl, 
(2) 10 mM, MgCl2,
(3) 10 mM MgSO4, 
(4) 20 mM glucose.
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A7. Gel-Extraction of DNA (Qiaquick Gel Extraction Kit, Qiagen)
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. Minimize 
the size of the gel slice by removing extra agarose.
2. Weigh the gel slice in a colorless tube. Add 3 volumes of Buffer QG to 1 volume of 
gel (100 mg ~ 100 μl). 
3. Incubate at 50°C for 10 min (or until the gel slice has completely dissolved). To help 
dissolve gel, mix by vortexing the tube every 2–3 min during the incubation. 
Solubilize agarose completely. For >2% gels, increase incubation time. 
4. After the gel slice has dissolved completely, check that the color of the mixture is 
yellow (similar to Buffer QG without dissolved agarose). Add 1 gel volume of 
isopropanol to the sample and mix. 
5. Place a QIAquick spin column in a provided 2 ml collection tube. To bind DNA, 
apply the sample to the QIAquick column, and centrifuge for 1 min. 
6. Discard flow-through and place QIAquick column back in the same collection tube.
7. Recommended: Add 0.5 ml of Buffer QG to QIAquick column and centrifuge for 1 
min.
8. To wash, add 0.75 ml of Buffer PE to QIAquick column and centrifuge for 1 min. 
9. Discard the flow-through and centrifuge the QIAquick column for an additional 1 min 
at 17,900 x g (13,000 rpm). 
10. Place QIAquick column into a clean 1.5 ml microcentrifuge tube. To elute DNA, add 
50 μl of Buffer EB (10 mM Tris·Cl, pH 8.5) or water (pH 7.0–8.5) to the center of the 
QIAquick membrane and centrifuge the column for 1 min.
A8. PCR Purification of DNA (Qiaquick Gel Extraction Kit, Qiagen)
1. Add 5 volumes of Buffer PB to 1 volume of the PCR sample and mix.
2. Place a QIAquick spin column in a provided 2 ml collection tube.
3. To bind DNA, apply the sample to the QIAquick column and centrifuge for 30–60 s.
4. Discard flow-through. Place the QIAquick column back into the same tube. 
5. To wash, add 0.75 ml Buffer PE to the QIAquick column and centrifuge for 30–60 s.
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6. Discard flow-through and place the QIAquick column back in the same tube. 
7. Centrifuge the column for an additional 1 min. 
8. Place QIAquick column in a clean 1.5 ml microcentrifuge tube.To elute DNA, add 50 
μl Buffer EB (10 mM Tris·Cl, pH 8.5) or water (pH 7.0–8.5) to the center of the 
QIAquick membrane and centrifuge the column for 1 min. Alternatively, for 
increased DNA concentration, add 30 μl elution buffer to the center of the QIAquick 
membrane, let the column stand for 1 min, and then centrifuge.
A9. PCR Cloning (pPCR-ScriptAmp Cloning Kit, Stratagene)
1. To prepare the ligation reaction, add the following components in order in a 0.5-ml 
microcentrifuge tube:
1 μl of the pPCR-Script Amp SK(+) cloning vector (10 ng/μl)
1 μl of PCR-Script 10× reaction buffer
0.5 μl of 10 mM rATP
2–4 μl of the blunt-ended PCR product or 4 μl of the control PCR 
insert
1 μl of Srf I restriction enzyme (5 U/μl)
1 μl of T4 DNA ligase (4U/μl)
Distilled water (dH2O) to a final volume of 10 μl
2. Mix the ligation reaction gently and incubate this reaction for 1 hour at room 
temperature.
3. Transform the ligation mixture to competent E. coli cells and select on agar plate with 
ampicillin and 80 µg/ml X-gal.
A10. Error-Prone PCR (GeneMorph EZClone Domain Mutagenesis 
Kit, Stratagene)
Mutant Megaprimer Synthesis
1. Prepare the sample reaction(s) as indicated below:
5 μl of 10× Mutazyme II reaction buffer
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x μl template 
x μl of sample primers (125 ng/μl of each primer)
1μl of 40 mM dNTP mix (200 μM each final)
x μl of ddH2O for a final reaction volume of 50 μl
1μl of Mutazyme II DNA polymerase (2.5 U/μl)
2. Centrifuge each reaction briefly.
3. Place the reaction in a temperature cycler.
Segment Number of cycles Temperature Duration
1 1 95 ⁰C 2 minutes
2 30
95 ⁰C 1 minute
Primer Tm-5 ⁰C 1 minute
72 ⁰C
1 minute (≤ 1kb targets) 
or 1minute/kb (≥1kb 
targets)
3 72 ⁰C 10 minutes
EZClone Reaction
1. Prepare the sample reaction(s) as indicated below and place in a thermal cycler:
25 μl of the 2× EZClone enzyme mix
50 ng of template plasmid
250 ng megaprimer (<1kb), or 500 ng for ≥1 kb megaprimer
3 μl of EZClone solution
ddH2O to a final volume of 50 μl
Segment Number of cycles Temperature Duration
1 1 95 ⁰C 1 minute
2 25 95 ⁰C 50 seconds
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60 ⁰C 50 seconds
68 ⁰C 1 minute/kb of plasmid
2. Add 1 μl of Dpn I restriction enzyme (10 U/μl) directly to each amplification reaction 
below the mineral oil overlay using a small, pointed pipet tip.
3. Gently and thoroughly mix each reaction mixture by pipetting the solution up and 
down several times. Spin down the reaction mixtures in a microcentrifuge for 1 
minute and immediately incubate each reaction at 37°C for 2 hours to digest the 
parental (i.e., the nonmutated) supercoiled dsDNA.
4. Transform the reaction into E. coli and select on screening agar plate with 
appropriate antibiotic for the plasmid vector. 
A11. Site-Directed Mutagenesis (Quikchange Multisite Directed 
Mutagenesis Kit, Stratagene)
1. Prepare the mutant strand synthesis reactions for thermal cycling as indicated below. 




2.5 μl 10× QuikChange® Multi reaction buffer
X μl double-distilled H20 to a final volume of 25 μl
X μl ds-DNA template (50 ng)
X μl mutagenic primers (If using 1–3 primers, add 100 ng of
each primer. If using 4–5 primers, add 50 ng of each primer.)
1 μl dNTP mix
1 μl QuikChange® Multi enzyme blend
Templates >5 kb
2. Cycle the reactions using the cycling parameters outlined in the table below.
157
Segment Number of cycles Temperature Duration
1 1 95 ⁰C 1 minute
2 30 95 ⁰C 1 minute
55 ⁰C 1 minute
65 ⁰C 2 minute/kb of plasmid
3. Add 1 μl of Dpn I restriction enzyme (10 U/μl) directly to each amplification reaction 
below the mineral oil overlay using a small, pointed pipet tip.
4. Gently and thoroughly mix each reaction mixture by pipetting the solution up and 
down several times. Spin down the reaction mixtures in a microcentrifuge for 1 
minute, then immediately incubate each reaction at 37°C for 1 hour to digest the 
parental (nonmutated) ds-DNA.
5. Transform the reaction into E. coli and select on screening agar plate with appropriate 
antibiotic for the plasmid vector. 
A12. Gateway Cloning (GatewayLR_clonase Enzyme Mix, 
Invitrogen)
1. Add the following components to a 1.5 ml microcentrifuge tube at room 
temperature and mix: 
Entry clone (50-150 ng) 1-7 µl 
Destination vector (150 ng/µl) 1 µl 
TE buffer, pH 8.0  to 8 µl 
2. Thaw on ice the LR Clonase™ II enzyme mix for about 2 minutes. Vortex the LR 
Clonase™ II enzyme mix briefly twice (2 seconds each time).  
3. To each sample (Step 1, above), add 2 µl of LR Clonase™ II enzyme mix to the 
reaction and mix well by vortexing briefly twice. Microcentrifuge briefly. 
4. Return LR Clonase™ II enzyme mix to -20°C or -80°C storage. 
5. Incubate reactions at 25°C for 1 hour.
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6. Add 1 µl of the Proteinase K solution to each sample to terminate the reaction. 
Vortex briefly. Incubate samples at 37°C for 10 minutes.
7. Transform into E. coli and plate on selective plates.
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Appendix B
Restriction/Digestion Analysis of the Plasmids
The following plasmid maps were constructed using Vector NTI software, Invitrogen. The 
DNA gels were obtained by DNA-gel electrophoresis. Please note that the plasmids 
generated by Gateway Cloning have not been listed here.



























                                            
     
Figure B2 Restriction analysis of pESTKnYFP                                                          
                                                                                                       
  Figure B3 Restriction analysis of pARSkp                                                          































































Figure B4 Restriction analysis of pPCRscriptLip                                                          


































































Figure B6 Restriction analysis of pETLipll                                                          
    






























































  Figure B8 Restriction analysis of pENTRLipll                                                          















rrnB T1 transcription terminator






































Figure B10 Restriction analysis of pllDsbCLipll   
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Figure B12 Restriction analysis of (A) pEHLYAPalB, (B) pEHLYAPalB, (C) 
p5´3´UTRPalB. The DNA sequences of these plasmids were not available for 
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